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ABSTRACT.
The work described in this thesis has been divided 
into three sections, INTRODUCTION (section one), RESULTS 
AND DISCUSSION (section two) and EXPERIMENTAL (section 
three).
Section one, CHAPTER ONE, gives a brief discussion of 
the methods of peptide synthesis that have been used for 
the synthesis of the target compounds described in the 
EXPERIMENTAL section. In addition, solid phase peptide 
synthesis is also briefly discussed, as are the recent 
developments in peptide bond formation. The coverage is not 
comprehensive and the reader is referred to the appropriate 
references as indicated in the text.
Subsequent chapters, CHAPTERS TWO-SIX, in section one 
discuss the various methods that have been used for 
enantiomeric separation, their mechanism and application. 
The chapters are broadly divided between the two methods, 
indirect and direct method, the latter describing the 
various modes that can be used to achieved such 
separations. The coverage is more comprehensive in order to 
give a detailed insight into this increasingly important 
area of analytical chemistry. In addition, computer 
assisted molecular modelling is discussed briefly.
Section two, CHAPTER SEVEN describes the convergent 
routes that were used for the synthesis of the cyclic 
peptides, and also an alternative for the synthesis of
-III-
unsaturated glycine derivatives. CHAPTER EIGHT and WINE 
describes the synthesis of the cyclic peptides and their 
functionalisation to silicon centres briefly, the mechanism 
of reaction, their identification and characterisation 
using a variety of methods. Modification of silica gel with 
the silicon functionalised cyclic peptides is also 
described. CHAPTER TEN describes the evaluation of the 
modified silica gel, described in CHAPTER NINE, using high 
performance liquid chromatography. Chromatograms of the 
actual separations observed are included.
Section three, CHAPTER ELEVEN describes in detail the 
synthetic procedure for each compound, together with 
characterisation data for that compound.
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For many reasons there is an ever increasing need to 
separate racemic mixtures into their components, and there 
has in recent years been an explosive increase in the use 
of high performance liquid chromatography (HPLC) and chiral 
stationary phases (CSP) to perform such tasks, especially 
in the fine chemicals and pharmaceuticals industries.
In 1970, Losse et al1 described the state of 
chromatographic resolutions of racemates as follows:- "The 
survey shows that reliably reproducible separation effects 
can now be demonstrated on many asymmetric carriers and 
phases."
From 1975-1990 the use of many different CSPs for 
enantiomeric separation was recorded in the literature. 
Many, however, require that the analyte be derivatised in 
order to achieve or enhance separation of the enantiomers, 
and many recent articles have updated the recent 
developments that have sought to overcome this drawback to 
the method.^
Alternatively in order to avoid the separation problem 
entirely, an asymmetric synthesis, in which prochiral 
groupings are converted to chiral groups, can be employed 
in order to prepare a specific enantiomer. Practical 
asymmetric syntheses are of two types. The majority involve 
addition to some unsaturated grouping and the selection of
-1-
enantiotopic or diastereotopic faces, to give a single 
enantiomer or a pair of diastereomers. Less common, is the 
selective substitution or modification of paired ligands at 
a prochiral centre.®"*® In 1974 Eliel** established three 
guidelines for an effective asymmetric synthesis:-
a) it must lead to the desired enantiomer in high 
optical, as well as chemical, yield;
b) the chiral product must be readily separable from 
the chiral auxiliary reagent needed in the synthesis;
c) unless the chiral reagent is very much less 
expensive than the desired product, it must be possible to 
recover the auxiliary reagent in good yield and in 
undiminished purity.
If the chiral reagent is a catalyst capable of functioning 
efficiently at a low catalyst/substrate ratio, ie turnover 
is high, recovery of the reagent might be unnecessary.
Although many asymmetric syntheses are being 
achieved, practical difficulties, and economic 
considerations are likely to ensure that even on a 
preparative scale, the use of direct HPLC methods for the 
resolution of racemic mixtures will continue unabated. But, 
in particular the pressure on developmental chemists in 
the fine chemical and pharmaceutical industries, to 
demonstrate the absence of a biologically undesirable 
enantiomer in an optically active product, will ensure 
improvements in the analytical applications of the 
technique. The consequences of failure in this area can be 
severe as was unforgettably demonstrated by the thalidomide
-2-
1?tragedy.11
The aim of this project was to synthesise small 
functionalised cyclic peptides, which could be chemically 
bonded to a variety of silicon centres, including silica 
and siloxanes, so permitting their evaluation for 
enantiomeric separations. The advantage of such an approach 
lies in the fact that it is entirely feasible to 
"construct" a cyclic peptide that is stereoselective when 
used in such a manner. If necessary, the "construction" can 
be performed using computer assisted molecular modelling 
techniques (CAMM) to generate possible host-guest docking 
shapes on the basis of preferred conformation and 
optimisation of hydrogen bonding and other electrostatic 
forces between the peptide and a specific guest enantiomer. 
Appropriate modification of the cyclic peptide can then be 
made, after experimental assessment, with a view to 
improving the binding. The molecular modelling, peptide 
modification, selective retention cycle should allow 
optimisation for a given host-guest complex and in the 
longer term, should lead to predictions concerning suitable 
hosts for specific substrate types.
-3-
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This chapter contains a summary of the important 
methods used for peptide bond formation in solution. The 
coverage cannot be comprehensive and more specific details 
are available in the texts noted in reference 1. In 
addition solid phase peptide synthesis is dealt with 
briefly. The methods that will be considered are:-
2.2.1 The acid chloride method
2.2.2 The acid aside method
2.2.3 Anhydride method
2.2.4 Active ester method
2.2.5 Coupling reagents
2.2.6 Enzyme catalysed bond formation
2.3 Solid phase peptide synthesis
In order to promote the formation of an amide bond, it 
is necessary to activate the carbon atom of the carbonyl 
group with an electron withdrawing substituent, X, so that 
its electrophilicity is enhanced towards nucleophilic 
attack by the amino group (Fig 2.1). This may be achieved 
in several ways as described in the following sections.
-6-
COOH ... *1— 1— X
Activation
r ♦ HX
Co u p IInf
Pig 2.1
2.2 Peptide Bond Formation In Solution.
2.2.1 The acid chloride method.
The chlorine atom is an obvious and well established 
choice for activating the carbon atom of the 
carbonyl group. Yet amino acid chlorides were used only 
infrequently for peptide synthesis in the early part of 
this century.* Initially, the carbonyl group of the 
protected amino acid was converted to the chloride by 
treatment at room temperature with phosphorus pentachloride 
(Fig 2.2). However, the phosphorus oxychloride so formed is
V-NH-CHR-COOH ♦ PClg — *> Y-NH-CHR-S-Ct * HC! * PQClg
Fig 2.2
-7-
difficult to remove from the product, and consequently 
thionyl chloride was soon preferred (Fig 2.3). Once formed,
R-COOH «■ S0CL2 R-C-Cl ♦ S02 ♦ HC1
Fig 2.3
these acid chlorides may be subject to intramolecular 
attack on the acid chloride group by a weak, but 
favourably placed nucleophile within the carbonyl 
component. This occurs in alkoxycarbonyl blocking groups, 
such as benzyloxycarbonyl amino acid chlorides (Fig 2.4),
s
Fig 2.4
/ HR— C-C 1
S - o
giving rise to N-carboxyanhydrides (Leuchs anhydrides).^ 
Although these derivatives are suitable for acylations, 
they cannot be used when a well defined sequence is 
required. Intramolecular nucleophilic attack in acyl amino 
acid chlorides, yielding oxazolones/azalactones,* can also 
occur, and are often implicated in racemisation (Fig 2.5). 
Attempts to revive the acid chloride method using, for
-8-
example oxalyl chloride® or N,N-dimethylformamidium 
chloride® (from dimethylformamide and phosgene) have met 
with little success.
W
u , v °
o ♦ HC1v
Fig 2.5
2.2.2 The acid azide method.
The only contemporary, viable alternative to the acid 
chloride method was the acid azide method originated by 
Curtius. It remains a widely used method, the chief 
attraction being the resistance of the azide activated 
peptide derivatives to racemisation. The azides are formed 
from hydrazides, which in turn are formed from 
hydrazinolysis of alkyl esters, using nitrous acid (Fig
2.6). In a useful modification of the Curtius method
0
hydrazides are converted to azides using alkyl nitrite, 
under anhydrous conditions, thus avoiding some side 
reactions. A further improvement was introduced by Shiori
R^ *0CH3 - ^ 0 *
Fig 2.6
-9-
et al,* whereby a free carbonyl group can be directly 
converted to the aside using diphenylphosphorylaside (Fig
2.7). However, none of these modifications circumvent the 
main shortcoming of the aside method, which involves the 





rearrangement^ (Fig 2.8). The isocyanates can react with 
the amine component to produce urea derivatives (Fig 2.9), 
which, since they resemble the desired peptide, can only be
8
-C-N=N=N R-N=C=0 * N;
Fig 2.8
Rl-N=C=0 ♦ HgN-R2 » R^ -NH-CO-NH-R2
Fig 2.9
-10-
removed with considerable difficulty. This side reaction 
can be minimised if low temperatures and high 
concentrations of reactants are used.
2.2.3 Anhydride method.
Perhaps the simplest and most efficient method of 
acylation is to treat amines (or other nucleophiles) with 
carboxylic anhydrides. However, the anhydride method 
remained unexploited for several decades, the chief reason 
being the wastefulness of the method (Fig 2.10). However, 
more recently, protected amino acids are being prepared 
with increasing facility and decreasing cost, and their 
anhydrides are more often used. An infrequently used,
1-1-0-S-R ♦  • R-CO-NH-R1 ¥ RCOOH
Fig 2.10
but novel approach to the synthesis of symmetrical 
anhydrides involves reaction of the acid with phosgene1* 
(Fig 2.11).
Unsymmetrical/mixed anhydrides are more widely used in 
peptide synthesis and the intermediates are constructed 
such that the blocked amino acid is the sole acylating 
moiety, while the acid playing the role of "activator" is 
eliminated. Originally acetic acid and benzoic acid were 
used as "activators", but the electrophilic character of 
the two carbonyl groups was not sufficiently pronounced to
-11-
2RCOOH ♦ C0C12 L U
n J - o J - R  ♦ C02 
Fig 2.11
ensure unambiguous nucleophilic attack from the amino 
component. Vaughan and Osato^ introduced the use of long 
chain fatty acids, such as isovaleric acid, to act as the 
activator, so that the "activating" carbonyl function 
becomes both electronically and sterically less 
electrophilic, (Fig 2.12). Nucleophilic attack by the 
amine component will therefore occur mainly at the carbonyl
f ♦ ClXR - C O O  - C - C H 2 C H ( C H 3 )2
R - C - 0 - C - C H 2 C H < C H 3 )2 ♦ Cl
R - C O - N H - R  * <CH3 )2 C H C H 2 C 0 0H 
Fig 2.12
-12-
group of the protected amino acid, and usually the second 
acylation product, an isovalerylamide is produced in very 
small, often negligible, amounts. An enhancement of this 
steric-electronic effect can be achieved using 
trimethylacetic acid (pivalic acid) mixed anhydrides.^
The introduction of alkyl chlorocarbonates or 
chloroformates marked an important development of the mixed 
anhydride method (Fig 2.13). The use first of ethylcarbonic 
acid mixed anhydrides, and latterly, isobutyl carbonic 
acid mixed anhydrides, quickly gained wide acceptance in
t 1 - C O O "  *  C 1- I - 0 R 2  - - - - - - - *  f ^ - C - O - f - O R 2  ♦  C l '
Fig 2.13
peptide synthesis, as the products of acylation are carbon 
dioxide and an alcohol, both of with can be easily removed 
from the product (Fig 2.14). In general,this procedure 
produces a small amount of the second acylation product, a
0CHoCH<CH3>£ ♦ HgN-ft2
Rl-C0-NH-R2 ♦ C02 ♦ <CH3 >2 CHCH2 0H
Fig 2.14
-13-
urethane, a complication not possible with symmetrical 
anhydrides, but the advantages of the method have led to 
its wide acceptance.
2.2.4 Active ester method.
By using active esters the ambiguity of two carbonyl 
groups, via coupling mixed anhydrides is avoided, as there 
is only one electrophilic centre available for acylation. 
Simple alkyl esters have only modest reactivity. However 
their reactivity is increased by C-substitution with 
strongly electron withdrawing groups, such as the cyano- 
group. Activated alkyl esters have been used for peptide 
synthesis,but satisfactory rates of reaction were only 
observed when the reactants were in a high concentration, 
so limiting the synthesis to dipeptides and short chain 
peptides. The use of aryl esters broadened the 
applicability of the method, as demonstrated by Bodansky, 
in reactions involving p-nitrophenyl esters and o- 
nitrophenyl esters. The latter, which is highly activated 
shows little dependence on the nature of the solvent. The 
former is most active in highly polar media, such as DMF 
and DMSO. Despite this solvent dependency, the para- 
derivatives are widely used, due mainly to the ease with 
which the derivatives crystallise. In addition, the 
introduction of the catalyst, 1-hydroxybenzotriazle 
(HOBt),^ reduced the differences in reactivity between the 
two reagents, due to the formation of a ternary complex 
between the active ester and the catalyst (Fig 2.15).
-14-
Esters of HOBt are very potent acylating agents, probably 
due to anchimeric assistance^' ^ (Fig 2.16). Similar 
catalytic affects are observed with other N-hydroxy 
compounds, such as N-hydroxypiperidine
R2
X J .  R* i 9R Rl-C0-NH-R2








The developing interest in the synthesis of 
biologically active peptides, such as oxytocin, stimulated 
studies on esters of even higher activity. Thus N- 
hydroxysuccinimide^ has proved popular for use in peptide 
synthesis (Fig 2.17), but its use has drawbacks^ as the 
succinimide carbonyl group is susceptible to nucleophilic
-15-
attack. Nevertheless, the side product, N- 
hydroxysuccinimide, can be readily removed by extraction 
with water, and the reagent remains an attractive one.
Pig 2.17
For the preparation of amino acid polymers, 
pentachlorophenyl esters are recommended.** However, the 
bulkiness of the activating group may outweigh the high 
degree of activation it provides when steric hinderance is 
a binding factor as in some solid phase peptide syntheses. 
This steric problem may be overcome somewhat by using 




The criteria for coupling reagents are very
stringent:-
1) it should be inert toward the amine component 
(already present during activation),
2) it should not generate a reactive intermediate that 
possess a nucleophilic centre (as this can compete with the 
amine component for the acyl group),
3) it should not cause overactivation which would lead 
to side reactions, and hence by-products.
A great advance in the history of peptide bond 
formation occurred on the introduction of the carbodimide 
coupling reagents,*® of which dicyclohexylcarbodimide (DCCI) 
is especially noteworthy. The coupling reagents can be 
added directly to the reaction mixture of the carbonyl and 
amine component, thus enabling activation and coupling to 
proceed simultaneously. Although amines react with 
carbodimides to give guanidine derivatives,** this reaction 
is too slow to compete significantly with the rapid 
addition of the carbonyl group (Fig 2.19). The N=C group, 
found in the O-acylisoureas formed from the addition of the 
carboxylic acid to the carbodimide, is powerfully 
activated, leading to facile coupling (Fig 2.20).
The use of DCCI has become very popular as it promotes 
a rapid rate of reaction, and allows coupling to be 
achieved in a single operation. However, it has the 
disadvantage of generating the by-product dicyclohexylurea 
(DCU), which has a low, but significant solubility in most 
organic solvents typically used for the reaction. Hence 
this impurity cannot be removed entirely by filtration, and
-17-
Rl-COOH ♦
q _ n_ P _ q
*-f=o




remains a contaminant in the product. The introduction of 
water soluble carbodimides3*' 33 overcomes this problem.
Another coupling reagent, carbonyldiimidazole,3* 
mediates coupling via reactive N-acyl intermediates (Fig 
2.21). Unfortunately the reagent is very sensitive to 
moisture, and is fairly expensive to prepare. The more 
convenient reagents, 1-ethoxycarbonyl-2-ethoxy-l,2- 
dihydroquinoline (EEDQ),33 and the improved version 1- 
isobutyloxycarbony1-2-isobutyloxy-1,2-dihydroquinoline 
(IIDQ),3* readily generate alkyloxycarbonic acid mixed
-18-
♦ HjN-H* -----► . J Q ,
Fig 2.21
anhydrides, offering some advantages in the coupling 
process (Fig 2.22). An important feature of EEDQ and 
IIDQ mediated couplings is the reasonable conservation
of chiral purity. This can be attributed to the lack of 
proton abstraction in EEDQ and IIDQ, and in the reactive 
intermediates. Since quinoline is released during 
activation, no additional base is needed to neutralise the 
HCl formed when mixed anhydrides are prepared via 
chlorocarbonates, and the base is not strong enough to 
cause racemisation by proton abstraction.
*t.J-0-C-0A8 * h2M-** — ♦  nl-CO-HH-R3 ♦ **-0H ♦ C02
Fig 2.22
-19-
Less successful alternatives to DCCI are Bates 
reagents (Pig 2.23),*7 and the benzotriazolyl-N oxytri- 
dimethylamino-phosphonium hexaf luorophosphate (BOP) reagent 
(Pig 2.24).31
C<CHa)a— H»aP*-0— P*CW— <CH3)2]3.2CH3—
Fig 2.23
It is often less demanding, to separate the activation 
and coupling steps, eg., DCCI often gives better results 
when used in activating mode, and the symmetrical 




2.2.6 Enzvme catalysed bond formation.
Peptide bonds are quite resistant to hydrolysis in the 
absence of acid or base, but this reaction is accelerated 
greatly by the presence of proteolytic enzymes. This has 
prompted attempts to use enzymes for the synthesis of, 
rather than the hydrolysis of, peptide b o n d s . A s  enzymes 
act only as catalysts, so accelerating the establishment of
-20-
equilibria, proteolytic enzymes can be used for amide bond 
formation, provided the equilibrium of the reaction is 
appropriate. Thus using papain, a vegetable pepsin, 
anilides of blocked amino acids can be prepared (Pig 2.25).
The anilide, being insoluble in water, precipitates, and 
provides the necessary driving force to shift the 
equilibrium toward synthesis. As the enzyme is specific for 
L-amino acids, the D-isomer in the starting material 
remains unchanged.
General applicability became more feasible on 
the introduction of water miscible organic solvents, such 
as glycerol and acetonitrile,^ which affected the 
dissociation constants of the carboxyl group, in a selected 
pH region, and shifted the equilibria towards synthesis. An 
example is the conversion of porcine insulin to human 
insulin (Fig 2.26).** Removal of aniline from the C-terminus 
of the B-chain by trypsin is fairly selective. The 
desalanino pork insulin is produced in good yield, and then 
subjected to the action of trypsin with a large excess of 




tert-butyl ester affords the human insulin.












There have been some successful attempts to apply 
enzymes to the systematic building of peptide chains, such 
as the artificial sweetener, aspartame,** which could be 
prepared without blocking the p-carbonyl group of aspartic 
acid.
In general, enzymes lead to a great variation in 
coupling rates in reactions, which involve different amino 
acids, and so for the synthesis of various peptide bonds, 
individual optimum condition, and perhaps even the enzyme, 
must be carefully selected. Care must also be taken, under 
which conditions, the new peptide bond is formed due to the
-22-
possibility of hydrolysis of the other peptide bonds formed 
previously. It would appear that enzyme catalysed is 
synthesis will play a major role in the preparation of 
certain selected target compounds, but it is unlikely to 
replace conventional methods of synthesis in general 
peptide chemistry.
2.2.7 A comparison of the coupling methods.
The moderate stability of the reactive intermediate of 
the azide (sec 2.2.2), and of the symmetrical and mixed 
anhydrides (sec 2.2.3) is a common feature of both these 
methods. The intermediates, which can be isolated, cannot 
be stored for long periods of time. Azides slowly undergo 
Curtius re-arrangement, and mixed anhydrides 
disproportionate to symmetrical anhydrides, which even then 
have limited shelf life. Active esters (sec 2.2.4) are 
different in this respect, in that they can be isolated, 
and stored in a refrigerator, but this stability is offset 
by only moderate reactivity.
Hence the use of coupling reagents (sec 2.2.5) is 
frequently preferred, due to simplicity of use. There are 
some 40 different coupling reagents so far proposed in the 
literature, and yet most of them generate well known 
intermediates such as anhydrides or active esters. There is 
no doubt a bias towards one pot synthesis, but there is a 
price to be paid for such simplification in terms of 
purity, yield, and loss of chiral activity.
The use of active esters** as reactive intermediates
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has advantages as the activation and coupling stages are 
separate, and the relative stability of protected, and 
activated amino acids allows them to be scrutinised before 
coupling. Bodansky advocated the use of active esters** in 
which the peptide chain is lengthened in a stepwise 
fashion. The condensation of peptide segments is perhaps 
best when coupling reagents are used, DCCI being the 
foremost among them, especially when used with axillary 
nucleophiles, such as HOBt.^'^ Good results can also be 
achieved in segment condensations with EEDQ and IIDQ. The 
use of proteolytic enzymes (sec 2.2.6) to catalyse 
syntheses of peptides holds great promise for the future.
2.2.8 Recent developments in peptide bond formation.
Complexes of amino acid chlorides with Pt(II) and 
Pd(II) have been prepared by Steiner et al.** Treatment of 
the corresponding amino acid complexes with a trialkylsilyl 
chloride gives CljHCNHj.CHR* .CC^SiRj^ which can be converted 
to Cl2M(NH2 . CHR * . COCl / by reaction with COClj. These can 
then be use to acylate amino acid esters and afford metal 
complexes of dipeptides esters.
Reactive esters derived from 2-chloro-4,6-dimethoxy- 
1,3,5-triazine have been of interest,*^ because of the weak 
basic properties of the reagent and by-products, which 
facilitate removal by washing with acid. Peptide synthesis 
is also claimed to proceed in good yield and without 
racemisation. Koga and Saski** reported the application of 
thiol esters to peptide bond formation, the key
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intermediate being a chiral crown ether having two thiol 
groups (Fig 2.27) The crown ether acts as a ligand for the
< r y ,i > Y cH2<ocH2cH2 >''8H





0 = c — CHR1 —ZNHCHR
ZNHCHR 1=0ZNHCHR1CHNHCHR^Cs=Q
Fig 2.27. a) *NH3-CHR1-C02Np, pH 5.0; b) ClCOjBzl; c) *HHj- 
CHR^COjNp.
NHj+-group of a 4-nitrophenyl amino acid ester salt. Peptide 
bond formation takes place in the presence of base to give 
a monothiol ester of a Z-dipeptide. Unfortunately,
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racemisation is high, and appears to be dependant on 
structure. However this method is of interest, because 
chain propagation is in the natural direction rather than 
from the N-terminus.
Benoiton et al^ have reported that mixed anhydrides of 
t-Boc, Z- and Fmoc-amino acids derived from ClCO.OCHMeg are 
fairly stable, and undergo aminolysis with less 
racemisation than related anhydrides. Reaction between 
sterically hindered benzimino chlorides and IT-protected 
amino acids give N-acylamides. The latter afford 
stereochemically pure peptide derivatives in reasonable 
yields (Pig 2.28),**
u
•ooNH-CM*l- C 0 W h C 0— x y
XaH02 , Cl 
Y«H, Cl
•OOMH-CHX1CONH-CH«*-COR8 
Pig 2.28. i) Boc-HH-CHRl-C02H; ii) NH2-CHR2-COR3
Galpin et al*3 have reported the synthesis of fragments 
of vasoactive intestinal peptide (VIP), using 
diphenylphosphinic chloride to form mixed anhydrides. 
Yields of the stereochemical ly pure peptides of N- 
methyl amino acids were good, when the amino group 
was protected as a urethane derivative.
Nemoto et al*° describe the development of a new acyl
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anion equivalent, a hydroxymalonitrile (I)# for the 
preparation of "masked active esters", and their use to 
prepare a dipeptide. The general strategy is illustrated 
in Fig 2.29. Reaction of (I) with an electrophile gives 
(III), which can undergo elimination of R, and a cyano 
group, to produce (II). After demonstrating that (I) showed 
similar reactivity to active methylene compounds, by 
reaction with 1-iodoundecane, Nemoto et al^ synthesised a 





Fig 2.29. Strategy via a masked activated ester; R= 
CfyCHj-O-CHjCHj, SiMejBu1
2.3 Solid Phase Peptide Synthesis.
Using conventional methods, peptide synthesis is often 
a formidable task, involving the introduction of blocking 
groups, coupling, deprotection, isolation, and
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purification. Hence, the synthesis of peptides containing 
many residues requires considerable effort by conventional 
synthesis. The need to automate the process was apparent.
Pig 2.30. Synthesis of a dipeptide; R^-CHjCHj-O-CHjCHj,
H; R2=H, -CHjOCHj.
in view of the repetitive nature of chain lengthening using 
active esters.** This was first realised by Merrifield*2 in 
the synthesis of a tetrapeptide L-leucyl-L-alanyl-glycyl-L- 
valine. The Merrifield resin, an insoluble support, 
obtained from the chloromethylation of a styrene- 
divinylbenzene co-polymer, was developed for this purpose, 
and remains one of the mainstay of solid phase peptide 
synthesis (SPPS). The advantages of SPPS is the ease with 
which the intermediates are obtained free from starting 
materials, reagents, and most by-products. These can be 
separated from the desired intermediate,which remains 





The chloromethyl group is allowed to react with the 
carboxyl ate form of a protected amino acid (Fig 2.31) to be
benzyloxycarbonyl group with hydrobromic acid gave the 
aminoacyl resin, which could then be acylated with the next 
amino acid required in the sequence. However, removal of 
the benzyloxycarbonyl group under these condition was not 
entirely selective, and in each de-protection step part of 
the amino acid or peptide was cleaved from the support and 
lost. Initially this was circumvented by nitration of the 
polymer/ since nitrobenzyl esters are quite resistant to 
acidolysis. A further advancement came with the 
introduction of the use of tert-butyloxycarbonyl group 
(Boc),^ since this group can be cleaved with dilute HCl in 
acetic acid or with a mixture of TFA in dichloromethane 
(Fig 2.32). Neutralisation of the amine salt with a 
tertiary amine gave the free amine, which could then be 
acylated with the next required amino acid residue, 
protected by a Boc group. In the initial studies by 
Merrifield, DCCI was used as the coupling agent, excess of 
which was removed, together with the DCU formed, by 
washing with dichloromethane (Fig 2.33). This cycle of
OLYMER
Fig 2.31
anchored via an ester bond. Removal of the
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<CHi >8C-0-C0-HH-CHR-C0-O-CH2- — P O L m R
fOLYHER
Pig 2.32
C l" .  Hall*-CHRl -C 0 -O -C H f- ^ ^ -# O L  VHE*
LcgHj),
H jR -C H R -C O -O -C H ^-^^-fO LY llC R
•oo-MH-CHl^COW
<CHS>SC-I-C0-NM-CM*8 -C0-HM-CHR1- C 0 - 0 - C H 2 - ^ ^ —FOLYHER 
Pig 2.33
deprotection, neutralisation, and acylation is repeated 
until the desired peptide is achieved, at which point the 
peptide is cleaved from the support with acid, such as 
hydrogen bromide in TFA or hydrogen tluoride. (Pig 2.34).
HX
1 -HH-CHRl-C00H ♦ K-CH2— ^ ^ - F O L Y H E R
Pig 2.34
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2.3.1 Recent development in solid phase peptide synthesis.
Ajayaghosh et al^ describe a convenient method for the 
SPPS of C-terminal peptide N-alkylamides using a 
photolytically detachable {[3-nitro-4-({alkyl}methyl)- 
benzamido)methyl]}polystyrene support (Fig 2.35). The 
method involves incorporation of an alkylamine moiety into 
the polystyrene resin, on which the peptides are assembled 
and subsequently cleaved, by photolysis, in the form of the 
peptide N-alkylamides. The N-alkylamino group acts as an 
anchoring function for the peptide as well as a latent 
function for the C-terminal modification of the attached 
peptide. The applicability of the method was demonstrated 
by the synthesis of N-alkylamides (70-77% yields), and 
analogues of the luteinizing-releasing hormone in 48-56% 
yield.
Fig 2.35. R=CHj, CjHj.
Albericio et al^ describe the preparation and 
application of 5-[4-(9-fluorenylmethoxycarbonyl)amino- 
methyl-3,5-dimethoxyphenoxy]-valeric acid (PAL) (Fig 2.36) 
for the SPPS for C-terminal peptide amides under mild 
condition. The methodology was demonstrated by syntheses of 
over a hundred peptides, among which acyl carrier protein 




releasing hormone, adipokinetic hormone, PHI porcine 
fragment (18-27), and human gastrin-I are highlighted. In 
comparative studies, yields and purities of peptide amides 
prepared with PAL were found to be equivalent or superior 
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THE HEED FOR ENAHTIOHERIC SEPARATIONS*
3.1 Introduction.
The fundamental concepts of stereochemical optical 
activity were set forth by Jean-Baptiste Biot1 in 1815 and 
Louis Pasteur* in 1848, and it is to Pasteur that credit is 
often given for the first resolution of enantiomers from a 
racemate by manually separating the non-identical crystals 
of the sodium salt of tartaric acid (Fig 3.1). These 
concepts were subsequently included in the general theory
HOOC COOH HOOC COOK
A  A
(+) R,R Tartaric acid (-) R,S Tartaric acid
Fig 3.1. Eanantiomers of tartaric acid; R,S, also known as 
meso tartaric acid.
of organic structure in three dimensions by Le Bel3 and 
Van't Hoff.4 The former postulated a square pyramidal 
arrangement of substituents around a apical carbon atom, 
whereas Van't Hoff correctly postulated a tetrahedral
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arrangement around a central carbon atom. In one of his 
lectures before the Council of the Soci6t€ Chimique de 
Paris reporting on what is now considered an epochal 
discovery, Pasteur said, "Host natural organic products, 
the essential products of life, are asymmetric and possess 
such asymmetry that they are not superimposable on their
images  Thus we find introduced into physiological
principles and investigations the idea of this influence of 
the molecular asymmetry of natural organic products of 
great character which establishes perhaps the only well 
marked line of demarcation that can at present be drawn 
between the chemistry of dead matter and the chemistry of 
living matter."* It was, however, soon found that the 
challenge of separating a racemic mixture into its 
enantiomers often presented difficulties of greater 
magnitude than the development of a stereospecific 
synthesis, and as a result, efforts to resolve racemic 
mixtures were initially very spasmodic. Only very rarely 
was a successful separation achieved, and then it was often 
treated as "lucky" or as a result of a tedious process of 
trial and error, and a systematic approach to the problem 
was not regarded as being feasible in these early days.
Consequently the technical feasibility of a synthesis 
was regarded as of greatest importance amongst scientist 
working on the development of a new drug, and the question 
of the biological effects, be they desired or undesired, of 
different stereomchemical forms of the drug molecule were 
often secondary. Without the availability of chiral high
-38-
performance liquid chromatography (HPLC), drug trials were 
often performed using the racemic mixture rather than the 
enantiomerically pure drug. The thalidomode tradegy
referred to below provides a sad reminder of the
consequences of ignoring such considerations.
3.2 Questions Of Clinical Efficacy And Safety.
Enantiomeric molecules only differ in behaviour if the 
property being investigated also has a characteristic 
"handedness". For example, enantiomers do not differ in 
melting point because there is no chirality in the
molecular vibrations which increase with increasing 
temperature, causing the solid to melt. However, the 
rotation of polarised light does have a specific 
"handedness" and the enantiomeric molecules thus behave 
differently with respect to this property. Similarly 
reaction with a chiral substrate (eg, an enzyme or a chiral 
HPLC stationary phase) is a process with a "handedness" 
leading to diastereomeric combinations which differ in 
properties. All resolutions rely on such differences, even 
when the diastereomers are only transient in their 
existence, as in the case of chiral HPLC.
In a physiological environment, ie.,in vivo, which is 
inherently chiral, a molecule of a drug must interact with 
enzymes, receptors, etc, all of which are asymmetric at the 
molecular level. Thus enantiomeric molecules would be 
expected to behave differently under such conditions, but
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the differences in physiological effect between enantiomers 
cannot be predicted.
Thalidomide was not marketed in the USA, but was in 
Europe. There was no apparent consideration between its 
biological activity and stereochemistry.* Despite the fact 
that it was claimed to be non-toxic, it was found to be 
both neurotoxic (causing peripheral neuritis) and 
teratogenic (causing foetal abnormalities, especially a 
birth defect, phocomelia, in which the hand or feet started 
immediately from the shoulder or hip). As a result of the 
tragedy, research was stimulated into this problem.
A stereospecific synthesis for thalidomide was 
ultimately developed,7-9 but initial developmental work was 
done without the technological tool of chiral HPLC. The 
racemate was synthesised, at the time of its initial use, 
in Germany,*® but a resolution of the racemate into its 
enantiomers does not seem to have been described in the 
open literature. The results of the investigations on the 
safety and efficacy of the stereoisomers of thalidomide 
suggests that the enantiomers differ significantly in their 
biological activity. This has led to the conclusion that 
the teratogenic effects are found in only one enantiomer.
A stereospecific synthesis for thalidomide, starting 
form glutamic acid or its derivatives7-9 is available. The 
absolute configuration of the chiral centre is always 
known, as the reaction sequence does not involve reaction 
at the chiral centre. Dextrorotatory thalidomide has the D 
configuration9 corresponding to the R configuration (Fig
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3.2) using the Cahn-Ingold-Prelog** nomenclature. A crystal
12structure has been reported on racemic thalidomide14 as well
13as its 4-bromo derivative. The racemate has also been 
resolved by HPLC.**
Fig 3.2. (H)-Thalidomide
The earliest report into the teratogenic effects of 
thalidomide^ at an oral dosage of 150mg/kg from day 7-12 
inclusive in New Zealand white rabbits, showed no 
difference in teratogenic action. The same report also 
claims that the LD q^ in SAS ICI albino mice was greater by 
a factor of approximately twenty times for the racemate 
relative to the pure stereoisomer. However, a later study^ 
showed that the teratogenic activity to be concentrated in 
the S(-)-isomer. This study, however, used SWS mice and 
Natal rats, rather than New Zealand white rabbits, which 
are known to be more sensitive to such effects as well as 
intraperitoneal instead of oral-administration. The effects 
of thalidomide on graft versus host reaction in chick 
embryos showed that S(-) and the racemic thalidomide had a 
significant immunosuppressant action which the R(+) did
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not.17 The most indicative evidence of the teratogenic 
action being restricted to S(-)-thalidomide comes from 
studies of its hydrolysis p r o d u c t s b u t  this conclusion 
should be accepted with caution as the mechanism of action 
remains uncertain. An article by Sumoyi,23 reviewing an 
earlier study by Pabro et al,*3 noted that the ratio of 
malformed to normal foetuses was less than half that found 
for the racemate. The implication is that the pure 
stereoisomers are mutually synergistic with respect to both 
toxicity and teratogenicity.
However, none of the studies have succeeded in 
answering the questions unambiguously and the definitive 
experiment has yet to be done. The investigations seem to 
have focused on the stereochemical aspects of the hypnotic 
and teratogenic effects of thalidomide and neglected its 
neurotoxicity, also an undesirable side-effect. To assume 
that the desirable and undesirable action must be separable 
between the enantiomers may be an over simplification and 
yet it is necessary to test such a hypothesis using pure 
enantiomers in order that the necessary experiments are 
performed.
In the light of the thalidomide tragedy, the US Food, 
Drug and Cosmetic Act was revised, leading to the 
establishment of the FDA's authority for evaluating the 
effectiveness of drugs and applications for investigational 
studies. Unfortunately routine resolution of racemates was 
not, at the time, feasible and the Kehauver-Harris 
Amendments of 1962 contained no requirement as to the
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effectiveness of a racemic drug to be evaluated relative to 
the pure stereoisomers.
3.3 Questions Of Pharmacokinetics.
Within a body, a drug exists in a chiral environment 
where its release, absorption, transport, action, 
degradation and elimination may involve interactions with 
enzymes, cell surfaces, receptor sites etc. This means that 
the two enantiomers should be acted upon differently by the 
body. These differences between enantiomers are not limited 
to pharmacological effects and it has been demonstrated 
that pharmacokinetic models for the racemic drugs are 
invalid when assuming a single substrate.
The family of non-steroidal anti-inflammatory drugs 
(NSAIDs), approved for marketing in the USA are racemic 
mixtures, except naproxen and its sodium salt. The 
enantiomers of 2-arylpropionic acids show stereoselectivity 
in their disposition kinetics,**'** and in addition, metabolic 
inversion of the JR enantiomer to the S form has been 
demonstrated for many members of this family, tiaprofenic 
acid being the exception.**
Benoxprofen was withdrawn from the market in 1982 when 
differences in pharmacokinetic behaviour of the enantiomers 
was discovered. It also exhibited inversion from its R(-) 
to its S(-) enantiomer following oral administration in 
humans,*® which later studies in vitro, indicated to occur 
as the drug passes through the intestinal wall.** The
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possibility that the effect of the conversion leading to 
hepatotoxicity due to the decreased rate of metabolism and 
excretion in the elderly, must be considered as a 
contributory factor in its withdrawal from the market.*®'**
Diisopyramide also shows stereoselective 
pharmacokinetics, its binding to plasma protein being both 
stereoselective and concentration dependant.** This 
combination of kinetic factors leads to data which are 
unexplainable by a model that assumes the drug to be a
single component, an assumption which appears to be common 
practice. In at least one case the enantiomeric ratio has
been varied to improve its therapeutic effect.** The
enantiomers of indeterminate, a long-acting, high-ceiling 
diuretic, both have uricosuric activity, the (-) enantiomer 
also being a potent natiurectic agent. A balance between 
the two natiuretic and uricosuric effects was found for a 
4:1 ratio of (+):(-) enantiomers.
The implication is that knowledge of the behaviour of 
the pure diastereomers can come about through the
understanding of the pharmacokinetics of a racemic drug. 
Given sufficient data about the kinetic behaviour of both 
enantiomers as well as the racemate, it is tempting to 
speculate upon the extent to which its pharmacokinetics 
might vary by using the partially rather than the fully 
resolved drug.
Improving therapeutic efficacy by using a combination 
of drugs is not unusual, and FDA regulations require that:- 
"each component makes a contribution to the claimed effect
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and the dosage of each component is such that the 
combination is safe and effective."
3.4 Investigations Of Pure Enantiomers.
The design of a clinical study, comparing efficacy of 
one drug with another, is required to be adequate and well 
controlled, such that the study uses a design that permits 
a valid comparison, with a control, to provide a 
quantitative assessment of drug effect. The control drug, 
in order for the comparison to be valid, should be 
administered in a clinically effective dose and regimen, 
but it must also be at a similar dose level and have
similar stereochemical composition. Clearly then, comparing 
the biological effect of a pure stereoisomer with the 
racemate at the same dose level does not meet this
condition.
Consider the case where two enantiomers R and S are to
be compared to the racemate RS. If all three were
administered at the same dosage in mg/kg, the experimental 
design, although simple, would be uninformative. If 
however, both R and S are equal in effectiveness and any 
synergistic effects are lacking, then an identical response 
is expected, irrespective of whether R, S or RS was 
administered, but an unequal response does not lead to an 
unambiguous conclusion. The conclusion that the biological 
effect is stereochemically dependant, as a result of a 
greater effect from R or S over RS, is only correct if a
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linear dose-effect relationship is shown and the other 
enantiomer is totally lacking in activity.
The R and S isomer should be considered with RS at the 
same level as well as twice the dose (RSX2), as the 
racemate is in a 50:50 composite mixture of the two 
potentially active substances. Each enantiomer at RSX2 is 
thus present at the same dose level as the enantiomerically 
pure drug and differences can then be attributed to the 
presence of the other enantiomer. Different results between 
R versus RSX2 and S versus RSX 2 could lead to the 
conclusion that one of the enantiomers is a stereoisomeric 
ballast with respect to efficacy or adverse effects. On the 
basis of such evidence, development of the racemic drug for 
marketing could not necessarily be excluded, unless an 
economical stereospecific synthesis was feasible, then the 
development of the effective enantiomer could be the more 
preferable option on the basis of efficacy and safety.
If however, both R and S possessed desirable 
biological activity to the same degree, the RSX2 experiment 
would show a greater effect, but not necessarily twice as 
great, as the dose-level would be doubled that of R, S or 
RS, and providing similar results from studies of toxicity 
and other undesired effects, then the stereochemically pure 
drug can be said to have no advantage over the racemate 
with respect to efficacy and safety. Hence it may be 
possible to eventually market the racemate using the 
argument that each enantiomer is optically pure!
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In the past few years there has been a dramatic 
increase in attempts to use liquid chromatographic (LC) 
means to resolve non-specific stereochemical problems. The 
extent to which the use of advanced-level LC apparatus has 
become routine augurs well for the general acceptance of 
this rapid, inexpensive and operationally simple method for 
determining enantiomer purity, absolute configuration, or 
actually separating useful quantities of stereoisomers.
Improved stereochemical methodology has accompanied 
the wide acceptance of the technique,consequently it is 
now possible to assess enantiomeric purity accurately for 
many compounds using analytical high-pressure (HPLC) 
chromatography, and in many cases absolute configurations 
have been determined simultaneously, as described in 
several relevant review articles.*"*® Whereas analytical- 
scale technology makes possible the separation of 
stereoisomers in milligram quantities, gram-scale 
separations can be effected on preparative, medium-pressure 
liquid chromatography (MPLC) systems, which can be easily 
automated. Unlike classical separation methods employing 
fractional crystallisation, the entrance of a "first-time*' 
separation is frequently predictable for chromatographic
-50-
methods.
The separation of enantiomers requires the interaction 
of a chiral agent. The agent can take the form of a long­
term derivatisation of a pair of enantiomers with a chiral 
derivatising agent (CDA) to afford chromatographically 
separable diastereomers. This approach requires a discreet 
derivatisation step and is often termed indirect 
resolution. For analytical applications the CDA chosen 
should be of essentially total enantiomeric purity and 
react non-selectively with both substrate enantiomers to 
afford stable diastereomers of sufficient separability for 
the instrument at hand. The cost of the reagent is not 
especially important owing to the small quantities 
required. However, indirect resolution methods are not 
absolute because incomplete enantiomeric purity of the CDA, 
or different rates of derivatisation of the substrate 
enantiomers, or non-identical response of diastereomers can 
adversely influence conclusions regarding substrate 
enantiomeric purity.
For preparative applications, CDAs should afford 
diastereomers from which the substrate can ultimately be 
retrieved. Moreover, the chromatographic separability of 
the diastereomeric derivatives must be greater (owing to 
reduced column efficiency), and the cost of the CDAs also 
becomes a consideration. Different rates of reaction of the 
enantiomers and different detectability of the 
diastereomers is not a serious problem, but the overall 
yield during derivatisation and de-derivatisation should be
-51-
high in order to obtain high enantiomeric purity after 
separation.
Alternatively, separation can be effected via a short­
term interaction of the enantiomers with a chiral agent to 
afford short-lived diastereomeric complexes. This direct 
resolution method utilises a chiral element on a 
chromatographic column itself ie, a column that is packed 
with a chiral stationary phase (CSP). Then the 
diastereomeric complexes will be of non-identical 
stability, and the enantiomers will elute at different 
times. Alternatively a chiral agent may be added to the 
mobile phase, a chiral mobile phase additive (CMPA), with 
the intention that the diastereomeric complexes will differ 
either in stability or in chromatographic behaviour on an 
achiral column. Direct chromatographic resolution methods 
are free from a number of restraints placed on indirect 
methods. In particular direct methods are absolute in the 
sense that no external standard of enantiomeric purity is 
needed to determine accurately the enantiomeric purity of 
a substrate. Chromatography, like nuclear magnetic 
resonance (NMR), gives a weighted time-average view of the 
dynamic process. Therefore, a less than enantiomerical1y 
pure CSP or CMPA affects the position but not the relative 
size of the two bands stemming from the solute enantiomers. 
Reduction of the enantiomeric purity of a CSP or CMPA 
diminishes a (see section 4.4) by increasing kj and kj 
until, at the racemic limit, the two values become 
identical. If a column packed with a CSP of 80%
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enantiomeric purity is used, the column will still function 
effectively, although the observed a-1 values will be ca 
80% of the maximum attainable. From a preparative 
standpoint, direct resolutions may afford higher overall 
yields, because derivatisation and de-derivatisation may be 
unnecessary. However, derivatisation is sometimes employed 
either to enhance detectability or to provide functionality 
necessary for the separation process. Since derivatising 
agents employed are achiral, no significant possibility 
exists for the selective derivatisation of one enantiomer 
and incomplete derivatisation is of little matter for 
analytical applications.
Offsetting the overall advantage of the direct method 
is the fact that commercially available CSP and CMPAs are 
expensive, but a chiral column can be used a great many 
times, thereby compensating for the initial expense or 
difficulty in obtaining the column. The CMPA requires an 
ongoing source (or recovery) of the chiral additive. This 
problem should be alleviated with the advent of micro-bore 
analytical columns giving reduced mobile phase consumption, 
but will remain a serious drawback for preparative 
separations. Moreover, the CMPA must ultimately be 
separated from each enantiomer after a preparative 
resolution.
As in the CDA method, the responses to diastereomers 
from the CMPA method need not be identical, whereas in the 
CSP approach identical responses are detected for the 
enantiomers.
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Absolute configuration can be determined by many 
chromatographic methods if a sample of known configuration 
is available for comparison. Failing this, absolute 
configuration can be assigned on the basis of elution 
order, provided that the absolute configuration of the 
chiral agent and the mechanism of chromatographic 
separation of the relevant stereoisomers is known. An 
additional advantage of the direct method is that the 
covalent diastereomers may differ in their NMR parameters 
and it may be possible to correlate these differences with 
relative and hence absolute configuration. Short-lived 
diastereomeric solvates can also differ in their NMR 
parameters and these differences may also be correlated to 
relative/absolute stereochemistry in favourable cases
4.2 Historical Background.
In 1904 Wilstatter** postulated that it should be 
possible to resolve racemic dyes from solution by 
enantioselective adsorption onto wool. Partial resolution 
of an optically active aniline on wool was subsequently
i j
demonstrated by Ingersoll and Adams, and then by Porter 
and Ihrig.** Although attempts to repeat some of these 
results using wool were unsuccessful ,**'** Porter and Ihrig's 
dyes were found to be partially resolved using powdered 
silk or potato starch as the chromatographic adsorbents.*® 
In further earlier studies by Henderson and Rule,** 
resolution of a racemic camphor derivative and of Troger's
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17base, using lactose as the adsorbent, provided conclusive 
experimental verification of Wilstatter's idea.
The classical method for the resolution of enantiomers 
involves the reaction of the racemate with an optically 
active reagent to form a pair of diastereomers which have 
different physical properties. The diastereomers can then 
be separated by fractional crystallisation or 
chromatography and the enantiomers recovered. However, this 
method is not without problems. The method requires that a 
suitable functional group be available in the racemic 
substrate as well as sufficient quantities of an optically 
pure reagent of suitable structure. In addition there is 
the problem of racemisation during diastereomer formation 
or retrieval of the individual enantiomers. In contrast, 
direct chromatographic methods do not rely on prior 
formation of diastereomers.
The resolution of enantiomers using an optically 
active stationary phase, coated onto a 100m gas
chromatography (GC) capillary column, was first achieved by
18Gil-Av et al . However, GC has the disadvantage of using 
higher operating temperatures, compared to HPLC, which may 
lead to racemisation of both the chiral stationary phase 
(with concomitant loss of chiral selectivity) and of the 
enantiomers to be separated. In the chromatographic 
methods, the covalent bond of a true diastereomer is 
replaced by the transient interaction between the optically 
active component (chiral selector) and the enantiomers of 
the racemate. If one enantiomer interacts more strongly
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with the chiral selector, then it will be more strongly 
retained on the column, and hence chromatographic 
selectivity is achieved.
Two decades ago, the direct resolution of enantiomers 
was rare, whereas now, there is an abundance of different 
LC solutions to this problem. This is due to several 
factors such as the break through in HPLC technology in the 
late 1960's, together with insights gained in the chiral 
resolution mechanism by Pirkle and others and the 
advancement of HPLC hardware (pumps, low dead-volume, 
injectors and detectors). These enabled fast and efficient 
LC, and of particular sigificance were the advances made in 
HPLC packing materials used as the basis for CSPs. 
Polystyrene and cellulose resins were not suitable for use 
under the high operating pressures of HPLC, plus their mass 
transfer characteristics were poor. These problems were 
overcome with the advent of mechanically stable, 
superficially porous supports in which a thin layer of 
silica was grafted onto the surface of glass beads, thereby 
reducing diffusion distances. The most significant advances 
resulted from the availability of small diameter, porous 
silica particles of re-producible dimensions (3-5um), and 
with these packing materials, modern phases, such as silica 
bonded cellulose, protein and synthetic chiral selectors
became possible. HPLC's increasing popularity in the 1970's
10 0 0
has been well documented.
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.4«3 Theoretical Background.
Senoh and co-workers** reported one of the earliest
examples of enantiomer separation on a CSP. They noted that
aromatic amino acid enantiomers could be separated on
paper, an adsorbent which is chiral both due to the glucose
component and by virtue of the helicity of the cellulose
22polymer. An extension of this work by Dalgleish 
foreshadowed the "three-point rule" for chiral recognition.
Dalgleish noted that derivatisation of the amino or 
carboxylate group or removal of the aromatic funtionality 
of the amino acid resulted in loss of separation and he 
concluded that three simultaneous interactions were 
necessary between the adsorbent and the enantiomers for 
enarxtioselectivity to occur. "Chiral recognition requires 
a minimum of three simultaneous interactions between the 
CSP and at least one of the enantiomers, with at least one 
of these interactions being stereochemically dependant."* 
This requirement can be shown as in Fig 4.1. The two 
enantiomeric structures can be "recognised" by the chiral 
selector if at least three active positions of that agent 
(A* # B* and C') simultaneously interact with the 
appropriate active positions (A, B and C) of one 
enantiomer. In this case the corresponding positions of the 
second enantiomer would appear in the wrong sequence (A, C 
and B) in respect to the chiral selector. This results in 
a difference in the total formation energy of the two 
diastereomeric adducts resulting in discrimination of the 
two enantiomers. Thus according to the "three-point rule",
-57-
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More retained Less retained
Fig 4.1. Three-point rule for chiral recognition. The more 
retained enantiomer is capable of three simultaneous 
interactions (A-A*, B-B’ and C-C') with the CSP, whereas 
the less retained is capable of only two interactions with 
the CSP.
any combination of three attractive or repulsive 
interactions in the vicinity of the chiral centre of the 
molecule could lead to chiral recognition of its 
enantiomers, provided that chromatographic conditions 
favour simultaneously, all interactions resposible for 
enantionselectivity.
The first practical application of the three-point 
rule to the design of CSPs was by Baczuk et al. Using 
space filling models, Baczuk suggested that 1-arginine 
might interact with the 1-enantiomer of 
dihydroxyphenylalanine, DOPA 1 (Fig 4.2) with three 
simultaneous electrostatic interaction, whereas for 1- 
arginine and d-DOPA, only two simultaneous interactions 
were possible. 1-Arginine 2 was covently bonded to Sephadex 
resin to separate the enantiomers of DOPA. Surprisingly, it 
was the d-enantiomer of DOPA that was most retained, 
indicating that the mechanism of chiral recognition was not 
that originally postulated.
1 2
Fig 4.2. Three point interaction proposed by Baczuk to 
explain the separation on enantiomers DOPA 1 on a CSP 
derived £rom 1-arginine 2.
There have been suggestions that three simultaneous 
interactions are not always necessary. The three-point rule 
was modified by Davankov and Kurganov** for certain cases 
where only two points of interaction between the adsorbate 
enantiomer and the immobilised chiral agent are necessary, 
with the extent of adsorption of the diastereomeric 
complexes on the achiral surface of the stationary support 
determining selectivity. This is considered further below, 
suffice to say here that the spatial orientation of the 
adsorbed species with respect to the achiral surface and 
the extent of the adsorption are still determined by the 
chirality of the moiety attached to the surface, and 
therefore Davankov's case is an extension of and not an 
exception to the three-point rule. The separation of W-acyl
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amino acid ester enantiomers on CSPs derived from N-acyl 
amino acids in terms of two interactions (head-to-tail 
hydrogen bonding between the N-H and C-terminal carbonyl 
oxygens of the CSPs and analyte), was discussed by Hara and 
co-workers**'^ (Pig 4.3). Unfortunately neither enantiomer 
of the analyte would be capable of forming these hydrogen 
bonds, and Hara's proposal is insufficient to account for 
chiral recognition. Pirkle*7 however, proposed a face-to- 
face rather than an edge-to-edge approach. This "stacking"
A
Fig 4.3. Hara's CSP 1 is capable of separating the 
enantiomers of acylated a-amino acid esters and amodes. He 
proposed a two point hydrogen bonding model to explain the 
separation.
attributed to dipole alignment between the analyte 
enantiomers and the CSP, explains the sense of enantiomer 
separation seen and is consistent with the three point rule
(Fig 4.4). "Stacking" of the dipoles is functionally 
equivalent to a two point interaction, but with a single 
additional interaction which suffices to afford chiral 
recognition. Similar arguments can be adduced for x -k 
interactions between aromatic rings. Hara^® has recently 
considered additional interactions with the silica support 






Fig 4.4. Pirkle*s proposed dipole stacking, which is face- 
to-face and gives a net four points of interaction between 
th CSP and analyte, as the mechanism of chiral recognition 
on Hara's CSP 1.
4.4 Chromatographic Terms.
A few chromatographic terms should be defined for 
readers who are not experienced with chromatography. The 
volume of the solvent required to elute a non-retained 
solute is equal to the void volume of the column. An 
additional volume of solvent is then required to elute a 
retained solute. The ratio of this additional volume of
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solvent to the void volume is the capacity ratio k. The 
separability factor a, for the two solutes is kj/kj , a 
volume which corresponds to the ratio of the two partition 
coefficients and is related to the energy difference 
between the retention mechanism of the two solutes (Fig 
4.5). The degree of separation of the two components 
depends on both kj and k2 and on column efficiency, which is 
a band shape consideration and is determined by factors 
such as column packing skills, particle size, samples size
5 10 15 20 25
Time (min)
Fig 4.5. Chromatogram illustrating the terms capacity ratio 
(kj=b/a; k2 = c/a) and separability factor (a=k2/kj).
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and flow rate. For a given column, the magnitude of a is 
the most important factor for the separation of two 
solutes. As in both analytical and preparative resolutions, 
total separation of stereoisomers is desired, so particular 
attention is paid to the magnitude of a for the 
stereoisomers under discussion. Reasonably good separations 
of two solutes having an a of 1.04 or greater is often 
observed for highly efficient analytical HPLC systems. MPLC 
systems typically use larger particle size-packings than 
HPLC systems and consequently preparative MPLC systems have 
reduced efficiency and a values of 1.20 or greater are 
required for effective resolution of sizable materials.
4.5 Thermodynamic Parameters.
As already mentioned in the previous section, the 
separation factor, , is the ratio of the capacity ratios 
of the D and L enantiomers, kg and k^ , for a given set of 
chromatogaphic conditions (Eq 4.1). As capacity factors are
Eq 4.1 QQpkjj/k^
equilibrium constants Eq 4.1 can be re-written as Eq 4.2
Eq 4.2
DLm
, AG*" exp(-— )
A  G? exp <~ ^ )
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where AG1} Are the molecular free energies of adsorption. 
Re-arrangement of Eq 4.2 gives the relationship between 
and 6G1, the difference in molar free energy of formation of 
the diastereomeric complexes (Eq 4.3). 6Ga is related to
Zq 4.3 6Gv=~RTInaBl
the difference in enthalpy and entropy of adsorption by Eq 
4.4. 6Ga may be non sero due to either the entropy or 
enthalpy terms of Eq 4.3. By monitoring a as a function of
Eq 4.4
bGa-6Hm-T%S*
temperature, it is possible to determine whether entropy or 
enthalpy differences control enantiomer separation. 
Relatively small values of 60* (%200J) are sufficient to 
afford observable chromatographic separations (a>l).
In the majority of cases the separation of enantiomers 
on a CSP is enthalpy-dominated, if three simultaneous 
interactions between the stationary phase and the analyte 
enantiomer occur, and at least one of them is 
stereochemically dependant, then separation will occur, 
with the enantiomer forming the most stable complex with 
the stationary phase being the more retained. The 
importance of the enthalpy term in Eq 4.4 for enantiomer 
separations explains the small separation factors typically 
observed on chiral GC stationary phases (high operating
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temperatures increase the relative importance of the 
enthalpy term, causing a decrease in 6Ga). Only one case of 
entropy controlled enantiomer separation has been reported, 
and this special case comes about because differing numbers 
of species are involved in the formation of the 
diastereomeric complexes. In such cases entropy changes 
are often a controlling factor in chemical equilibria. 
Davankov, who reported this instance, noted that the 
enantiomers of N-benzylproline were separated on CSP 2,
ii
derived from 1-N-benzylproline, in the presence of Cu1 and 
that the degree of separation increased slightly with 
temperature, indicating entropy control. It was 
hypothesized that the diastereomeric complexes formed 
between the enantiomers of the analyte, Cu^, and the fixed 
1-N-benzylproline moiety of the CSP contained different 
numbers of ligands. In the 1,1-complex, a solvent molecule 
(water), may form an axial ligand to the Cu^4, while steric 
hindrance, resulting from the positioning of the N-benzyl 
group in the d,l-complex, prevents this additional bonding 
interaction. It is clear that the d,1-complex, involving 
fewer ligands, is favoured entropically (Fig 4.6). At 
temperatures close to ambient, the entropy term is larger 
than the enthalpy term in the free energy Eq 4.3, for 
this separation. This example does not, however, 
contravene the three point rule, since three interactions 
between the two chiral species involved in the separation, 
whether direct or mediated by an axial ligand, are still 





Fig 4.6. Entropy control of 6G during the separation of N- 
benzyl-proline enantiomers on CSP 2. The more favoured 
diarstereomeric complex (d,l) has fewer species (two) 
involved in its formation and hence is favoured 
entropically over the (1/1) complex. As expected, 
separation factors increase slightly with temperature.
entropy-controlled, it must be concluded that the three 
point rule remains valid.
One can also imagine situations in which direct three- 
point interaction between chiral centres may not be 
necessary for a degree of stereo-selectivity to occur. 
Solution aggregates of chiral molecules might be expected
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to display differences between the homochiral and 
heterochiral aggregates based solely on symmetry 
considerations alone.** These considerations, however, are 
not expected to apply to CSP-analyte interactions, because 
the CSP and analyte can never occur, and the above argument 
will not apply to separations on CSPs. For solutions 
of racemates, such effects will cancel out, since equal 
amounts of the meso and enantiomeric forms will be present. 
On the other hand, effects might be noticeable for 
enantiomerically enriched samples during achiral 
chromatography (leading to enrichment of fractions in one 
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CHAPTER FIVE.
INDIRECT RESOLUTION OF ENANTIOMERIC MIXTURES.
5.1 Introduction.
A variety of approaches to the chromatographic 
separation of enantiomeric mixtures have been reported. 
Among these, indirect methods are based on the reaction of 
a racemic mixture with a chiral reagent to form a pair of 
diastereomers as described in the previous chapter:- 
(R)-A ♦ (R,S)-B — > (R)-A(R)-B + (R)-A(S)-B 
These diastereomers possess different physicochemical 
properties and can generally be separated by GC, HPLC or on 
non-chiral columns. Although the indirect methods have been 
extensively used in the past, eg., in the analysis of 
enantiomers of 0-blockers,* they have certain 
disadvantages:-
1) they are time-consuming, tedious and require 
optically pure (and hence expensive) derivatising agents, 
since the enantiomeric contamination of the reagents could 
lead to false determinations.4
2) they often fail to accomplish total separation of 
the enantiomers.* As the resulting diastereomers have 
different physicochemical properties, the rate of formation 
may not be the same for each member of the pair. This may 
result in the generation of two diastereomeric products 
differing in properties from the starting enantiomer.*
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3) a further chemical treatment is necessary if the 
starting enantiomers are to be recovered.
5.2 Scope and Chemistry.
The chiral substances most commonly resolved as 
diasteromers are amines, alcohols and carboxylic acids, the 
main types of derivatives formed being:-
AMINES:- amides, carbamates, thioureas and ureas; 
ALCOHOLS:- carbamates, carbonates and esters;
CARBOXYLIC ACIDS:- amides and esters;
Amines are the easiest to derivatise, the amino group being
the site for derivatisation in compounds such as amino 
acids and amino alcohols. Amines, alcohols and carboxylic 
acids also act as chiral pre-cuurors for chiral 
derivatising agents, eg., isocyanates are prepared from the 
action of phosgene and the corresponding hydrochloride salt 
of the amine, and chlorof ormates are prepared from the 
action of alcohols with phosgene.
Derivatisation should be in high yield to prevent 
changes in the enantiomeric ratio and ensure good accuracy.
5.2.1 Diastereomeric amides, carbamates and ureas.
Helmchem and co-workers*"11 have focused on the 
separation of diastereomeric amides 1 (Table 5.1) derived 
from acids (or lactones) and amines. One of the reaction 
partners is used as the chiral derivatising agent (CDA) and 
must be available as a single enantiomer. Helmchem has
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separated a wide variety of diastereomers on silica gel, 
the reported a values (Table 5.1) being significantly large
Table 5.1. Chromatographic separation of diastereomeric 
amides.
1
Rl R2 R3 R4 aa
Et Ph Me a-Naphthyl 1.80
Me Ph Me Ph 1.81
Me nBu Me p -no2c6h4 2.21
Me CH3Ph ch2oh Ph 2.56
ch2oh Ph Me Ph 2.81
(c h2)3oh Ph Me Ph 2.13
a:- The diastereomer with the relaive configuration shown 
is eluted last.
for straight forward preparative resolutions. Subsequent 
retrieval of the chiral acid can be complicated by 
racemisation during hydrolysis. Helmchem typically used 
acid-promoted hydrolysis and reports that amides containing 
appropriately situated hydroxyl groups will hydrolyse under
-73-
mild conditions without racemisation of the acid component.
A series of diastereomeric carbamates has been 
examined by Pirkle and co-workers.22’1* The carbamates 2 
(Table 5.2) are derived either from alcohols and 
isocyanates or from chloroformates and amines. In each case





. R1 R2 a1 R1 R2 a1
cf3 Ph 1.58 Me (ch2)4cn 1.4
cp3 a-Naphthyl 1.56 c b c(ch2)3ch3 (ch2)3cn 1.8
n-C3F7 Ph 2.12 ch2sc6h5 Et 1.16
Ph Me 1.30 ch2sch2ch3 n-Octyl 1.17
Et Ph 1.22 C3CH Et 1.21
t-Bu a-Naphthyl 1.31 C=CH n-Hexyl 1.43
a:- The diastereomer with the relative configuration shown 
above is eluted last.
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one of the components is the CDA and must be available as 
a single enantiomer. Table 5.2 provides a values for a 
number of carbamate diastereomers, these values generally 
being adequate for facile preparative separation on silica 
or alumina columns. After separation, enantiomerical1y pure 
alcohols can be retrieved from the carbamates by the use of 
trichlorosilane,^ a reagent that functions under mild 
conditions in a variety of solvents and that tolerates the 
presence of a number of other functional groups in the 
carbamates.
Although a number of diastereomeric ureas are known to 
be chromatographically separable, no systematic study of 
ureas such as 3 has been reported. Such ureas are usually 
rather insoluble, quite polar and, if hydrolysed, would 
give two amino components. Unsymmetrical acylureas such as
4 and 5 have been studied and found to be resolved quite 
well (Table 5.3) in a systematic manner. These compounds, 
derived from the action of isocyanates on lactams 6 and 
oxazolidinones 7 can be derivatised smoothly. This method 
offers great promise for the resolution of a number of 
heterocycles. Alternatively, oxazolidinones CDA's such as 
8 can be used to resolve amines.
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Table 5.3. Chromatographic separation of diastereomeric 










a:- The diastereomer with the relative configuration shown 
above is eluted last.
5.2.2 Mechanism of chromatographic separation.
Two substances separate chromatographically owing to 
a blend of differential solvation by the mobile phase and 
differential adsorption by the stationary phase. Nuclear 
magnetic resonance (NMR) and infrared (IR) studies of the 
aforementioned amides, carbamates and ureas strongly 
indicate that these compounds have a more or less Semi­
te-
rigid planar backbone composed of all the atoms in 1-5 not 
indicated to project from the page. Extensive population of 
the conformations shown in 1-5 (Tables 5.1-5.3) stem from 
combinations of hydrogen bonding, dipolar repulsion, steric 
and carbonyl hydrogen bonding effects. Owing to multiple-
rU L  a
** Q nh
R l R2 Ph Ph
6 7 8
site binding of the polar backbone to the adsorbent, the 
backbone lies more or less flat on the adsorbent with the 
two substituent projecting from the "bottom-face" (Fig 5.1)
^  ?  TOP FACE
4 ------- V  BOTTOM FACE
/777T77T777V77777
Fig 5.1
of the backbone directed towards the adsorbent. The "top- 
face" substituents project away from the adsorbent. The 
"bottom-face" substituents provide important interaction
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with the adsorbent, which may be either repulsive or 
attractive. The relative disposition of the substituents 
(eg, whether R* is syn or anti to in the depicted 
conformations) coupled with the extent and sense of their 
interactions with the adsorbent determines the elution 
order of the two diastereomers. Differential solvation 
seems important. When R* is more "repulsive” towards the 
adsorbent than R^ , and R^  is more "repulsive” than R*, the 
diastereomer having R* syn to R* will be more strongly
1 *
retained. Alternatively, if R is more "attractive" than R , 
and R^  is more attractive than R*, the diastereomer having 
R syn to RJ will be the more strongly retained. By using 
such simple concepts and ranking the interactive capacity 
of the substituent, one can correlate stereochemistry and 
elution order. The actual magnitude of interaction of a 
given substituent with the adsorbent depends on the 
adsorbent, other substituents present and the type and 
rigidity of the backbone itself. Although no serious 
attempts at quantification have been made, repulsive 
interactions toward silica and alumina can be ranked 
approximately as H < methyl < phenyl s ethyl < propyl < 
tert-butyl < trifluoromethyl < a-naphthyl *
pentafluoroethyl < heptafluoropropyl. Size and 
hydrophobicity are both relevant; incorporation of polar 
functionality (hydroxyl, carboxy, cyano) leads to 
attractive rather than repulsive interactions with the 
silica or alumina.
The drawings shown in Tables 5.1-5.3 represent the
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stereochemistry of the more strongly retained diastereomer. 
The NMR spectral differences between diastereomers can 
sometimes be used to check stereochemical inferences drawn 
from the elution orders. In general, an aryl substituent 
will more heavily shield a syn than an anti substituent.
It should also be noted that the chiral acyclic 
subunits 1-5 bear a single hydrogen on the chiral centre. 
The presence of this hydrogen confers a degree of 
conformational control (essential to separation), which may 
not be present if some substituent other than hydrogen is 
present. However, if conformational rigidity is still 
present, separation of the diastereomers might still occur 
for essentially the same reasons. It is also important that 
the chiral amine subunits 1-5 be primary so that the (Z)- 
amide rotamer is preferentially populated. Diastereomers 
derived from secondary amines have been observed to 
separate, but with diminished a values.
5.3 Applications.
Subject to the limitations in Chapter 4, the
chromatographic separation of diastereomeric amides and
carbamates can be used to assay enatiomeric purities and
assign absolute configuration for a variety of alcohols,
acids and amines. In applying this method to chiral acids,
diastereomeric amides derived form 1-(phenyl)ethylamine^'^
91or 1-(a-naphthyl)ethylamine“ are typically used. Several 
research groups,^ "24 have applied this method to a series of
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isoprenoid and terpenoid acids using (R)-1-(p-nitropheny1)- 
ethylamine or 1-(a-naphthyl)ethylamine as CDAs (Table 5.4).
Table 5.4. Resolution of chiral isoprenoid acids via the 
chromatographic separation of a diastereomeric amide 
derivative.







A:- l-(p-Nitrophenyl)ethylamine; B : - 1-(a -
Naphthyl)ethylamine.
-80-
It is important to note that sizeable a values are observed 
even though the chiral centre of the acid is separated by 
a methylene unit from the amide functionality. The 
chromatographic separation of diastereomeric hydroxyamides 
has been utilised to obtained optically active acids and
o
amines on a preparative scale. Helmchem et al have shown 
that the hydroxyamides exhibit very favourable 
chromatographic properties (Table 5.1) and are hydrolysed 
under mild non-racemising cond itions, overall resolution 
yields typically being 80-90%. (R)-Phenylglycinol 9a is 
suggested as a CDA for the resolution of acids whereas 1- 
(phenyl)ethylamine 9b is suggested for the resolution of 
lactones such as 10a and 10b. Conversely, amines can also 
be resolved by using lactone 10c as a CDA. The observed 
elution order for all hydroxyamines examined by Helmchem 
are those expected on the basis of the described 
chromatographic mode. Hence, relative/absolute 
configurations of the resolved components can be assigned.
Ade and co-workers“ have utilised the chromatographic 
separability of diastereomeric hydroxyamides in the 
synthesis of the optically active hydrocarbon 11, the 
pheromone of the tsetse fly. In this synthesis 
diastereomeric amides 12 were separated by chromatography 
and then hydrolysed. Due to the relatively large a value, 
the diastereomeric amides were readily resolved in 3g lots 
on a medium pressure liquid chromatography system (MPLC) 
(Fig 5.2). The optically active acid was subsequently 






CHg |H3 | h3 |h
CH3<CH2 ) ls CHCH2CH2CH2CH<CH2)15CHg CH3<CH2 ) l5 CHC0NHCHCH2 0H
11 12
26Enders and Louters demonstrated that diastereomeric 
a-hydroxyamides 14 can be easily separated with a values 
ranging between 1.5 and 2.0. The resolved a-hydroxyamides 
are versatile intermediates because they can be converted 
into optically active a-hydroxyketones 15, diols 16 or oc- 
hydroxyacids 17 (Scheme 5.1). A chromatographic model 
correlating elution orders and a values with 
stereochemistry and structure was not proposed.
A number of amino acids have been indirectly resolved 
by HPLC. Generally, the CDA is used to derivatise the amino 
group, the carbonyl group being previously converted to an 




T i m e  ( m i n)
40
Fig 5.2. Preparative LC separation of the diastereomeric 




Scheme 5.1. a, LiTMP, -100°C; b, R^OR2; c,
chromatography; d, leg MeLi; e, 2eq MeLi; f, cone HCl.
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such as 18-20 seem to be the most suitable. Although the 
amide derivatives are the most readily separated, the 
isothiocyanate CDAs are more readily accessible, and the 
thiourea chromophore facilitates ultraviolet detection. 
Chromatographic separability of diastereomeric carbamates
0NHCHC09 H
n h c n h c h c o 9 h
NHCHCOoCH
has proved to be a useful and general method for 
preparatively resolving secondary alcohols. Typically, 
carbamates derived from either 1-(a-naphthyl)ethyl 
isocyanate 21a or 1-phenylethyl isocyanate 21b are used. 
The use of 21a usually leads to higher a values, but 21b is
1C
much less expensive. Pirkle and co-workers15'* and Fimr 
have used this method to resolve a series of 
trifluoromethyl carbinols 22a-22d, which are of value as 
chiral solvating agents and used for precursors of CSPs. 
Fig 5.3 shows the chromatogram for the automated repetitive 
resolution of l.Og-samples of the carbamate derived from 
22d and CDA 21a. By the use of larger scale operations,
hundred gram quantities of the resolved carbinols have been 
obtained.
21a





C R=0CH2 CH2 Br
Fig 5.3. Automated repetitive chromatographic separation of 
the diastereomeric carbamates derived from 21a and 22d. The 
R,R diastereomer is the first of the two major bands.
Mori and Sasaki31 resolved alcohol 23, a key 
intermediate in the synthesis of the pheromone lineatum, by 
chromatographically separating the diastereomeric
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32carbamates derived from CDA 21a. Schid and co-workers“ 








Diastereomeric carbamates derived from tertiary 
alcohols can also be separated chromatographically, as 
demonstrated by Corey and co-workers^ in their synthesis of 
gibberellic acid, in which the resolution of alcohol 25 was 
accomplished using the carbamates derived from 21b.
The advantage of indirect resolution is that the 
selectivity of the derivatisation and de-derivatisation 
reaction permits the presence of additional functionality. 
Diastereomeric carbamates derived from cyano alcohols 26 
are valuable for the broad spectrum synthesis of optically 
active lactonesa 15,34,35 These diastereomers are generally easy 
to separate (Table 5.2), and trichlorosilane cleavage and 
nitrile hydrolysis readily lead to optically active 
lactones 27 (Scheme 5.2). A number of optically active 
pheromones have been prepared.
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f  *4 1 if"3
R'^ ‘-^ <CM2>nCN — ► NC<CH2)'*5^^°'^'^,J,,^ ^,,^ ‘ntPh
26 A
o,d,e| o,di*
2 7 t  27b
Scheme 5,2. a, 21a; b, chromatography; c, HSiCl^; d, HO’; 
e, 1actonisation.
Optically active epoxides 29 can be obtained by 
carbamate resolution of (3-hydroxysulphides 28 # S- 
alkylation, and treatment with a base** (Scheme 5.3). This 
route was used in the synthesis of (+)-disparlone, the sex 
attractant of the gypsy moth.^ Pirkle and Boeder*^ similarly 
resolved propargylic alcohols 30, some of which were used 
to prepare optically active allenes 31 (Scheme 5.4),
47
including the sex pheromone of the male bean beetle. 1
Below are given examples on chiral derivatisation of 
p-blockers of the l-isopropyl-amino-2-propanol type. They 
are treated as a group as they have similar chemistry 
involved in derivatisation even though they may differ in 
terms of lipophilicity and spectral properties.
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Scheme 5.3. a, 21a; b, chromatography; c, HSiCl3; d 
MeOBF4; e, HO*
31i 32b
Scheme 5.4. a, 21a; b, chromatography; c, R^CuLi.
38Benoxoprofen racemate was resolved by Weber et al by 
preparative LC separation of the (R)-(+)-a-methyl- 
benzylamide diastereomers. The R form was converted to (R)- 
benoxoprofen chloride 47 with an enantiomeric purity of
-88-
96.5%. Pflugmann et al3® prepared crystalline derivatives of 
(3-blockers, used as reference substances, by reaction in 




Metoprolol, oxprenolol and propranolol, extracted from 
urine, were derivatised with (R)-benoxoprofen chloride at 
room temperature overnight. Separation was performed on 
thin-layer silica plates and the pairs of diastereomers 
from the three (3-blockers were adequately resolved. The 
absolute recovery of propranolol after extraction and 
derivatisation was 78%.
The symmetrical anhydrides of tert-butyloxycarbonyl-L- 
leucine, from commercial Boc-amino acids and phosgene, were 
prepared by Hermansson.*® Propranolol was extracted from 
plasma and derivatised using the pure reagent. The reaction 
with alanine reagent was complete in ca 5min at room 
temperature, and the reaction with leucine was found to be 
6X slower. Separation, after removal of the tert- 
butyloxycarbonyl group and extraction, was performed on a 
reverse phase LC system with the addition of
-89-
dimethyl octylamine in the mobile phase to reduce peak 
tailing, a Values of 1.3 and 1.7 were observed for the 
alanine and leucine derivatives respectively with detection 
levels in plasma as low as lng/cm.
Linder et al^ approached the analytical and 
preparative resolution of the enantiomers of the (3-blockers 
in a different manner by preparation of disubstituted (R,R) 
or (S,S)-tartaric acid anhydrides 45 an derivatisation with 
the (3-blocker in an aprotic media. Very high separation 
factors were obtained on reverse phase systems for 
diastereomeric pairs from the different disubstituted
45
tartaric anhydrides. An intramolecular interaction 
involving the free carboxyl group of the tartaric acid 
residue and the free amino group of the (3-blocker is given 
as the explanation for the separation observed. The 
enantiomeric purity of the reagent was reported as > 99.9%, 
while racemisation was < 0.1% for reaction with
propranolol. Since the diastereomers are esters they are 
amenable to hydrolysis in order to recover the enantiomer. 
This, coupled with the high a values, makes derivatisation 
with substituted tartaric acid anhydrides a useful 
technique for determining the enantiomeric purity of (3-
-90-
blockers.
Using the isothiocyanate reagents GlTC 34 and AITC 35, 
Sedman and Gal^ investigated the resolution of various p- 
blockers as thiourea derivatives. Using a reverse phase 
system, a values ranged from 1.21-1.28 for GITC derivatives 
and 1.09-1.22 for AITC derivatives. Christ and Walle^ 
applied this method to a p-blocker metabolite, 4f- 
hydroxypropranolol sulphate, isolated from plasma, and 
achieved excellent resolution of the two enantiomers with 
detection levels down to 20ng of each enantiomer. Darmon 
and Thenot^ reported a study on the use of napthyl ethyl 
isocyanate for the enantioselective determination of 
betaxolol in whole blood. Reverse phase chromatography gave 
base line separation (a=l.l) of the enantiomers.
34 GITC 35 AITC
Einarsson et a showed that p-blockers could be 
separated as carbamates after reaction with l-(9- 
fluorenyl)ethyl chloroformate 36. Metoprolol was separated 
on a reverse phase system with an a value of 1.1.
The above examples are taken from just a few from the 




this method of resolution, and the widely different aspects 
of the methodology. Yet despite the ever increasing use of 
direct chromatographic methods, the indirect method will, 
at least, for the forseeable. future, be continued to be 
used, due to increased knowledge of their rationale, 
efficiency and separation proces. A scan through the 
Journal of Chromatography between the years 1985-1989 
serves to illustrate the still wide ranging use that this 
method of chiral recognition enjoys (Table 5.5 and 5.6).
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Table 5.5. Selected applications from the Journal of 
Chromatography (1985-1989).
Compound Reagent ,Xo;name Appla Chrom^ Detc Ref
AMINES
Ampbetanines 37 Xaphthylsulphonyl-L-propyl X,R uv 46
chloride
38 Flunoxaprofen plasma X uv 47
Tertairy amines 39 Phenylethylisocyanate X UY 48
Amino alcohols
40 OPA/Boc-L-cysteine H R OV
41 a-Hapthyl isocyanate X UV 49
42 o-Phthalidaldehyde R FI 50
43 (-)-Hethylchloroformate R UY 51,52
Acebutolol/diacetolol 39 Phenylethylisocyanate R FI 53
Betaxolol 44 laphthylethylisocyanate blood R FI 44
-^blockers 45 Tartaric acid anhydrides X UY 54
Epinephrine 45 GITC PP R 55
Bydroxypropranolol 46 GITC plasma R UY 56
Metoprolol 39 Phenylethylisocyanate plasma R FI 39
Ketoprolol/propranolol 47 Benoxaprofen chloride urine X FI 39
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Propranolol 45 Tartaric acid anhydrides R FI 57
























Alkylglcerols 44 Raphthylethyl isocyanate UV 64
Deacetyltiazea 37 Haphthylsulphonyl~L~propyl ep 
chloride
UV 46
l-Kethyl-3-pyrrolidinol 52 Dibenzoyl tartaric acid ep R UV 65
CARBOXYLIC ACIDS
53 Raphthylethyl amine ac N 66
2-Aryl propionic acids 54 L-Leucinanide plasma R UV 67
53 Raphthylethyl amine urine N UV 68
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H-Acetyl penicillanine 58 OPA/Arginine R FI 75
a:- Appl, application; H, hydroylate; PF, pharamceutical 
formulation; ep, enatiomeric purity; ac, absolute 
configuration; BF, biological fluid; b:- Chrom, 
chromatographic mode; N, normal; R, reverse; c:- Det, 
detection mode; UV, absorbance detection; FI, fluresence 
detection.
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In recent years, greater attention has been devoted to 
devising methods for the direct resolution of enantiomers 
without prior derivatisation. These methods involve the use 
of a chiral stationary phase (CSP) that form transient 
diastereomeric complexes with solute enantiomers. The 
difference in stability between the complexes leads to a 
difference in retention time and when this process is 
repeated many times as the solute is eluted separation 
occurs. These methods avoid some of the drawbacks of the 
indirect method mentioned earlier and are relatively simple 
and less time consuming. CSPs can be used in both gas 
chromatography (GC) and high performance liquid 
chromatography (HPLC), but HPLC has the added advantage*'* 
that the enantiomers need not be volatile and they can be 
recovered with relative ease. Furthermore, GC requires more 
extensive clean-up procedures and the higher column 
temperatures can reduce the efficiency of the separations, 
or even cause racemisation. For these reasons the present 
trend is towards the use of CSPs whenever HPLC is 
considered for enantiomeric drug analysis.*'* Dappen et al* 
have discussed in detail the applications and limitation of 
commercially available CSPs for HPLC.
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In this chapter, the various types of chiral 
stationary phase (CSP) are considered under two general 
types i) Empirical CSPs and ii) Designed CSPs. Ion-pair 
chromatography is considered separately, as the chiral 
selector is a mobile phase additive (CMPA), although 
strictly speaking it could be considered under the heading 
of empirical CSPs as separations are achieved as a result 
of practical experimentation and observation. In addition, 
computer assisted molecular modelling will also be briefly 
discussed.
6.2 Empirical Chiral Stationary Phases.
The concept of separating enantiomers by differential 
adsorption onto a CSP is not new. The expectation that the 
enantiomers of chiral dyes might be differentially adsorbed 
by naturally occurring enantiomerically pure materials was 
anticipated as early as 1923 by Ihrig and Porter.*
The initial discoveries of Senoh and Dalgleish have 
already been mentioned (CHAPTER 4, section 4.3), and 
attempts to use natural cellulose for enantiomer separation 
continue to be reported.* However, the chromatographic 
qualities of cellulose have been an impediment to their use 
as chiral supports, and attempts to use other 
polysaccharide such as Sephadex* and p-cyclodextrin*'** as 
CSPs have also been of limited success because of the poor 
mechanical properties of these saccharide and their 
unfavourable mass transfer characteristics. Slow adsorption
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and desorption and/or slow diffusion through the polymeric 
network leads to band broadening with concurrent loss of 
resolution. Rather large a values are necessary if useful 
separation are to be afforded. In an effort to improve the 
chromatographic properties of cellulose, a number of 
chemical alterations have been attempted. Peracetylation of 
microcrystalline cellulose yields a triacetylcellulose 
(TAC) (CSP 3, Fig 6.1), which shows improved 
chromatographic behaviour and is capable of separating a 
wide range of enantiomers. First introduced by Hesse and 
Hagel, microcrystal line cellulose is acetylated under
Fig 6.1. Monomer of triacetylcellulose, CSP 3, and some 
racemates separable on this CSP.
heterogeneous conditions in order to preserve the original 
crystal structure. It was found that solution and re­
precipitin of TAC led to poor separation and in some cases 
reversal of elution orders. Evidently, the tertiary
CSP 3
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structure of TAC is of great importance in separations
using this material. Several reviews of separation
employing TAC and related materials are available,*7'*8 and 
inexpensive TAC columns and packings are commercially 
available. Although many different enantiomeric separations 
have been achieved on these columns, little rationale for 
predicting separations is available. For this reason, the 
mechanism/s of chiral recognition has not yet been
established, but an intercalation mechanism seem likely.*7-*8 
Nevertheless, the materials have been used in practice for 
a wide range of analytical and semi-preparative scale 
separations. TAC powder and various cellulose derivatives 
coated onto silica (triacetylcellulose, tribenzoate and 
triarylcarbamate) are now commercially available (Chiralcel 
materials; Diacel). Typical mobile phases include aqueous 
alcohol mixtures to hexane-isopropanol. Okamoto** has shown 
that the material obtained by bonding cellulose 
triarylcarbamate to silica had similar chromatographic
efficiency to the coated material but with the advantage 
that more polar solvents could be used without dissolving 
the cellulose carbamate. Empirically it has been found that 
an aromatic or cyclohexyl ring close to the chiral centre 
is desirable but not a requirement (eg., the separation of 
the enantiomers of diazoxyalkane (74)**). Polar
functionality on the substrate is not necessary, as a 
variety of helicenes and oxiranes have been separated on 
TAC.*3'** Several of the other separations cited in Table 6.1 
have been used for moderate amount (>100mg) of racemates.
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Two proteins have been used as chiral selectors in LC 
and both have given rise to commercially available packing 
materials. Albumin is the principle plasma binding protein 
for weakly acidic drugs and aj-acid glycoprotein (otj-AGP),
74
the major plasma binding protein for basic drugs. Stewart 
and Doherty2* reported the chromatographic resolution of 
D,L-tryptophan using bovine serum albumin (BSA) bonded to 
agarose and thereby confirmed an earlier report using 
equilibrium dialysis, which suggested that L-tryptophan had 
an affinity for albumin one hundred times greater than that 
of D-tryptophan.2* Following on such work from Allenmark and 
co-workers22, a CSP with BSA covalently bonded to 7pm silica 
became commercially available (Resolvolsil; Macherey- 
Nagel). The BSA material can be used with aqueous buffer 
mobile phases for a wide range of analytical-scale 
separations2®, including sulphoxides, benzodiazepines and 
coumarins such as warfarin, as well as monitor the 
stereoselective microbial conversion of racemic 
substrates .2®
As the protein-bound materials have such low sample 
capacity they have not been used for preparative-scale 
separations. The main interactions between BSA and the
-106-
solute enantiomers are hydrophobic and electrostatic 
interactions, although hydrogen bonding or charge transfer 
interactions could also contribute to chiral selection. In 
working with protein stationary phases, optimisation of 
chiral resolution can be achieved by varying the buffer pH 
or ionic strength and shorter retention times are obtained 
by adding an organic modifier such as propanol to the 
mobile phase. Albumin has also been used as a chiral mobile 
phase additive (CMPA) in reverse-phase chromatography with 
ODS-silica for the chiral resolution of carboxylic acids.30 
In 1983 Hermansson reported a silica-bonded aj-AGP chiral 
material for LC and obtained useful resolution of a series 
of basic drugs. As with the BSA material, hydrophobic and 
electrostatic interactions are involved in the retention 
mechanism, along with hydrogen bonding31. The -AGP/silica 
material is now commercially available (Enantiopak; LKB).
6.3 Designed Chiral Stationary Phases.
As the understanding of the mechanism whereby 
molecules interact with each other has increased, the 
design of CSPs which separate enantiomers by a pre­
conceived and testable mechanism has become feasible. Such 
CSPs offer many advantages over the empirical CSPs 
discussed above. If the mechanism of enantio- 
differentiation is known (the "chiral recognition 
mechanism"), the order of elution for a given enantiomeric 
pair can be stipulated. Hence absolute configurations can
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be assigned for many enantiomers, even though such 
assignments have not been made by more classical 
techniques. ^ ,^33 Furthermore, a clear mechanistic 
understanding removes the empirical aspect of selecting a 
CSP to effect a given resolution. Finally, rationally 
designed CSPs are valuable tools for basic research into 
the mechanism by which chiral molecules interact, an 
important field of study applicable to many areas of 
chemistry and biochemistry.
At present, the design of CSPs for the chromatographic 
separation of enantiomers can be divided into three 
distinct categories. The first and most widely studied of 
these is ligand exchange chromatography (LEC). The theory 
and practice of LEC has been the subject of several 
reviews**'** and this subsection will attempt to update some 
of the developments that have occurred in the past seven 
years or so. The second type of designed CSP incorporates 
chiral cavities which selectively includes one enantiomer 
of a racemate. This category includes the imprinted 
polymers of Wulff ,**'** the chiral crown ether phases designed 
by Cram and co-workers,** and the chiral polymers of 
Okamoto,** which are derived from triphenylmethyl- 
methacrylate. These CSPs warrant a separate discussion 
because they seem to behave in an understandable and 
predictable fashion. The last designed CSP to be discussed 
are the donor-acceptor or Pirkle type CSPs, which rely on 
weak interactions between the analyte and CSP to bring 
about separation. These weak interactions include hydrogen
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bonding and dipolar, steric and van der Waals forces. 
Typically prepared by bonding a chiral precursor covalently 
to microparticulate silica, these CSPs resemble HPLC 
silica-bonded phases in chromatographic behaviour (high 
theoretical plates count, generally good kinetic 
behaviour), and are therefore the most easily adapted to 
routine use in research and analysis. These CSPs show 
exceptional scope and often afford such selectivity as to 
make facile preparative resolution of racemates. Since low- 
polarity volatile mobile phases are often used with these 
CSPs, they are especially well suited to preparative work. 
They have proved to be durable and long lived. The chief 
disadvantage of these CSPs is that certain type of analytes 
must be derivatised prior to analysis. In some instances, 
derivatisation may be undesirable, especially for 
preparative separations.
6.3.1 Chiral ligand exchange chromatography.
Chiral ligand exchange chromatography (LEC) was the 
first direct chiral resolution method that became easily 
accessible to the practising analyst. LEC has proved a 
powerful technique for the chiral resolution of un- 
derivatised amino acids. In the original system of Davankov 
and Rogozhin^, L-proline was chemically bonded to a 
chloromethylated styrene-divinylbenzene co-polymer. Using 
an aqueous mobile phase containing Cu*+ ions, the racemic 
solute, D,L-proline, formed diastereomeric metal co­
ordination complexes with the bonded amino acid and the
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copper ions. As the ternary complexes formed with the 
individual solute enantiomers differed in energy, 
chromatographic resolution was achieved. Davankov has
determined the conditions for optimising chiral resolutions 
with CSPs in LEC by varying the resin, metal ion, bonding 
chiral group and the nature, pH and ionic strength of the 
buffer.54-41
The poor mass transfer characteristics and long 
analysis times of the original polystyrene-based materials 
were improved in subsequent generations of chiral ligand 
exchange materials such as the silica-bonded material 
described by Linder.*^ The usefulness of the technique for 
both analytical and preparative scale separations has led 
to the appearance of several commercial CSPs for LEC. These 
utilise silica-bonded amino acids and are recommended for 
use with aqueous Cu2* buffered mobile phases (Chiralpak, WE, 
WH, WM; Daicel: Nucleosil Chiral-1; Macherey-Nagel). The
scope of chiral LEC was extended by Karger and co-workers**'** 
who were the first to use an achiral stationary phase (ODS- 
silica) along with an aqueous mobile phase containing the 
chiral selector. The latter was an optically active zinc or 
cadmium complex of a hydrophobic triamine and dansyl amino 
aids were well separated under alkaline conditions.
LEC was the first chromatographic method for the 
separation of enantiomers for which a testable mechanism 
was proposed. Based on the observed behaviour of the
analyte enantiomers, it was proposed that the separations 
occur because of the difference in stability of the
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complexes formed with the CSP, the stability difference 
being related to several factors, the most critical of 
which is the choice of the chiral portion of the stationery 
support. On non-polar supports, the d-amino acid is 
generally the most retained when l-proline is the chiral 
ligand. If the stationary support is polar (ie., capable of 
acting as a axial ligand for the metal ion in the 
diastereomeric complex), the 1-amino acid is generally the 
most retained on the l-proline derived CSP.
Fig 6.2 illustrates the mechanism to account for the 
observed behaviour. Both amino acids involved in complex 
formation act as bidentate ligands, the amino and 
carboxylate groups being arranged alternately as equatorial 
ligands in a octahedral complex with the metal ion. The 
degree of steric interaction between the side chains of the
amino acids, the presence or absence of axial ligands, and
the nature of the second solvation sphere influences the 
sense of enantioselectivity,^»46 Qn p0iar phases, such as CSP 
4, in which the support provides an axial ligand for the
metal ion, the d,l diastereomeric complex hinders the
formation of the interaction, and hence is less stable. 
This polymer supported LEC CSP was designed specifically
17
for optimum axial ligation of the copper ion.
Conversely, the hydrophobicity of the sterically bulky 
alkyl groups in the d,1-complex shields the metal ion from 
the non-polar environment of the hydrophobic stationary 
support. Consequently, the d,l form is the more favoured 
and the d-enantiomer of an amino acid is generally more









Fig 6.2. Control of enantiomer elution order in LEC by 
choice of achiral support.
iO
retained on non-polar l-proline derived CSP 5. Exceptions 
to these general trends occur on type CSP 5, when the amino 
acid to be resolved is tridentate in nature, such as 
ornithine, threonine or aspartic acid. Here, the 1-forms
i A
are often the most retained. 7
If a CMPA is used instead of a CSP for LEC, the 
situation becomes more complex. In this case, separations 
may result from a) intrinsic energetic differences between 
the diastereomeric complexes in solution (with the
complexes and the un-associated enantiomers having 
different partition co-efficients between the mobile and 
stationary phases, b) the diastereomeric complexes having 
different partition co-efficients, c) the CMPA 
concentrating in the stationary phase, converting it to a 
de facto CSP or d) a combination of all these effects. 
Finally, because at least three distinct entities are 
involved in the formation of each complex, entropy 
considerations are relatively more important in LEC than in 
normal phase chromatography, as noted previously (CHAPTER 
4 section 4.4).
It is suitable to describe in more detail the 
advantage and disadvantages of using LEC as a routine means 
of enantiomer separation. For analytical purposes, LEC at 
present has no peer for monitoring the enantiomeric purity 
of un-derivatised amino acids. Since detection of un- 
derivatised amino acids can be difficult under the 
conditions of LEC, the amino acids may be derivatised prior 
to separation with a dansyl group or other fluorescent 
markers5®'5* or allowed to react with a derivatising agent 
such as phthalaldehyde after separation.52 These techniques 
allow pico molar quantities of amino acids to be detected. 
LEC is compatible with biological samples because polar 
solvents are used and non-dedicated achiral columns are 
used. However, LEC can be applied only to selected 
bidentate analytes. While enantiomeric a-amino acids are 
readily separated by LEC as a rule, only poor separations 
have been obtained with (3-amino acids.53 Weinstein and
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Grinberg5* have separated the enantiomers of a-naphthyl-a- 
amino acids using a chiral mobile phase LEC system. Other 
workers have, however separated the enantiomers of 
catecholamines, amino alcohols, fl-hydroxy-a- 
phenylethylamines, aliphatic and aromatic a-hydroxy- 
carboxylic acids.55’58 Although LEC has been successfully 
utilised for preparative purposes,5* difficulties with 
removal of polar mobile phases, recovery of the CMPA 
(should one be used), and isolation and purification of the 
now separated enantiomers may be encountered. One approach 
of the removal of the metal ion is to pre-charge the CSP 
with the metal ion** and pass the effluent through a 
scavenger column to remove traces of metal ion which may 
elute.5* An additional chromatographic disadvantage of LEC 
is the generally low rates of desorption, broad bands and 
long retention times are often seen.5* Many attempts have 
been made to improve LEC kinetics by addition of 
monodentate ligands such as ammonia to the mobile phase to 
increase exchange rates.5* LEC is generally conducted at 
elevated temperatures to minimise the effect of slow 
kinetics.5*
6.3.2 Chiral stationary phases with chiral cavities.
Cram and co-workers55,5* after extensive studies of the 
water-chloroform partitioning of diastereomeric complexes 
formed between chiral crown ethers and the enantiomers of 
a variety of chiral ammonium salts, prepared a number of 
silica- and polymer-supported crown ethers CSPs. These were
-114-
used for the separation of enantiomers of chiral amines, 
amino acids and amino esters all as their ammonium salts.** 
From solution studies the complex most favoured was found 
to have the least steric hinderance between the naphthyl 
rings of the crown ether and the R-group of the amino acid, 
while still maintaining strong hydrogen bonding 
interactions between the ammonium proton and the ether 
oxygens (Fig 6.3). Although elegant in the extreme, the 
difficulty of preparing these CSPs and the relatively poor 
peak shapes they afford have precluded any general attempt 
at usage. However, the work has stimulated considerable 
interest in other types of chiral crown ethers.
The cyclodextrins are a group of cyclic oligo­
saccharides which have found wide application in chiral LC. 
a, |B and y cyclodextrins, containing 6, 7 or 8 D-glucose 
units respectively, each possessing a chiral cavity 
proportional to the number of glucose units present (eg., 
8A for p-cyclodextrin) and the materials are capable of 
forming inclusion complexes with a variety of racemate. The 
inclusion complex is formed between the hydrophobic groups 
of the guest molecule and the relatively hydrophobic chiral 
cavity of the cyclodextrin and involves various hydrophobic 
and hydrogen bonding forces. These CD complexation 
processes are highly stereoselective, and can be considered 
as the method of choice for the resolution of various 
isomers namely:- structural; geometrical; diastereomeric 
and enantiomeric isomers. Initially the materials were used 




Fig 6.3. Most favoured diastereomeric host-guest complex 
between an a amino acid and a chiral crown ether.
complexes which could be separated by fractional 
crystallisation to give enantiomer enrichment. Modern 
commercially available materials for HPLC include 
cyclodextrin and actey 1 cyclodextrin bonded to 5\xm spherical 
silica (Cyclobond range; Astec). These materials are used 
in reverse-phase mode with an aqueous alcohol mobile phase6* 
and have been employed successfully in chiral separations 
of prostaglandins, sulphoxides and vitamins. Partial chiral 
resolution of mandelic acid was also achieved using (3-
cyclodextrin as a CMPA in conjunction with an achiral 
reverse-phase column.
Wulff and co-workers0' approached in a different way, 
the construction of chiral cavities in a stationary 
support. They pioneered the use of chiral templates to link 
chiral cavities into a polymeric framework. Typically one 
enantiomer of the template molecule is bound by an easily 
cleaved linkage, such as a Schiff base or boronic ester, to 
a monomeric unit, which is allowed to polymerise with a 
second monomer having cross-linking capability. Subsequent 
chromatography of the racemic template compound often gives 
separation of the enantiomers. A typical example is the 
separation of the enantiomers of nitrophenyl manopyranoside 
(75) on a chiral polymer derived from methyl methacrylate, 
ethylenedimethacrylate and the 4-styrenylborate ester of a- 
d*4-nitrophenylmanopyranoside. A separation factor of 1.4 
was obtained, although baseline separation was not seen.
75
As was expected, a high degree of cross-linking is 
necessary for the separation of enantiomers to occur on 
these CSPs, otherwise the large "holes" produced are 
effectively achiral. Moreover, swelling of the polymer by 
solvents distorts the chiral holes, and diminishes
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separation.^ Such imprinted CSPs may eventually prove 
useful for specific applications such as repeated large- 
scale resolution of a particular racemate. They are also of 
theoretical interest as models for synthetic enzymes, since 
the stereo- and regio-chemical course of a reaction may be 
influenced by the presence of a properly templated 
polymer
CSPs in which the chiral selector is a synthetic
polymer have only recently become available, although their
conception is not recent. The origins of these material
77lies in the theory proposed by Pauling which accounts for
the natural formation of antibodies specific for a given
antigen. Pauling proposed that the antigen protein adopts
a tertiary structure complimentary to that of the antigen
template. This idea was later applied to the preparation of 
70 71silica. 1 Silica prepared in the presence of methyl orange 
or related azo dyes was shown to adsorb specifically the 
given template molecule and in 1949 Dickie^ mentioned that 
he was investigating "the possibility that optical isomers
can be separated with such adsorbents**. Later Wulff and
7?Sarahanprepared a series of enzyme-analogue polymers for 
chiral LC. Wulff*s method involved synthesising highly 
cross-linked co-polymers which incorporated chiral 
carbohydrate template molecules. Subsequent removal of the 
template by hydrolysis yielded polymers with chiral 
cavities which were used to resolve racemates of the 
template molecules.
The polymers have also been bonded to silica,^ but the
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chromatographic efficiency of such materials is fairly 
poor. Okamoto and co-workers^’75 polymerised 
triphenylmethacrylate in the presence of a chiral anionic 
initiator and obtained a polymer, the chirality of which 
was due solely to its helicity. Modern materials for chiral 
LC in which the polymer is bonded to silica are 
commercially available (Chiralpak OT and OP; Diacel). In 
the OP material, the phenyl groups are replaced by 
pyrazine. Recently the chiral template approach was applied 
to another type of CSP. Aubel and Rogers^ reported initial 
results regarding the possibility of re-orienting the 
tertiary structure of silica-bonded BSA in the presence of 
a single enantiomer.
In a very recent advance, synthetic polymer CSPs have 
been prepared commercially using optically active monomers 
as building blocks.^ Development of these materials has led 
to the commercial exploitation of a silica-bonded chiral 
polymer prepared from N-acryloyl-(S)-phenylalanine ethyl 
ester (Chiraspher; E. Merck).
As chiral recognition on CSPs with chiral cavities is 
dependant on the formation of inclusion complexes, the 
chromatographic efficiency afforded by such systems is 
invariably worse than that of standard HPLC columns. This 
is a limitation for analytical applications to enantiomers 
which afford but modest level of chiral recognition or for 
samples containing a number of components.
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6.3.3 Donor-acceptor type chiral stationary phases.
CSPs based on CSP-analyte interactions weaker than 
ionic interactions encountered in LEC will, for the 
purposes of this discussion, be called donor-acceptor CSPs. 
In general (but not exclusively), relatively non-polar 
mobile phases are used for the CSPs and chromatographic 
conditions and parameters are similar to those of typical 
bonded phases. Although a variety of CSPs of this type have 
been prepared in the past ten years, the principles behind 
most of them are similar. Many of these CSPs contain 
aromatic or x functionality, which may take part in a van 
der Waals (x-x), donor-acceptor or dipole-stacking complex 
with the analyte. The importance of aromatic groups for the 
success of donor-acceptor CSPs lies in the nature of the 
donor-acceptor interaction between the species. The 
relative energy of the x-orbitals (HOMO and LUMO) in 
aromatic systems, is determined largely by the nature of 
the substituents on the aromatic system. Electron- 
withdrawing groups such as NO2 tend to lower the orbital 
energies (HOMO), making nitro-substituted aromatics good x- 
electron acceptors. Electron-donating groups such as amines 
and hydroxyl groups, raise the relative energies of the x- 
orbitals (LUMO) making such aromatic systems good x- 
electron donors. The donor-acceptor interaction involves 
the approach of the frontier x-orbitals of the aromatic 
systems in a parallel fashion. For the most effective 
interaction, the highest occupied molecular orbital (HOMO) 
of the x-donor species is isoenergetic with the lowest
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unoccupied molecular orbital (LUMO) of the %-acceptor 
system. As the frontier orbitals approach each other, the 
LUMO is raised in energy while the HOMO is lowered, as 
called for by the perturbation theory, and the lowering in 
energy of the HOMO determines the strength of the 
interaction (Fig 6.4).^ Since the orbitals must be non- 
orthogonal to interact, the rings interact most strongly
Fig 6.4. Energy diagram of x-donor-acceptor complex 
formation. On close approach, the LUMO is raised in energy, 
while the HOMO is lowered by an energy , resulting in
a net gain in energy of AH^ for a fully occupied HOMO.
when they are parallel. Thus the strength of the donor- 
acceptor interaction between the aromatic moieties of the 
two molecules is dependant on the relative position of 
these groups. The face-to-face nature of these donor- 
acceptor interactions places restrictions on the relative 
motion of the aryl rings. Such interactions constitute more 
than a single point interaction. When the aryl rings show
HOHO LUMO
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conformational preference relative to the remainder of the 
chiral molecule, the restrictive nature of the donor- 
acceptor interaction may prove invaluable for chiral 
recognition. It is no accident that CSPs utilising these 
donor-acceptor interactions are among the most effective 
known.
An interesting consequence of strong x-donor-acceptor 
interactions is the appearance of a charge-transfer band in 
the visible spectrum of such complexes. The enantiomer 
incorporated into the more stable adsorbates will often 
give a much more deeply coloured complex with a chiral x-
acceptor than does it antipode, and column separations can
79often be monitored by the progress of two coloured bands.
Hydrogen bonding, dipole-dipole and steric interaction 
effects are also frequently present in these CSPs, and 
although not necessarily directly responsible for high 
enanti oselectiviti es®** are nevertheless frequent 
contributors to the observed separations.
The precursors used to prepare donor-acceptor CSPs are 
often readily available enantiomerical1y pure materials, 
such as amino acids or ct-arylalkyl amine and carbinols, 
which are resolved either chromatographically or by 
classical methods. Appropriate introduction of 
functionality is followed by attachment of the precursor to 
a solid support, usually silica gel. Since the design of 
such stationary phases is almost invariably based on 1:1 
interactions between the CSP and analyte, the mechanism 
involved can often be deduced.®**
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Some early successes in the design of donor-acceptor 
CSP were obtained by Mikes and Boshart.81,82 Using chiral 
1,1'-binaphthylphosphate esters and nitroflurenyl- 
derivatives of hydroxypropionic acid bound to silica 
supports, these workers reported successful separation of 
the enantiomers of a number of helicenes. Despite low 
separation factors, the high efficiencies of these 
stationary phases allowed complete separation of 
enantiomers (a>l), indicating that for many analytical and 
preparative tasks, donor-acceptor silica bonded CSPs were 
the method of choice.
In his first CSP, Pirkle88 bonded a chiral anthryl 
alcohol to silica and used it to resolve a wide range of 
racemates (sulphoxides, lactones and derivatives of amines, 
amino acids and alcohols). An important interaction in the 
chiral selection process was the x-x interaction between 
the anthryl x-base substituent and a x-acid group on the 
solute enantiomer (eg., a nitroaromatic group), while 
hydrogen bonding between the stationary phase and the 
enantiomeric solute was also important. Pirkle's detailed 
understanding of the interaction between the CSP and an 
enantiomeric solute led to the possibility of predicting 
the elution order of individual enantiomers. In generalised 
form the process of chiral selection is illustrated in Fig 
6.5. In Fig 6.5a, the chiral selector in the stationary 
phase forms three interactions with one enantiomer whereas 
only two interactions are possible with its mirror image 
(Fig 6.5b). The latter is therefore less strongly bound by
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the CSP and will elute first. Pirkle utilised the 
reciprocity of the chiral selection process to prepare a 
second generation of CSPs. His original anthryl alcohol CSP 
gave good resolution of dinitrobenzoylphenylglycine 
enantiomers and hence dinitrobenzoylphenylglycine was 
bonded to the surface of silica.The resulting CSPs 
possessed such wide versatility for chiral resolution that
Fig 6.5. Generalised representation of the tree-point 
rul e.
two materials with N-(3,5-dinitrobenzoy1)phenylglycine 
ionically or covalently bonded to silica are commercially 
available (J.T. Baker; Regis). The material are used for 
normal-phase chromatography, for example with hexane- 
isopropanol mobile phases. An intrinsic advantage of having 
the chiral selector in the stationary phase is that only 
small quantities of the chiral selector are required, in
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contrast to diastereomer formation or methods in which the 
chiral selector is a component of the mobile phase. Further 
more, as the Pirkle CSPs are well suited to preparative 
scale separations**, the presence of a bonded chiral 
selector is advantageous because in cases where the chiral 
selector is a component of the mobile phase, it must be 
subsequently separated from the resolved enantiomer 
fraction.
Pirkle and co-workers** performed a series of solution 
magnetic resonance studies of chemical shift non­
equivalence between enantiomers induced by the presence of 
a chiral reagent known as chiral solvating agent (CSA). It 
was shown that chemical shift non-equivalence could be 
induced between the enantiomers of a variety of racemates 
by complexation with single enantiomers of a series of 
trifluoromethyaryl carbinols.** The non-equivalence was 
ascribed to the formation of diastereomeric complexes of 
the enantiomers of the racemate and the carbinol. Often 
only two points of direct interaction between the CSA and 
analyte were invoked to account for the observed chemical 
shift non-equivalence, and the essential third 
"interaction" being a perturbation of the magnetic 
environment. It was recognised that often more than two
07
interactions were involved, and that in such instances 
magnetic non-equivalence might be indicative of energetic 
differences between the diastereomeric complexes. Such 
differences are not essential to the chemical shift non­
equivalence, although they may contribute to this non­
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equivalence if present. Chromatography of the Ji-acceptor 
substituted lactone 76 on silica gel using the (R)- 
trifluoromethy1 carbinol 77 as the CMPA resulted in 
enrichment of (R)-76 in the first eluted fraction (Fig
6.6). The enrichment resulted from the preferential 
solvation of the (R)-76 by the CMPA, causing it to be less 
retained. Preferential solvation results from the three- 
point rule interaction between the (R)-76 and the (R)-77 
(Fig 7.5).^ Interactions include a hydrogen bond between
77 76
Fig 6.6. Three-point interaction between lactone 76 and 
chiral solvating agent 77 in the favoured diastereomeric 
complex.
the hydroxyl proton on 77 and the carbonyl oxygen of 76, a 
second weaker hydrogen bond between the carbonyl hydrogen 
of 77 and the lactone ring oxygen of 76, and a x-donor- 
acceptor complex between the aromatic rings. Covalent 
linkage of enantiomerical1y pure 2,2,2-trifluoro-1-[9-(10-
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bromomethyl)anthryl]ethanol to a silica support through a 
sulphide linkage resulted in CSP 6 capable of separating 
the enantiomers of a large number of x-acceptor substituted 
amine, amino acids and sulphoxides. Increasing the x-donor 
nature of the anthryl ring (CSP 7), substituting 
bromomethoxy for bromomethyl, improves the performance, 
indicating that the x-x interactions are indeed important 
in the separation of these enantiomers.85 The high degree of
CSP 6 CSP 7
separation displayed on CSP 6 and 7 by the enantiomers of 
N-(3,5-dinitrobenzoyl) amino acids derivatives indicated 
that these analytes might themselves be suitable candidates 
for incorporation into CSPs which could separate the 
enantiomers of x-donor substituted species. This inverse 
relationship between CSP and analyte has been called the 
reciprocality concept, and within limits, is a useful guide 
to the development of CSPs.50 That N- (3, 5-di nit robenzoyl ) 
amino acids were useful CSP precursors was demonstrated 
when these x-acceptor CSPs, particularly those derived from 
(R)-phenylglycine (CSP 8) and (S)-leucine (CSP 9), found 
rapid acceptance for the chromatographic separation of the
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enantiomers of a myriad of x-donor substituted amino 
alcohols, amino acids, sulphoxides and other compounds (Fig
6.7) .91
Further application of the concept of reciprocality, 
prompted the generation of a third generation of donor- 
acceptor CSPs, based on compounds which incorporate a good
CSP 8 RL=Ph R2=H
CSP 9 R*=H R2=i-Bu
Fig 6.7. x-acceptor CSPs derived from N-(3,5- 
dinitrobenzoyl)-derivatives of phenylglycine and leucine.
x-donor, and which show a high degree of separation on the 
N-(3,5-dinitrobenzoyl) CSP 8 and 9. Racemates separable on 
these "third generation" CSPs must, in general, be 
derivatised in order to incorporate the functionality 
necessary for separation. *2'*4 Derivatisation usually 
incorporates a electron-deficient x-system and is often 
accomplished by acylation of amino and hydroxyl groups with 
3,5-dinitrobenzoyl chloride or 3,5-dinitrobenzoy1- 
phenylisocyante. Carboxylic acids have been resolved as 
their dinitroani 1 ide derivatives.*4
Many of these x-donor CSPs have been derived from 1-
a * qq qc qc
aryl-l-amino alkanes. Oi and co-workersJ*'J,,,,J'70 have
-128-
demonstrated the usefulness of CSP 10, prepared from
enantiomerical1y pure l-(l-naphthyl)-ethylisocyante and
aminopropyl-derivatised silica gel, for the separation of
the enantiomers of N- and O-dinitrobenzoyl and
dinitroanalido-derivatised amines, alcohols and related
97compounds. Pirkle and Hyun, ' using a series of related 
CSPs, demonstrated that alkyl substitution of the aromatic
functionality of the homologs of l-(l-naphthyl)-1-amino 
alkanes, bonded to silica either by am amide linkage (CSP 






x-donor nature of the CSP, and consequently the extent of 
separation seen for a wide variety of racemates. They 
further demonstrated that the mode of attachment of the 
chiral a-arylalkyl amine to the silica support was of great 
significance for determining the extent and sense of chiral 
recognition, as more than one mechanism for chiral 
recognition is often operative on these types of CSPs. In 
the event of multiple chiral recognition mechanisms, these 
may differ in degree and sense of selectivity. It was noted 
that inversion of the elution order of enantiomers in a 
homologous series was often seen as the alkyl chain length 
of a given substituent increased. For example, the 
homologous series of N-(3,5-dinitrobenzoy1)-1-aryl-1-amino 
alkanes show, on CSP 12, an inversion of elution order from 
(R), most retained, to (S), least retained, as the chain 
length of the alkane increases. This behaviour has been 
explained in terms of competing chiral recognition 
processes of opposite enantioselectivity, the contribution 
from each being influenced by the length of the alkyl 
chain. H'10®
A number of donor-acceptor CSPs not incorporating 
strong x-donor or x-acceptor groups have evolved, based on 
N-acyl amino acids. CSPs developed by Hara and Oi, are 
related to CSPs developed for GC,*^ and are capable of 
separating the enantiomers of N-acyl amino esters. ^ -104 
These depend on hydrogen bonding and/or amide dipole 
interactions for their effectiveness. Either the dual 
hydrogen bonds or dipole-stacks may be considered analogous
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to a x-donor-acceptor interaction in that both are also 
two-point interactions, and therefore conformationally 
restrictive. The most effective phases of this type are 
those which are prepared from the amino acid N-formamides. 
Increasing the steric bulk of the amide substituent tends 
to decrease the effectiveness of the CSP.1®5
Several hybrids CSPs incorporating both x-donor and an 
amide functionality, often with multiple chiral centres, 
have been developed by Oi and co-workers (CSP 13 and 
1 4 ) . 93,106 These are prepared from acylated amino acids and 
chrysanthemic acid bonded covalently to silica through a 
variety of linkages, and can be used to separate a wide 
variety of racemates, but the relative complexity of these 
phases makes it difficult to establish a coherent chiral 




which may be prepared simply and directly from 
enantiomerically pure starting materials, such as N- 
aroylamino acids an<j show a very high degree of
enantiomeric separation on CSP 8 and 9. Chromatographic 
studies of the relationship between the structure of the N- 
aryl amino acids and their enantiomeric separability, 
allowed optimisation of the designs of these x-donor CSPs.32 
As the &G values, calculated from the separation factors 
observed for the diastereomeric adsorbates of N-aryl amino 
acids derivatives on CSP 8 and 9, are quite large, (as 
large as 6.7kJ mol"* in some cases), spectroscopic studies 
of the interactions of these analytes with soluble analogs 
of the CSPs was undertaken. Significant ultra-violet (UV) 
and NMR spectral differences were noted for the 
diastereomeric complexes. Such data, combined with observed 
intermolecular nuclear Overhauser effects, allowed for 
accurate delineation of the interactions responsible for 
chiral recognition in solution of N-aryl amino esters and 
the soluble analogs of CSP 9.*®3 These interactions (Fig 6.8) 
involve x-x interaction and two hydrogen bonds. Steric 
interactions are implicit in controlling the conformational 
preferences of the enantiomers. The complex (Fig 6.8) 
represents the structure of the more stable diastereomeric 
complex formed by interaction of the enantiomers of N-aryl 
amino esters and those of N-(3,5-dinitrobenzoyl)-amino acid 
derivatives. This finding may be generalised to account for 
the enantiomeric elution of a variety of analytes on CSPs 




Fig 6.8. More favoured diastereomeric complex between an N- 
(3,5-dinitrobenzoyl)-a-amino amide and an N-(2-napthyl)-a- 
amino ester.
uniformity permits assignment of absolute configuration to 
analyte enantiomers based simply on their elution order.
The most generally useful CSPs yet derived from N-aryl 
amino esters have been prepared from alanine (CSP 15) and 
valine (CSP 16). Both of these separate the enantiomers of 
a wide variety of N-(3,5-dinitrobenzoyl)- and N-(3,5- 
dinitroani1ido)-derivatives of amines and amino-substituted 
compounds. On the other hand 3,5-dinitrobenzoyl esters of 
chiral alcohols show little enantiomeric separation on CSP 
15 and 16 because they lack the acidic proton necessary for 
chiral recognition (Fig 6.8). Therefore, chiral alcohols 




isocyanate in order to achieve usable separations, the 
resulting dinitrophenyl carbamates containing the almost 
indispensable acidic N-H proton.
CSP 15 and 16 are somewhat limited in scope, generally 
requiring that the chiral centre also be the point of 
hetero-substitution and derivatisation. CSP 11 and 12 have 
been found to separate the enantiomers of compounds in 
which the chirality was one or two carbons removed from the 
derivatised substituent. CSP 15 and 16, however, generally 
give more rapid turnaround times than CSP 11 and 12, 
require less polar mobile phases and are more predictable 
in their behaviour. The lower cost and ease of preparation
of CSP 15 and 16 (as opposed to CSP 11 and 12) have also
allowed their rapid commercialisation (Regis). Pirkle and 
co-workers have also prepared several preparative scale 
MPLC columns packed with CSP 15 and 16 bonded to larger 
irregular silica particles. Fig 6.9 shows the chromatogram 
of the separation of 0.5g of ethyl ot-hydroxyisoval erate as 
the dinitrophenyl carbamate derivative on 300g of CSP 16 
bonded to 40um Brinkman silica gel. These MPLC columns have 
allowed the preparative separation of the enantiomers of a
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BFig 6.9. Preparative separation of methyl e-hydroxy- 
isovalerate as the 0-(3,5-dinitrophenyl)carbamate using CSP 
(R)-16 as chiral stationary phase.
number of chiral alcohols as their 3,5-dinitrophenyl
carbamates, including 1-phenylethanol , 1-tetralol and a
iq
number of 1,2-alkandiols. The enantiomerical1y pure free 
alcohols were then recovered by cleavage of the carbamate 
with HSiClj/EtjN.112
6.4 Chiral Mobile Phase Additives.
A chiral counter-ion dissolved in the mobile phase can
be used to separate enantiomers of acids and amines. The
basis for such resolutions is the formation of
diastereomeric ion-pairs with different stabilities or 
distribution properties between* the mobile phase and the 
stationary phase.
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Pettersson and Schill^ separated enantiomeric 1- 
aryloxy-3-isopropyl-amino-2-propanol derivatives using (+)- 
10-camphor-sulphonate as the counter ion in the mobile 
phase. The solutes, such as alprenolol, metoprolol, and 
propranolol, were resolved using silica gel columns with 
eluting solvents that contained as low a proportion of 
polar solvent, such as alcohol, as possible. 
Stereoselective association was believed to occur via 
diastereomeric ion-pair formation between solutes and the 
chiral (+)-10-camphorsulphonate counter ion. Such ion-pairs 
have structural differences substantial enough to 
distribute themselves differently between the organic 
mobile phase and the stationary adsorbent. The assumption 
that interaction at three-points adjacent to the chiral 
carbon atom is necessary for stereoselectivity was believed 
to be valid in this work. The necessary interactions in the 
ion-pair stereoselection process seem to be i) 
electrostatic attraction, ii) hydrogen bonding between the 
hydroxyl of the solute (1-chain and the oxo group of the 
camphorsulphonate, and iii) hydrophobic interaction between 
the ring systems.
The influence of hydrogen bonding agents in the mobile 
phase was found to be detrimental . In no cases could 
resolution be obtained if water was even a low 
concentration mobile phase component. Lipophilic alcohols 
of different structure, such as 1-pentanol and isopropanol, 
gave about the same selectivity, and hydrogen-donating 
agents gave slightly higher separation factors, but less
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symmetrical peaks (Table 6.2). Table 6.3 illustrates the 
structural effects of the sample on the separation factor. 
Oxprenolol enantiomers are unresolved probably due to the 
presence of the 2-alkoxy group at such a position in the 
ring that internal hydrogen bonding with the side chain 
hydroxyl was possible. Terolidine, which lacked a hydroxyl 
group, and hyosyamine, with its hydroxyl substituent too 
far removed from the amino group, were also unresolved.
Table 6.2. Influence of polar components in the mobile 
phase.
Polar solvent content (%) k* ( + ) a Asfa
Pentanol 0.5 20.3 1.08 1.5
1.0 10.8 1.06 1.1
5.0 2.0 1.02 1.1
Isopropanol 0.5 13.5 1.07 2.6
Acetonitrile 1.0 25.1 1.09 2.2
Tetrahydrofuran 1.0 11.9 1.10 3.7
Ethyl acetate 1.0 29.0 1.10 3.6
Asf, back part of the peak/front part of the peak.
Use of (+)-3-bromo-10-camphorsulphonate counter ions caused 
total stereoselectivity loss, probably due to steric 
interference which prevented good ion-pair formation.
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Table 6.3. Separation of enantiomers.
Enantiomer k'( + ) k'(-) a
Alprenolol 24.9 27.4 1.10
Metropolol 34.9 38.7 1.11
Oxprenolol 15.0 15.0 1.00
Propranolol 40.9 46.0 1.12
Terodiline 4.9 4.9 1.00
Hyoscyamine 7.3 7.3 1.00
i nPettersson and Schill extended their work with chiral 
counter ions to next study separation of 10- 
camphorsulphonic acid on a hydrophillic adsorbent with (+)- 
alprenolol (78) as the chiral counter ion in the organic 
mobile phase. Pettersson and No*^ presented extensive 
results of a study of resolution of enantiomeric carboxylic
78
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and sulphonic acids using the cinchona alkaloids, quinine 
(79), cinchonidine or quinidine (80) as the chiral counter 
ion (Fig 6.10). A further benefit of the study was the 
demonstration that detection could be improved, with high 
UV-adsorbing counter ion species. Even non-UV-adsorbing 
acids and anions could yield a UV response and the 
detection at low levels.***
Fig 6.10. 79 Quinine X=OCtt3, [3(R),4(S),8(S),9(R)];
cinchonidine X=H, [3(R),4(S),8(R),9(S)]; 80 quinidine 
[3(R),4(S),8(R),9(S)].
As in earlier work*** the negative effect of 1-pentanol 
on stereoselectivity was observed. Influence of the alcohol 
may be due to competitive interaction with functional 
groups in the ions, thus disturbing the selective 
interaction producing the diastereomeric ion-pairs. The 
nature of the anion in the mobile phase was especially
-139-
influential on the retention and stereoselectivity of 
carboxylic acids.^ Table 6.4 shows the results which were 
obtained with different counter ions, all having a distance
Table 6.4. Influence of counter ion structure on the 
stereoselective retention of 10-camphorsulphonic acid.
Chiral salt Content 1-Pentanol a +/-
(mol/1 10*) (%, v/v)
(+)-Alprenolol 10.0 0 0.95
chloride
(-)-Quinine 3.0 1 1.33
chloride
(-)-Quinine 3.5 1 1.47
acetate
(+)-Qininidine 3.5 1 0.77
acetate
(-)-Cinchonidine 3.5 1 1.24
acetate
of two carbons between the hydroxy and amino functions. 
(+)-Alprenolol (78), which has both of these functional 
groups incorporated into a straight chain gives a fairly 
low separation factor. Better a values were obtained when 
quinine and other cinchona alkaloids were used. The latter
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counter ion compounds contain a tertiary amino group in a 
ring system. It was suggested that improved 
stereoselectivity was due to the interaction of bulky and 
rigid groups in the vicinity of the chiral centre in the 
counter ion which could possibly increase the differential 
interactions with the enantiomers. In this work, 
enantiomeric camphor derivatives, mandelic, carboxylic and 
amino acid derivatives, were resolved, and 
structure/resolution correlations were made. Carboxylic 
acids, such as 2-phenylpropionic acid and naproxen with the 
aromatic ring structure, and a methyl group attached to the 
asymmetric centre, could not be separated by using cinchona 
alkaloid counter ions. A polar function such as a phenoxy 
group near to the chiral centre appears to be necessary for 
stereoselective retention. The fact that enantiomers of N- 
(1-phenyl ethyl)phtholmic acid were separable indicated that 
the carboxy group need not be directly bonded to the 
asymmetric carbon atom.*^
Recently quinine and other cinchona alkaloids have 
been immobilised on silica and used as CSPs.*** Acetylquinine 
has been used as the solid phase in combination with a 
chiral eluent.*** A low stereoselectivity was observed for 
naproxen without a chiral additive in the dichloromethane 
mobile phase. The presence of an amine, dimethyl octyl amine, 
in the mobile phase decreased the retention without 
affecting selectivity. Adding quinidine (ie., the same 
selector as in the stationary phase) drastically decreased 
stereoselectivity. However, using quinine as the counter
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ion gave a significant improvement in stereoselectivity. 
The explanation for this is due the fact that quinine and 
quinidine are diastereomers (Fig 6.10), and generally yield 
chromatographic systems with reversed retention order for 
enantiomers. A possible explanation for the observed 
stereoselectivity with quinine in the mobile phase is that 
the chiral stationary phase binds to the (+)-naproxen 
stronger than (-)-naproxen, and that the quinine molecules 
interact more strongly with the (-)-naproxen and accelerate 
its elution through the column.
Ion-pair chromatography is a flexible technique with 
several possibilities to regulate retention and 
selectivity. The counter-ion character and concentration, 
as well as the addition of alcohol and protolytes to the 
mobile phase, can be used to control the resolution. A 
change of the stationary phase can also be used to effect 
both the retention and the stereoselectivity.
6.5 COMPUTER ASSISTED MOLECULAR MODELLING.
One of the most useful tools for the study of 
interaction mechanisms of CSPs is computer assisted 
molecular modelling (CAMM). With the aid of powerful 
software packages, it is possible to visualise and optimise 
the structure of possible diastereomeric complexes. 
Optimisation in this context means the computation of 
structural parameters required for favourable 
intermolecular interactionss between the bonded chiral
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selector and the analyte enantiomers. This knowledge 
permits an approvement in the design of the CSPs, but at 
present in undertaking such computations some assumptions 
are made. For example, solvent effects are typically 
ignored, although it is known that the molecular size and 
shape of solvent molecules in the stationary zone occupied 
by the virtually stationary solvent, can effect
HI
enantioselectivity. The case is further complicated when 
mixed solvents are used since it is not necessarily correct 
to assume that the stagnant zone has the same composition 
to the free moving eluent.
At present CAMM systems that will indicate the 
appropriate CSP for a given separation are far from 
perfect, but with ever increasing computing power and 
software sophistication, the ability of CAMM systems to 
predict stable conformations and interaction forces, and 
consequently the ability to explain observed enantiomeric
discrimination will increase.
199Lipkowitz and co-workers1* made a detailed study of the 
covalent Pirkle CSP, N-dinitrobenzoyl-(R)-phenylglycine 
(CSP17). Using W. Clark Stills program and other supporting 
software, they established that the favoured conformation 
was syn rather than anti about the glycine's C-N bond (CSP 
18), a difference of ca 21 kJ mol"* existing between the two 
forms. Lipkowitz*^ also correctly predicted that the (S)- 
isomer of trifluoroanthrylethanol would form the more 
stable association complex with CSP 17, and thus be more 
strongly retained. However, their prediction differs
-143-
significantly from that proposed by Pirkle,22* who suggested 
that different conformations were adopted by the two 
enantiomers when associating with the CSP.
r,
CSP 17
Similar CAMM studies by Bridger et al125 of CSP 19 and 
20, derived from N-formyl-(S)-phenylalanine and 
nitrophenyl-(R,R)-tartramide respectively, have also been 




cyclodextrin with (R)- and (S)-propranolol, which required 
molecular structures of greater rigidity and complexity to
-144-
be modelled.
Despite the comparative ease of computing the separate 
conformations of each association complex, it is often time 
consuming, and more difficult to compute reliably the 
energy surface of the association complex together with
interactions as a result of weak intramolecular forces. The 
association complexes are compared visually in such a way 
that the physical modes are used. The interatomic distances 
can be compared and the angles at which hydrogen bonds may 
arise can also be considered. Yet despite such limitations, 
alternative mechanisms can often be discerned and placed in 
order of probability. With the imminent introduction of the 
transputer, such computations will, it is certain, become 
both faster and more reliable.
-<ch2 >3hh'
CSP 19 CSP 20
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CHAPTER SEVEN.
7.1 CONVERGENT SYNTHESIS OP THE TARGET CYCLIC PEPTIDES.
The initial target compounds, cyclo-leucyl- 
(allyl)glycine (13, 14) (Scheme 7.1), were synthesised as 
a diastereomeric mixture in order that a comparative test 
compound could be used subsequently for evaluation in HPLC
19 14
Scheme 7.1
separations. Both 13, 14 are derived from a linear peptide 
of the type shown above, which is compounded from two amino 
acids, R* being an L-amino acid, L-leucine, and R* being an 
amino acid of either L- or D-configuration. L-Leucine was 
chosen, from the twenty constituent amino acids, as 
together with alanine it is generally free from those side 
reactions^ which might interfere with the successful 
realisation of the target compounds. This lack of by- 
product formation obviates the need for tedious 
purification of the intermadiates, and also reduces the 
opportunity for racemistion to occur. The component Rl,
-156-
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which possesses an unsaturated terminal side chain required 
for eventual polymer attachment, is a glycine residue 
modified by an alkylation reaction (Scheme 7.2). The 






for the synthesis of structurally diversified amino acids, 
especially if both L- and D-isomers are required. The 
alkylation procedure chosen in this study is based on that 
reported by Stork et al,2 and involves the synthesis of a 
Schiff base, derived from bensaldehyde and glycine esters, 
which can be alkylated in the presence of strong bases 
under anhydrous conditions (Scheme 7.3). Other literature 
routes are available, notably those of O'Donnell,*"* who 
synthesised the alkylated glycine residue via alkylation of 
either ketimine or aldimine derivatives (Scheme 7.4).* These 
alternative methods were not evaluated in view of the 
success of the first chosen procedure described above.
The dipeptide intermediate, t-butyloxycarbonyl-leucyl- 
(allyl)glycine methyl ester (11), was sythesised by each of 
the three methods shown (Scheme 7.5). In addition a fourth
-157-
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, . 1 )  R3 -X/K2C03/CH,CN p3
R ^ H - C O g R 2 <n-C4H9 )4NfBr", reflux I
- ;  *  *> kv^ w .i.---------
4 3) ?H»6 W gn
R*=H; R2=C2H5; R3=C6H5, H; R4=CfiH5/ C6H4Cl; R5=CH2=CH(CH2)n-X
(n=any number, X=halide).
Scheme 7.4
method was tried in which the peptide bond was formed with 
the aid of the coupling reagent dicyclohexylcarbodimide 
(DCCI). The usefulness of this reagent was first determined 
by synthesising the simple dipeptide, t-butyloxycarbonyl- 
leucyl-leucine mehyl ester (3). However, it was found that 
this peptide was invariably contaminated by dicyclohexyl 
urea, formed in the course of the reaction. This problem 
may be overcome by using water soluble carbodimides such as 
N' - (4-diethylamino cyclohexyl)- (Fig 7.1a) or N-ethyl-N'-
-158-




•u C  * — N 0--— HN— L*
a=Mixed anhydride method 
b=Active ester method 
c=Azide method
Scheme 7.5
o  N = 0 = N  —^  — n<c2 h2 >2
C2H5-N = C = N -<  CHo >0-<  CH* >2'3 'tn3'2
Fig 7.1
(3-dimethylamino propyl )-carbodimide (Fig 7.1b) but in 
view of the success of the other methods detailed below, 
this fourth pathway to (II) was not pursued further. Of the 
methods finally used, method a involved the formation, in 
situ, of a reactive mixed anhydride intermediate, using 
isobutyl chloroformate (IBC),® of the amino-protected 
leucine residue (Scheme 7.6). The main advantage of this 
method is that the main by-products are the corresponding 
alcohol, isobutanol, and carbon dioxide, so facilitating
-159-
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work up of the required product (Scheme 7.7). 1BC was 
chosen on the basis of claims made by Vaughn et al* that 
this alkyl chloroformate was superior to a number of
< CHj )2CHCMjjO—-6=0 <ch3 )2chc h2oh * C02
Scheme 7.7
other alkyl chloroformates in giving the best yield, a 
claim later confirmed in studies by Anderson et ml.*
Method i> involved the synthesis of an activated ester 
intermediate, a para-nitrophenyl ester10 of the amino- 
protected leucine residue (Scheme 7.8). The active ester 
was subsequently coupled with the alkylated glycine residue 
to afford the required dipeptide. Various other active 
ester intermediates, such as the cyanomethyl ester11 or 
penta-halide aryl esters (eg., pentachloro/fluoro phenyl
-160-
Scheme 7.8
esters), ^»*3 could have been used in this synthesis, but 
para-nitrophenyl esters were chosen due to their proven 
usefulness in peptide synthesis, most notably in the 
synthesis of the nonapeptide oxytocin (Pig 7.2),** formed by 
the stepwise elongation of the peptide chain by the 
addition of single residues.**
R f - t t u - O l w N H g
Fig 7.2
Method c involved the formation of a reactive 
intermediate, in situ, using diphenylphosphoryl azide 
(DPPA) (Scheme 7.9).** DPPA converts carboxylic acids into
C X
a




the corresponding acid azide and subsequent nucleophilic 
attack by the amino component affords the required 
dipeptide. It is possible to form the acid azide via the 
hydrazide intermediate, but this would require isolation 
and purification of the intermediate. In addition, this 
method^ also requires the use of DCCI as a coupling 
reagent/dehydrating agent, and persistent contamination 
would again be anticipated (Scheme 7.10). Using DPPA 
simplifies the synthesis as the reactive intermediate is 
formed in situ and requires no isolation. Cylcisation of 
the dipetide was acheived using the method of Nitechi et
An alternative strategy for the preparation of the 
initial target compounds (13, 14) involves the synthesis of 
the linear dipeptide (1 1 ) such that the alkylated glycine 
residue is the first residue counting from the N-terminus 
(Fig 7.3). This route involves the synthesis of alkylated 





retro-synthetic scheme is in Scheme 7.11. It would have 
been equally suitble had not the saponification of the 
ester to the free acid given only moderate yields.
The synthesis of the next target compound (Scheme 
7.13)# a cyclic tetrapeptide (24), could be achieved by 
several methods. These involve the formation of a linear 
tetrapeptide (22) prior to cyclisation to give the required 
product. Two routes towards the linear tetrapeptide were 
attempted. Route 1 involved the hydolysis of the di-leucine 
methyl ester peptide (3), using the method of Iselin et 
al,^ to give the corresponding carboxylic acid. Had this 
method worked satisfactorily, the mixed anhydride method* 
would have been used to form the tetrapeptide. However, a 
very poor yield resulted from the hydrolysis step and so, 
this second stage was not attempted.
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n=l (13, 14) 
n=3 (18, 19)



















Scheme 7.13. Convergent synthesis.
Boc-Leu2-CO-NHNH2 21
Boc-Leu2-OCH3 3 



























Route 2 involved the synhesis of a hydrazide 
intermediate which could then be converted to the azide 
using sodium nitrite*® or butyl nitrite**. Subsequent 
coupling with the alkylated glycine residue would afford 
the linear tetrapeptide (Scheme 7.14). For the cyclisation 
of the linear tetrapeptide several options are possible, 
and are discussed in more detail in CHAPTER EIGHT, section 
8 . 1 1  of this thesis.





7.2 ALTERNATIVES TO THE SYNTHESIS OF UNSATURATED GLYCINE 
DERIVATIVES.
Subsequent to the work described in this thesis, there 
has appeared in the open literature, several alternative 
syntheses of allyl glycine (7).**"**
In their study of the synthesis of functional amino
-166-
acids by reaction of an electrophilic glycine cation 
equivalent with neutral carbon nucleophiles, O'Donnell and 
Bennett^ synthesised diphenylmethyl-D,L-(allyl)glycine 
ethyl ester. Thus reaction of an ot-acetoxyglycine Schiff 
base with allyl trimethylsilane, in the presence of TiClj, 
gave the a-substituted amino acid in yields of up to 44%. 
The acetate derivative has been described as "a versatile 
cationic equivalent, being easily prepared and containing 
several structural subunits of interest for bond formation 
to the a-carbon." Reactions are of the general type shown 
in Scheme 7.15.
, h j C H = * ' ^ ' C O a C jH s  H r m o t i o n -  H u -C H -C O jH
Scheme 7.15
This work was confirmed by Castelhano et al^3 who 
studied the synthesis of a-amino acids with (3,y-unsaturated 
side chains. Under Lewis acid conditions N-carbobenzyloxy- 
(allyl)glycine methyl ester was synthesised with ca 80% 
conversion of the starting material to the product (Scheme
7.16). Van der Werf and Kellogg^ studied the synthesis of 
a-allyl-a-amino acids by means of a palladium catalysed 
intramolecular re-arrangement via a variation of the 
Carroll reaction.^ Various L-a-amino acids were converted 
to the allylic ester, and then to the imines (80) (Scheme
7.17). The overall yield for these steps was 75-80%.
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Scheme 7.16
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Compound 80 re-arranged cleanly to 81 (Scheme 7.18) in the 
presence of 1 ,2 -bis-diphenylphosphinoethane palladium(O) 
(Pd(dppe)j). Quenching the carboxylate salt with CH3I and 
subsequent in situ hydrolysis of the imine, afforded the 
methyl esters (82) as stable compounds. No reaction occurs 
in the absence of catalyst. Yields for the re-arranged 
product from the imine range from 65-90% depending on the 
base used.
All the alternatives described above afford the 
racemic product. A recent paper, by Williams and Zhai,^ 
describes a versatile, stereocontrol1 ed, asymmetric
-168-
synthesis of £-vinyl glycine derivatives (Scheme 7.19). 
Yields ranged from 70-80% with enantiomeric excess (ee) of
__ bast KOBu1 y + P«dpp#>280 -------- » 80 H .. ■    »
2 ) CHaZ











a:- NBS/CC14; b:- RjSn-C^C-R, ZnCl2 /CCl4, reflux; c:- 
Na/NH3/EtOH
R=CH3, n-CjHy, n-C6H13, (CH^OSiMejBu1.




55-70% for the Na in liquid ammonia/EtOH reduction. Reduced 
yields were obtained using Li as reductant, but ee 
increased to 98%. This method is of potential use in a 
modified form for future synthesis of unsaturated glycine 
derivatives with a terminal double bond. The proposed route 
would be similar, except that a trialkyl tin derivative 
would be the carbanion source as shown in Fig 7.4. Such tin
R ^ 9 n——< C Hg > H
Fig 7.4
compounds can be easily synthesised beginning from the 
corresponding unsaturated alcohols, as outlined below 
using the methodolgy described by Seyferth^ (Scheme 7.20), 
and Corey and House (Scheme 7.21).^'^ Protection of the 
hydroxyl function can be achieved by conversion to the 
trimethylsilylether.
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8.1 Synthesis of tert-butyloxycarbonyl-L-leucine (1) and L- 
leucine methyl ester hydrochloride (2 ).
The synthesis of tert-butyloxycarbonyl-L-leucine (1) 
(Scheme 8.1) was achieved in 84% yield using the method of 
Schwyzer et al.* Elemental analysis of the product indicated
Scheme 8.1. a) Dioxane/^O, NajCOj (Boc^O, 0°C-->RT
that a mono-hydrate had been isolated, and the product was 
stored in this form. Prior to further use in synthesis, 
samples of the product were first dried by azeotropic 
distillation of water with benzene, which had been dried 
with sodium-lead alloy, and then held in vacuo for ca 24h 
before use.
L-leucine methyl ester hydrochloride (2) was 
synthesised (Scheme 8.2) by either one of two methods. 
Method a involved the use of 2,2-dimethoxypropane (2,2 
DMP),* which serves both as a de-hydrating agent, and as a 
source of methoxy-groups (Fig 8.1). This has the advantage 
that it does not require the use HCl gas or specially 
prepared solvents. Both methanol and acetone can be easily
-175-
removed, and the method is well suited to small scale
J L ^  Method a, 68<< Jl ^HpN-^ cOoH M ° 11 ► HC).H2*r,N:oPCH32 2 Method b, 87*/. 2 2 3
Scheme 8.2. Method a:- 2,2 DMP, cone HCl , RT, 48h;
method b:- MeOH, dry HCl gas, RT.
preparation, where the cost of the 2,2 DMP is not 
prohibitive. Method b (Scheme 8.2) was based on the 
procedure given by Schott et al ,* in which dried HCl gas was 
bubbled through a suspension of L-leucine in dried 
methanol. The procedure gave good yields of very pure 
product, and had the advantage over method a that it could 
be scaled up without difficulty and prohibitive costs.
hV h»n-chr-co9h




8.2 Synthesis of oliqo-L-leucine peptides.
The synthesis of tert-butyloxycarbonyl-L-leucyl-L- 
leucine methyl ester (3) was achieved, for comparative 
purposes, by two methods a and b. The two methods used to 
synthesise (3) are shown in Scheme 8.3. In method a . 
peptide bond formation was achieved with the aid of 
dicylclohexylcarbodimide (DCCI) , ^ ' 6 and in method b via the
Scheme 8.3. Method a:- DCM, disopropylamine, DCCI, HOBt, 
0<fc-->RT; method b:- THF/DMF, base, IBC, -15°C, 6-24h.
formation of a reactive mixed anhydride intermediate, 
formed from isobutylchloroformate (IBC) . 6 Of the two 
methods, method b gave better yields. There was also a 
large difference in the measured optical rotation of the 
compounds produced by the two methods ([ct]D= -26 and -4 9 . 8  
for (3) from method a and b respectively). Papers published 
by Nitechi et a 1 and Suzuki et al, 6 give optical rotations 
of -50.4 and -55 respectively for (3), both groups using 
the carbodimide method of synthesis, but Shields et al6 
reported a measurement of only -25.7 using the mixed 
anhydride method. It would appear AXxat the pure compound 
has a [u]D value of ca -50, and can be prepared by either 
procedure. However, lower values presumably reflect impure 
material either due to racemisation or dicyclohexylurea
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(DCU), which is inherently difficult to remove 
satisfactorily. The wide melting-range of (3) produced by 
method a (100-105°C), is also considerably lower than that 
quoted in the literature (136-137°C; 141-142°C; 132-133°C) ,6'8 
and is also indicative of persistent contamination.
8.2.1 Mechanism of peptide bond formation with 
dicyclohexylcarbodimide.
The mechanism of this coupling reaction was elucidated 
by Smith et al5 (Fig 8.2). Activation of the carboxylic acid 
group is initiated by the transfer of its proton to the 
double bond of the carbodimide (I). The resulting compound 
(II), may react in two different ways. 0->N Acyl migration 
can occur with the formation of an N-acyl urea (III) if no 
further protons are available. In the presence of excess 
acid, the second addition of a proton takes place, and 0->N 
acyl migration is prevented so that (IV), a symmetrical 
anhydride, is formed together with a di-substituted urea, 
DCU. It is the anhydride which appears to be the species 
that reacts with the amine to give the desired product (V), 
and an acid, which can be "re-cycled" in to the reaction. 
The product (V) might also be formed from (II), but there 
exists here the opportunity for racemisation via 
oxazolones/azalactones The mechanism can be shown as
illustrated in Fig 8.3, where X is an electronegative group 
of the type present in activated intermediates for peptide 
synthesis. Enhancement of the electrophilic character of 
the carbonyl carbon C5 facilitates the attack of the
-178-
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carbonyl oxygen Cl. The oxazolone formed has a strong 
tendency, especially in the presence of base, to lose a 
proton at carbon C4, thus giving the resonance-stabilised
-179-
anion of oxazolone, leading to racemisation of the amino 
acid (Fig 8.4).
Fig 8.3
Oxazolones are good acylating agents, and could be 
used for the activation of the carbonyl component, yet 
delocalisation of the negative charge in the de-protonated
Fig 8.4
intermediate provides them with sufficient lifetime to 
endanger the chiral purity of the product. The formation of 
oxazolones has been demonstrated by Williams et al ,** using 
infrared spectroscopy to monitor the characteristic 
carbonyl frequency (1832cm"*) observed when benzoyl-L-
-180-
leucine-para-nitrophenol ester was exposed to tertiary 
amines (Fig 8.5). Racemisation through oxazolone 
intermediates is influenced by a number of factors, such as 
the nature of the amino acid involved, the solvent used in 
the reaction, or the presence of tertiary amines. The acyl 
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in the conservation or loss of chiral purity. For example, 
under identical conditions, benzoyl amino acids are more 
extensively racemised than acetylamino acids.^ Such 
differences seem to be related to the electronic forces 
operating on the acyl-group. Beyond the formation of 
oxazolones, the W-acyl substituent of the oxazolinone can 
also affect the acidity of the hydrogen atom on the chiral 
centre ie., the stability of the anion produced in the 
proton abstraction by bases is enhanced by the electron 
with-drawing effects of the acyl-group (Fig 8 .6 ). Oxazolone
-181-
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formation is probably not as important as the electronic 
effects of the substituent of the oxazolinone, including 
those in the W-acyl-group, in determining the extent of 
racemisation. Oxazolones can however, be obtained in 
optically active form,*3 and if immediately trapped by good 
nucleophiles,^ can yield optically active products.
The influences of the N-acyl-group on the stability of 
the anion generated through proton abstraction from the
oxazolone can range from extreme stabilisation, found in
the formyl and trifluoroacetyl-groups, to pronounced de- 
stabilisation, shown by the benzyloxycarbonyl, tert- 
butyloxycarbonyl (Boc), and other alkyloxycarbonyl groups. 
It had been generally assumed that benzyloxycarbonylamino 
acids, and in general, amino acids protected by a urethane
type blocking group, did not produce oxazolones, and were
therefore resistant to racemisation during activation and 
coupling. However, isolation^ of optically pure oxazol- 
(4H)-ones eg., from the reaction of tert-butyloxycarbonyl- 
L-valine with water soluble carbodimides, contradicts such 
assumptions, and suggests that the beneficial effects of
-182-
urethane type protecting groups rests on the electron 
release provided by them, and on the resulting de- 
stabilisation of the anion which could be formed by proton 
abstraction (Fig 8.7). It is highly probable that in 
addition to the already mentioned mechanism of base- 
catalysed racemisation, other pathways also exist.
The role of bases, in at least some racemisation 
processes, is beyond doubt. For instance, it has been noted 
that there are advantages of free amines over amine salts 
in suppressing racemisation. So far less attention has been 
paid to the possibility of intramolecular base catalysis. 
Since O-alkylisoureas have pronounced basic character, it 
could be assumed that proton abstraction by a basic 
nitrogen atom in the O-acylisourea intermediates of the 
carbodimide mediated coupling reaction is possible (Fig 
8.8). Alternatively enols stabilised by hydrogen bonding 
formation might play a role in such processes (Fig 8.9). 
This becomes analogous to the effect of excess acetic 
anhydride on optically active amino acids, where 















The re-arrangement of O-alkylisoureas (II) (Fig 8.11) 
to the N-acylurea (III) also "stops" the reaction, as the 
latter are not acylating agents. However, their formation 
can be minimised by performing the reaction at 0°C or lower, 
and also by using non-polar solvents, such as DCM or MeCN.
A technical difficulty in the preparation of peptides 
using DCCI, referred to earlier, is the complete removal of 
the DCU formed when reactions are carried out in most
-184-
organic solvents except alcohols. This problem has been 
circumvented by the introduction of carbodimides which give 







8.2.2 Mechanism of peptide bond formation via mixed 
anhydrides.
The use of alkyl chlorof ormates as peptides bond 
forming reagents was independently proposed by three
of speed, yield, and relative purity of products. Previous 
methods of mixed anhydrides employed alkyl-groups of the 
type illustrated in Fig 8.12. In general, if X=CHj or 
phenyl, low yields were obtained, since, in the case of 
X=phenyl, the electron with-drawing effect rendered the 
carbonyl carbon of the benzoyl residue sufficiently 
electrophilic to compete in the acylation of the amine to 
a significant extent with the protected amino acyl moiety 
(Fig 8.13). For more satisfactory results, an electron 
releasing structure was required. This was partially 
fulfilled by the use of longer aliphatic chains, especially
g r o u p s . T h e  method became popular due to its advantages
-185-
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Protectsprotecting group; X=alkyl [CHj, (CHj)jC, 
(CH3)2CHCH2] or phenyl.
Fig 8.12
acids with branched chains eg., Xs(CH3)3C, which gave good 
yields with little by-product formation. However, it may be 
reasonable to assume that steric hinderance also 
contributes to the formation of the required product.
Fig 8.13
A different approach was proposed18-*® in which the X- 
group was an alkoxy-group, the alkoxy-group being the 
electron releasing part of the molecule ie., replacement of 
carboxylic acids with half esters of carbonic acids (Fig
8.14). In the presence of an acid binding agent, such 
triethylamine (TEA), a rapid reaction occurs between the 
protected amino acid, or peptide, and the chloroformate, to 





carbonic acid carbonyl is diminished by the effect of the 
unshared pair of electrons on the neighbouring atom (Fig
8.15). Hence only little second acylation product, a 




advantage of the method that the by-products formed in the 
decomposition of the leaving group are an alcohol and 
carbon dioxide, which do not interfere with the isolation 
of the protected peptide. Participation of the "wrong " 
carbonyl group in the acylation reaction was further 
reduced by the modifications proposed by Vaughn, who 
introduced isobutylchioroformate (IBC) (Fig 8.17), one of 
the most widely used activating reagents in peptide
-187-
synthesis. In this method, the undesired attack on the 
carbonyl-group of the carbonic acid usually yields less 
than 1% of the urethane.
Prot*et'
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Formation of the mixed anhydride is practically 
instantaneous, even at low temperature (-15°C), as indicated 
by the immediate precipitation, if insoluble in the 
solvent used, of the corresponding hydrochloride salt of 
the base. The mechanism of the reaction is illustrated in 
Fig 8.18.
Factors which affect yield, and racemisation using 
this method have been reviewed by Anderson et al.21 He 
states that the tertiary base used for mixed anhydride
-188-
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a=base eg., N-methylmorpholine; b=IBC
Fig 8.18
formation of an acyl-amino acid or acyl-peptide with an 
alkylchioroformate is not merely a hydrogen chloride 
acceptor. It first reacts with the chloroformate to form a 
quaternary compound, which in turn reacts with the 
carboxylic acid. Hethyl-amines give the fastest reaction, 
showing the importance of steric factors. However, methyl- 
amines also cause most racemisation, indicating that 
racemisation is also sterically influenced (Fig 8.19). The 
discovery that bases, such as N-methylmorpholine (NMM), 
gave rapid anhydride formation without racemisation in test 
cases, indicated racemisation to be a separate process from 
anhydride formation. Anderson et al21 also state that 
triethylamine, although a good racemising agent, when used 
in excess, could be used without causing racemisation, if 
not in excess, and the precipitation of the HCl salt could
-189-
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be used as an indicator for mixed anhydride formation.
In earlier reports Young and co-workers, and Vaughn,22‘2* 
noted that the mixed anhydride method had been reported to 
produce a substantial degree of racemisation. Anderson et 
al22 showed that oxazolone formation was evident in the 
mixed anhydride method. However, other workers22*22 suggest 
racemisation can be minimised if the reaction is performed 
at low temperatures (-15^C) and that no more time than 
necessary is allowed for the formation of the mixed 
anhydride. Applewhite and Nelson28 suggest that "inverse" 
addition also reduces racemisation. According to this 
procedure, a solution of the salt of the protected peptide 
with a tertiary amine is added to a solution of the alkyl- 
chloroformate, which is used in excess (2-5 molar). In this 
way the basic carboxylate anion is present in the reaction 
mixture for a very limited period. However, Anderson et al22
-190-
have reported that the method of "inverse" addition appears 
to produce a substantial degree of racemisation, in the 
range of 3-6%, in the synthesis of benzoyloxycarbonyl- 
glycyl-L-phenylalanyl-glycine methyl ester.
8.2.3 Removal of the protecting group. tert- 
butyloxycarbonyl.
Cleavage of the Boc group was accomplished using 
trifluoroacetic acid (TFA)^ (Scheme 8.4). The deprotected 
oligo-peptides were either precipitated from ether/pet 
ether, or the solvent removed in vacuo, and used without 
further purification or characterisation.
8.2.4 Synthesis of tri- and tetra-L-leucine methyl ester 
peptides.
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Scheme 8.4
achieved in a similar fashion to that of the oligo-di-L- 
leucine methyl ester (3) (Scheme 8.5). Yields, as expected
<C h 3 :
\
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a:- TFA, lh, RT; b:- base, THF/DMF, IBC, -15°C, 24h
Scheme 8.5
decreased with increasing peptide chain length due to 
steric crowding around the carbonyl group which the amino 
component attacks. Again a discrepancy is found in our 
measured optical rotations, and those reported by Shields 
et al* (Table 8.1). However, the identity of the product is 
confirmed by both NMR and MS data, with no sign of 
impurity.
-192-
Table 8.1. Comparison optical rotation of oligo-L-leucine
peptides.
Boc-L-(Leu)B-OMe 
n Measured value Literature value
la
rHCMCM1 -24.0l
2b -26.0 -50.47; -55.08;
2C -49.8 -25.76
3C -64.3 -21.76; -75.ld
4° -86.9 -16.46; -92.6d
a:-Boc-L-Leu-OH; b: -Dicyclohexylcarbodimide method or 
variation of; c:-Mixed anhydride method; d:- G.M. Benora, 
A. Maglione and C. Toniolo; Polymer, 1974,15,767.
8.3 Synthesis of benzylidine glycine methyl ester (6).
The synthesis of benzylidine glycine methyl ester (6), 
was achieved by the method of Stork et al88 (Scheme 8.6). 
The product, although synthesised in high yield, was 
slightly impure (NMR data), but this was considered 
suitable for direct use in the next synthetic step.
8.3.1 Alkvlation of benzylidine glycine methyl ester with 
al1vlbromide.




a:- DCM, PhCHO, TEA, RT, 48h.
Scheme 8.6
in poor yield (ca 40%) due to a second alkylation reaction, 
in which the glycine residue is di-alkylated to give (8) 
(Scheme 8.7). Evidence for this comes from NMR data, which
shows two OCHj peaks at 3.85 and 3.88ppm for the mono- and 
di-alkylated products respectively. The ratio of mono-:di- 
alkylated product was calculated by the ratio of the 
integral peak heights of the ct-CH of the mono-alkylated 
product (7) to that of the combined integral peak height 





40%, isolated as the hydrochloride salt, but this was 
increased considerably to 60% under the reaction conditions 
used, as described in the EXPERIMENTAL section.
The presence of (8) was also confirmed by MS data [m/e 
(C.I.); (M+l)*, 170; hydrochloride salt]. The two products 
were not separated as it was considered that (8) would 
react very much more slowly than (7), due to the greater 
steric hinderance, as a result of the two alkyl-side 
chains.
The alkylated glycine could be de-protected by one of 
two methods:- i) by bubbling HCl gas into an aqueous 
methanolic solution of the product, followed by removal of 
the methanol in vacuo, before washing with ether, and 
removal of the water in vacuo or ii) by vigorously stirring 
a solution of the product, dissolved in 2M HCl, with ether 
for one hour at ambient temperature, before washing with 
ether, and subsequent removal of the aqueous acid in vacuo.
8.3.2 Synthesis of tert-butvloxvcarbonvl-D.L-(allyllalvcine 
methyl ester (9).
The synthesis of this compound (9), was achieved by 
using a slightly modified method to that used for the 
synthesis of (1) (Scheme 8.8). Considerably more base is 
used to ensure that any remaining acid from the previous 
step was neutralised. A slightly larger quantity of (Boc^O 
was also used to ensure complete reaction of the starting 
material. As proposed earlier, the rate of reaction of the 
di-alkylated (8), compared to that of the mono-alkylated
-195-
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a:- dioxane/fyO, NajCOj, (BocJjO, 24h, 0°C— >RT.
Scheme 8.8
(7) glycine residue, would be slower. This has been 
confirmed by NMR measurements on (9), which shows only one 
peak due to OCH^ at 3.74ppm. The absence of (8) is also 
shown by the greater simplicity of the NMR spectrum.
8.3 Hydrolysis of tert-butyloxycarbonyl-D,L-(allyl)glycine 
methyl ester (10).
Hydrolysis of (9) to the free carboxylic acid (10) 
(Scheme 8.9), was affected using aqueous NaOH, a method 
based on that of Iselin et al.^ Hydrolysis of alkyl esters
9 10
a:- MeOH, NaOH (aq), 0°C, 3h.
Scheme 8.9
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of peptides with alkali is a frequently used method for the 
removal of blocking groups from the C-terminal carbonyl 
group, but the method is far from being specific, 
especially if the peptide chain is long, where a danger of 
hydantoin formation exists (Fig 8.20). If found, the 
hydantoin could ring open under the influence of excess
alkali with the production of a urea derivative. This ring-
35closure-elimination reaction** occurs particularly readily 
if glycine is the second amino acid in the sequence.33 
Fortunately hydantoin formation only appears to occur if 
the carbonyl group in urethanes is flanked on both sides by
atoms with unshared pairs of electrons, as illustrated 
above in Fig 8.20. Most side reactions can be kept to a 
minimum by performing the saponification at 0°C rather than 
at room temperature, by adding the alkali in small






portions, and avoiding excess. However, methyl ester 
peptides are useful as they are easily converted to the 
corresponding hydrazide.
8.4 Synthesis of tert-butyloxycarbonyl-L-leucine-D,L- 
(al1vl)glycine methyl ester (11).
The synthesis of this compound (11), was achieved by 
three methods:- a. mixed anhydride method using IBC, b 
activated esters, and c. acid azide method (Scheme 8.10).
a:- DMF, (7)/base, IBC, -20°C-->RT; b: -DMF, (7)/base, DPPA, 







8.4.1 Mixed anhydride method.
The synthesis of the di-peptide (11), was successfully 
achieved in 49% yield. The methodology is similar to that 
used for the synthesis of the oligo-leucine peptides (3), 
(4) and (5), the mechanism of which has already been 
discussed.
The lower yield in comparison to the synthesis of the 
di-leucine peptide (3), 49% compared to 80%, may be due to 
steric factors (Fig 8.21). The carbons at Cl and C2 are 
both electrophilic, but C2 is less so, due to the electron 
releasing nature of the alkoxy-group. It would therefore be
<c h,>.,c h c h*-o -
Fig 8.21
reasonable to assume that the amino component is more 
likely to attack the "correct" carbonyl group. However, 
because the alkenyl-glycine residue (7) is less sterically 
hindered than the corresponding leucine residue (2), it may 
be possible for amino component to attack at C2 as well as 
at Cl even though C2 is less electrophilic. (Fig 8.21). 
Initially this method for synthesising the di-peptide was 
unsuccessful, as the amino component attacked the "wrong" 
carbonyl carbon centre, to form instead a urethane type
-199-
compound (Fig 8.22). The formation of this product was
neutral amino acids that had been modified eg. , 
halogenated, nitrated, unsaturated, could be employed with
the mixed anhydride method. Two explanations seem possible 
for the formation of the urethane by-product:- i) as 
already mentioned, attack at the "wrong" carbonyl centre 
after the formation of the mixed anhydride or ii) attack of 
the amino component on the un-reacted IBC, which had failed
to form the mixed anhydride (Fig 8.23). Extensive urethane
35formation has however, been reported by Alberston in the 
coupling of the IBC mixed anhydride of 2-acetamidononanoic 
acid with amines, and in the attempted coupling of mixed 
anhydrides of pyruvic acid with esters of amino acids. In 
the latter case, a cyclic intermediate has been inferred, 
which altered the point of attack of the amino ester from 
which would normally be expected (Fig 8.24). Subsequent 
syntheses of the di-peptide using this method did not 
produce any urethane by-product detectable by either TLC 
analysis or by *H NMR spectroscopy on the crude reaction 
mixture.
unexpected, as it had been reported by Alberston,^ that
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8.4.2 Activated ester method.
Unequivocal coupling reactions can only be achieved if 
a single electrophilic centre is present in the acylating 
agent, and thus the nucleophile, the amino component, is 
acylated in a unique way. The inherent presence of two 
electrophilic groups in mixed anhydrides suggests that they 
cannot entirely fulfil this requirement of a "ideal" 
acylating agent, although mixed anhydrides obtained with 
phosphoric acid may be exceptional in this respect. 
Symmetrical anhydrides of protected amino acids also have 
two reactive carbonyl groups, but because of the symmetry 
of the molecule, the two acylation products are the same. 
An alternative addition to unequivocal acylation is if the 
electron with-drawing substituent used for the activation 
of the carbonyl-group were to play the role of an acylating 
agent, then only the amino acid carbonyl can become part of 
the newly-formed peptide bond. Such substituents include 
acid chlorides, and azides, which, although prone to other 
side reactions, do not form second acylation products since 
the leaving group cannot form amides.
Bodansky was prompted to re-consider the relationship 
between the electron distribution in thiophenyl esters, 
originally proposed by Wieland et al,38 after Gordon, Miller 
and Day3*'38 observed that the ammonolysis rates of vinyl and 
phenyl esters exceeded those obtained with alkyl esters. 
The comments of Gordon, Miller and Day37'38 suggested that 
thiophenyl esters of protected amino acids owed part of 
their reactivity to the fact that they are esters of thio-
-202-
esters, and that their ability to form amides under mild 
conditions was probably due to the fact that they are acyl
substituted phenols ortho-, meta-, para-nitrophenols, and 
2,4-dinitrophenol. However, esters of the latter were too 
reactive, and accordingly too sensitive to hydrolysis by 
water in the reaction mixture. Of the mono-substituted 
phenols, the para-derivative was selected as the main-stay 
of peptide synthesis, due mainly to the readiness of its 
esters to crystallise. Some advantages of the ortho-nitro- 
analogs were overlooked, and were not recognised until many 
years later, and para-nitrophenyl esters of
benzyloxycarbonyl-amino acids were used in practical 
s y n t h e s i s a s  demonstrated by the synthesis of oxytocin.
The synthesis of the para-nitrophenol ester derivative 
(12) was achieved in 60% yield. para-Nitrophenol was re­
crystallised from toluene before use, and the product 
prepared with careful exclusion of moisture due to the ease 
with which the ester hydrolyses when in solution. The
esters (Fig 8.25). Bodansky*0 examined the negatively
Fig 8.25
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reaction vessel was also covered if aluminium foil in order 
to minimise the possibility of photo-decomposition of the 
product formed in the reaction mixture.
The di-peptide (11), was synthesised in 38% yield. The 
low yield obtained is attributed to a poor batch of the 
mono-alkylated glycine. The addition of 1-hydroxy- 
benzotriazole (HOBt) is claimed to catalyse acylation,** and 
to suppress racemisation, although there has been some 
doubt about the latter. The mechanism for its catalytic 
action is a little unclear, but it has been suggested that 
the HOBt displaces the ester functional group, protecting 
the carbonyl group of the amino acid ester, to from a more 
reactive HOBt ester intermediate. Supporting evidence for 
this postulate comes from the isolation of a crystalline 
compound* (Fig 8.26), bands in the IR spectrum of which are
in o r y s t a l l l n e  sta to  
<IR c* 1 7 3 0 c n ’ 1 )d
(IR 1 8 1 5 - 1 8 2 0 c n ” *>
In sol ution
Fig 8.26
consistent with A (solid state, 1730cm’*), and in solution 
with B (1815-1820cnf*). The displacement of the para- 
nitrophenyl ester can be written as illustrated in (Fig
8.27). Subsequent nucleophilic attack by the amino acid 
component gives the peptide, and also re-generates the 
catalyst (Fig 8.27).
The additive HOBt, is usually employed in an equimolar 
amount with the two components to be coupled, hence there 
are two moles of nucleophile present in the reaction 
mixture for each mole of carbonyl component. Therefore, the 
life-time of highly reactive reactive intermediates is 
considerably reduced. The concentration of the additive, 
which is acting as a second nucleophile, hardly changes 
during the coupling reaction, because it is continually 
being re-generated. Hence there is a significant change in 
the kinetics of the process. The active ester, formed in 
situ, is less conducive to side reactions, and yet it is 




8.4.3 Acid azide method.
Synthesis of the di-peptide (11), was achieved in 61% 
yield using diphenylphosporylazide (DPPA) to form the azide 
in situ.^ The DPPA reagent converts peptides with a free 
carboxyl group at the C-terminus to the desired acid azide 
without the need to isolate intermediates. The mechanism of 
this reaction was elucidated by Shioira et al^ (Fig 8.28).










The carboxylate anion may attack the phosphorus atom of 
DPPA to give the penta-valent compound (VIII), and the 
mixed anhydride (IX). An equilibrium exists between (VIII), 
and (IX). The amino component will attack (VIII), and (IX)
-206-
to give the amide. Spectroscopic studies of racemisation 
during the Young test** were also performed by Shioira et 
al.*® They found no oxazolone formation, by observation of 
the IR spectrum at 1830cm’* when an equimolar mixture of 
benzoyl-L-leucine and TEA in chloroform was treated with an 
equimolar DPPA at 0°C. However, when the Young test was 
performed after the formation of (IX), by the action of 
dipheny1phosphorochloridate with benzoyl-L-leucine in the 
presence of TEA using the Zervas procedure,** both the yield 
and optical purity were inferior to that of the DPPA method 
above. This suggests that direct attack of the amino 
component to (IX) will occur to a lesser extent. The 
intramolecular migration of the azido-group of (VIII), from 
the phosphorus to the carbonyl carbon by an S|i type re­
arrangement, will give the carboxylic acid azide (X), which 
may also be formed from (IX), by an S|2 type reaction of the 
azide anion with (IX). The intermediacy of the acyl-azide 
(X) was demonstrated by the detection, by TLC, of 
benzazide, when benzoic acid was condensed with n- 
butylamine using a mixture of DPPA and TEA. The acyl-azide 
(X) is an intermediate of the azide method of Curtius,** 
which is thought to be essentially free of racemisation, 
but it is now known that a loss of optical purity, 
particularly in the presence of excess base,** can occur.
8.4.4 Conclusion.
The low yield from method b is attributed to a poor 
batch of the mono-alkylated glycine, in which the ratio of
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mono-:di-alkylated glycine may have been less than 1:1. In 
any event, the extra step required to synthesise the pa ra­
ni trophenyl ester intermediate (12) more or less prohibited 
the use o£ this method, based on a yield consideration 
alone, in which the intermediate was isolated in 60% yield, 
although yields of up to 75% have been reported** for the 
synthesis of para-nitrophenyl esters. The esters are also
Table 8.2. Comparison of yields, and elemental analyses of 
the di-peptide (11) from the three methods above (8.4.1- 
8.4.3).
Method Yield/% Found elemental
analyses1 (C, H, N)%
a) Mixed anhydride 49 59.8, 9.06, 7.98
b) Activated esters 38 60.2, 9.06, 7.89
c) Acid azide 61 59.6, 9.11, 8.19
a:- requires:- C, 59.7; H, 8.77; N, 8.19%.
very easily hydrolysed when in solution, so all solvents 
must be rigorously dried in order to obtain the maximum 
yield of the ester product. The product, once isolated in 
its crystalline state, can be stored, sealed in a dark 
container in order to minimise photo-decomposition.
The mixed anhydride, method a, gave yields that were 
less than expected. This may be because reaction is also 
favoured at the "wrong" carbonyl group due to the fact that
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the attacking amino component may be less sterically 
hindered than the corresponding leucine derivative, and so 
provides a greater opportunity for attack at the "wrong” 
carbonyl group, to form the urethane by-product, although 
none was detected from the reaction mixture.
Of the methods employed, method c was considered to be 
the best, based solely on a yield consideration alone. 
However, the product (11) was formed in the presence of a 
number of unidentified side products, but this may have 
resulted from the use of a mixture of mono- and di­
alkylated glycines. It may therefore be beneficial if, in
future, the mono- and di-alkylated glycine products were 
separated, and isolated before proceeding to the next stage 
of the synthesis.
The data obtained on the product (11) from all three 
methods confirms its identity. The MS spectra of the 
product from the above methods gave a molecular ion peak 
[342 (M*) or 343 (M+l)1], with the characteristic loss of 
the protecting group [ (CHp^COCCO); (M*-101)]. The *H NMR
spectrum of the products were very similar, with few 
differences in the shape or position of the peaks, and
elemental analysis of the products is in good agreement
with that calculated for the required product. The product 
was also assayed using HPLC, but without conclusive 
results, for although the chromatogram suggests the 
possibility of two peaks, they were not well enough 
separated to be positively identified.
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8.5 De-protection of tert-butyloxvcarbonvl-L~leucine-D.L- 
(al1yl)glycine methyl ester.
De-protection of (11) was performed in a similar 
manner to the de-protection of the oligo-leucine peptides, 
except that anisole was added as an electrophile trap (Fig 
8.29). This minimises/prevents electrophi1ic attack by any 
free protons on the terminal double bond of the alkylated 
glycine residue forming a carbonium ion, and possible 
subsequent polymerisation (Fig 8.30). While anisole was
tC<CH3>3
Fig 8.29




- 2 1 0 -
found to fulfil the purpose of de-protection in this step, 
it is not considered as an ideal "scavenger" as it can 
participate in electrophilic aromatic substitution with 
carbonyl groups in amino acid side chains, or the C- 
terminal a-carbonyl group. It can also be the source of 
methylating agents, which in turn can alkylate sensitive 
amino acid side chains, such as the thioether sulphur in 
methionine.^ The de-protected di-peptide was used without 
purification or characterisation.
8. 6 Synthesis of cyclo-L-leucine-D.L-(allyl)qlycine (13) 
and (14).
The de-protected di-peptide (11) was cyclised (Scheme 
8.11) using the method of Nitechi et al.7 The diastereomers 
were successfully separated by column chromatography using 
silica gel. The two individual diastereomers [isomer-1 (13) 
and isomer-2 (14)] were isolated from an approximate 1:1 
mixture (1.95g and 1.83g; total 3.78g, 86%).
IS
a:- toluene/butan-2-ol, reflux, 48h.
Scheme 8.11
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Using the TLC solvent system [chloroform-methanol- 
acetic acid (14:2:1)], and developing in KMnOj solution, the 
configuration of the diastereomers was provisionally 
assigned, since using the above solvent system, the anti­
isomer has been shown by Nitechi et al^ , in their study of 
a simple route to sterically pure diketopiperazines, to run 
consistently ahead of the syn-isomer. The Rj values of the 
two isomers in solvent system were 0.74 [anti-isomer 
{isomer-1} (13)], and 0.71 [syn-isomer {isomer-2} (14)].
The NMR, taken in Dj DMSO shows clear differences 
between the two isomers-1 and 2. The peaks, 6=0.87ppm 
[(CHjJj, leu] (CIO, Fig 8.31), are a set of quartet, or a 
doublet of doublets (J=6 .8 Hz) for isomer-1, and a set of 
triplets (J=6 .6 Hz) for isomer-2. In the spectrum of one 
isomer, the expected pairs of doublets appears as a triplet 
due to the overlap of the inner lines, and in the other, as 
four evenly spread lines since Jj = -Sj. The set of peaks
.NH 6
Fig 8.31
due to C8 appears as a triplet (6=1.54, J=6 .8 Hz) for
isomer-1 , but as a pair of identical multiplets (centred at
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6=1.45 and 1.60) for isomer-2. The protons at C3 resonate 
as a pair of identical multiplets (centred at 6 = 2.39 and 
2.56) for isomer-1, but as a broad multiplet (6=2.44) for 
isomer-2. The peaks from C2 (6=3.70 and 3.76) and Cl 
(6=3.97 and 3.91), the chiral centres, are well defined in 
the spectrum for isomer-1 , but merge into one another in 
the case of isomer-2. There is variation in the coupling 
constants of C5 and C4. In isomer-1, both the trans and cis 
coupling constants are greater by ca 3-5Hz (Table 8.3).
Nuclear Overhauser experiments were performed on both 
isomers- 1  and 2 in an attempt to assign configurations to 
the two diastereomers, but they were inconclusive.
Table 8.3. Trans and cis coupling constants (Hz) of the 




The problem was resolved by performing lanthanide 
shift studies on both isomers using Eu(fod)^ (Fig 8.32) as 
the shift reagent, the results of which are tabulated
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IFig 8.32
(Table 8.4). The data listed in the table indicate a 
reasonable linearity for both isomers in the concentration 
range used in the experiment. Isomer-1 experienced stronger 
paramagnetic induced shifts at H-4, 6 , 8 and 9, and to a 
lesser extent at H-l and 3, which indicates stronger 
binding to the lanthanide atom, and so a more stable 
lanthanide complex is formed.*® 1 The paramagnetic induced 
shifts for isomer-1 are strongest at H-4, 6 , 7, 8  and 9. 
Complexes formed between the lanthanide shift reagent, and 
both isomers are probably of the type illustrated in Fig 
8.33. In the possible complexes formed, by isomer-1, the 
lanthanide atom may approach the ring from either side (Fig 
8.34AB). For isomer-2, only approach form one side is
NB 1 The ability of Eu to change chemical shift because of 
the paramagnetism associated with its unpaired electrons is 
a through space effect, which falls off inversely with the 
cube of the distance between the Eu atom and the nucleus 
concerned. This has been named pseudo-contact to 
distinguish it from the so-called true contact shift. This 
latter term is used for an association phenomemon in 
radical chemistry, in which direct coupling between the 
unpaired electron of a radical and the nuclear spin causes 
changes in NMR resonance frequency of the nucleus suffering 
the coupling. Although the preferred generic term is shift 
reagent, these compounds are often named lanthanide shift 
or contact shift reagents.
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Table 8.4. Lanthanide shift studies of cyclo-L-Leu-D,L- 




E u ( f o d ) 3 a H - l H- 2 H-3 H-4 H-5 f l - 6 H-7 H- 8 H-9 H-10
I s o m e r - 1
1 ) 0 4.03 3.96 2.65 5.73 5.25 6.48 6 . 2 1 1 . 6 8 1.78 0.97
90.4 5.40 5.12 3.56 6.37 5.54 7.89 7.27 2.58 2.26 1.19
245.5 5.88 4.86 3.35 7.56 6.03 10.28 9.40 4.57 4.17 1.59
2) 482.3 6.15 5.91 5.27 10.47 6.65 13.23 1 2 . 2 2 8.25 8.81 2.08
A&flb 2 . 1 2 1.95 2.62 4.74 1.40 6.75 6 . 0 1 6.57 7.03 1 . 1 1
I n t e r c e p t 4.59 4.28 2.71 5.50 5.28 6.61 6 . 2 1 1.44 1 . 2 0 0.99
Slope 3.80 3.34 4.88 9.84 2.90 13.99 12.57 13.81 14.94 2.31
I s o m e r - 2
1 1  0 4.05 3.97 2.64 5.76 5.24 6,72 6.47 1.84 1.65 0.98
- 2 1 5 -
81.0 4.82 4.82 3.18 (.15 5.4S 7.53 7.38 2.51 2.23 1.15
313.7 4.73 4.73 3.47 7.10 5.99 10.51 9,82 4.33 4.33 1.(5
2) 4(8.9 (.11 (.11 -4.31 7.92 (.32 11.24 8.47 5.3( 5.(5 2.23
i«Hb 2.0( 2.14 1.(7 4.1( 1.08 4.52 2.00 3.52 4.00 1.23
litereept 4.17 4.13 2.73 5.7( 5.2( (.81 (.93 1.88 1.(0 0.94
Slope 3.SO 3.(2 3.11 4.51 2.29 10.15 5.14 7.54 8.(4 2.59
a:- moles Eu(fod>3/1110les substrate xlO-3; b:-A%=1)-2)
possible to give the complex/ as shown in Fig 8.34C. Both 
complexes A and B of isomer-1 (Fig 8.33) are expected to be 
present in solution. Of particular note is the extent to 
which H-7/ 8 and 9 of isomer-1 are affected by the shift 
reagent in comparison to isomer-2 .
From the data in Table 8.4 A&( for H10 changes very 
little for either isomer, indicating that the two methyl 
groups of the leucine residue do not lie over the plane of 
the ring, perhaps due to steric hindrance. H- 8  and 9 change 
quite dramatically for isomer-1 , because the lanthanide 
atom is able to approach the plane of the ring such that 
the induced paramagnetic effect is experienced much more 
strongly by these protons.
It may be possible that the alkenyl chain of either 
isomer to lie in such a way as to lie over the plane of the 
ring (Fig 8.35). This might also be possible for the 











the plane of the ring (Fig 8.36). For isomer’2, steric 
hindrance will ensure that only the leucine or the alkenyl 
side chain will lie over the plane of the ring.
The protons H-l and 2, the aCH protons, of isomer-1, 
experience changes in chemical shift, but never coincide 
throughout the experiment, unlike those of isomer-2 , which
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do become co-incident, remaining so with increasing 
concentration of shift reagent. This indicates that these 
protons of isomer-1 remain in different magnetic 
environments, ie., the protons are on opposite sides of the
plane of the ring, and that the protons in isomer-2 remain 
in a similar magnetic environment throughout the experiment 
(Fig 8.33C and Fig 8.34C). This supports the view that the 
protons of isomer-1 are on opposite side of the plane of 
the ring (Fig 8.33A/B and Fig 8.34A/B).
H-3 and 4 show a much smaller change in A$g* however, 
the difference between isomer-1 and isomer-2 may suggest 





closer in isomer-1 than in isomer-2. On the basis of the 
above argument, the configurations of the two diastereomers 
have been assigned as:- isomer- 1  has been asigned the anti­
configuration (13), and isomer-2 the syn-configuration 
(14).
Further supporting evidence comes form the measurement 
of the optical rotations of each diastereomer, in which the 
anti-isomer gave a measured rotation of [a]B= +13°, and the 
syn-isomer [a]D= -53.9°.
A blocky crystal of cyclo-L-leucine-D-(allyl)glycine 
(13), of approximate dimensions 0.35x0.4mm, was produced in 
order to perform X-ray crystallographic studies, and 
confirm the above findings.
Crystal data:- 9uKlt°^ 2' M=210.26/ monoclinic,
a=7.435(2), b=7.559(5), c=10.109(3)A, b=107.992(2),
U=576.7A, space group P2j, Z=2, Dc=l. 37gcm‘*, u= (Mo- 
Kt)=0.49cm‘*, F,(000) = 228. Data were measured at room
temperature on a Hilger and Watts Y290 four-circle 
diffractometer in the range 2<8<22°. 1537 reflection were 
collected of which 1213 were unique with I>3o(I). Data were 
corrected for Lorentz and polarisation effects and for 
absorption.^ The structure was solved by conventional 
direct methods.*'* All atoms were allowed to vibrate
1. N. Walker and D Stuart; DIFABS, a program to correct for 
absorption effects in crystals, Acta. Cryst., 1983,A39,158 .
2. G.M. Sheldrick; SHELX8 6 , a computer program for crystal 
structure determination, uinversity of Goetingen, 1986.
3. G.M. Sheldrick; SHELX76, a computer program for crystal 
structure determination, uinversity of Cambridge, 1976.
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anisotropically in the final stages of convergence.
Hydrogens were included at calculated positions. Final
residues after twelve cycles of ful1-matrix least squares
were R=Kjj=0.0786 for weight units. The total number of
parameters varied was 135. Maximum final shift/esd was
0.002/ and the maximum and minimum residual densities were
*
0.21 and -0.20eA . Final fractional atomic co-ordinates and 
isotropic thermal parameters, bond lengths, and angles are 
given in Tables Table 8.5 and 8.6 respectively. Tables of 
anisotropic temperature factors and hydrogen atom positions 
are available as supplementary data Table A.1-A.5. The 
asymmetric unit is shown in Fig 8.37, along with the 
labelling scheme used. The amide bonds are in a cis 
arrangement. This is because the thermodynamic stability of 
the six-membered ring compensates for the energy required 
for the trans->cis arrangement. It is possible however, 
that the ring may not be entirely flat, but have a slight 
twist. A slight twist would also release some of the 
torsional strain that might be present if the ring were 
perfectly flat.
Table 8.5. Bond lengths (A) for cyclo-L-leucine-D- 
(allyl)glycine (13).
01-C1 1.241(9) 02-C3 1.242(10)
Nl-Cl 1.336(10) N1-C4 1.473(10)
N2-C2 1.462(10) N2-C3 1.324(10)
220-
C1-C2 1.501(12) C2-C5 1.534(11)
C3-C4 1.501(11) C4-C8 1.553(10)
C5-C6 1.503(13) C6-C7 1.330(130
C8-C9 1.520(12) C9-C10 1.523(11)
C9-C11 1.481(14)
Table 8.6. Bond angles for cyclo-L-1eucine-D-(allyl)glycine 
(13).
C4-N1-C1 124.7(7) C3-N2-C2 125.1(7)
Nl-Cl-01 122.2(7) C2-C1-01 118.6(7)
C2-C1-N1 119.2(7) C1-C2-N2 114.9(7)
C5-C2-N2 108.7(6) C5-C2-C1 112.5(6)
N2-C3-02 121.7(7) C4-C3-02 118.3(7)
C4-C3-N2 119.7(7) C3-C3-N1 113.2(6)
C8.C4-N1 111.4(6) C8-C4-C3 107.7(6)
C6-C5-C2 112.5(8) C7-C6-C5 125.0(1)
C9-C8-C4 116.4(7) C10-C9-C8 109.3(7)













Fig 11.37. Asymmetric unit of cyclo-L-1eucine-D- 
(allyl)glycine (13).
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8.7 Synthesis of D,L-(pentenyl)glvcine methyl ester (15).
This compound (15), was synthesised in a similar 
manner to that of D,L-(allyl)glycine (7), starting from the 
imine (6) (Scheme 8.12). No di-alkylated product was found 
to be present in the reaction mixture, and was confirmed by 
MS analysis. Assignment of the (3, y and 6 protons in the 
alkenyl side chain in the *H NMR spectrum was attempted by 
performing double irradiation studies, but these were not 
conclusive. However, after derivatisation with a tert- 
butyloxycarbonyl group, the product was easier to purify 
and definitive assignments were possible.
f«v«ral itvps
JS
  C02 CHg . N  . ■■ A  H C U H 2N ^ ^ c o 9CH-
6
Scheme 8.12
8.7.1 Synthesis of tert-butyloxycarbonyl-D,L-(pentenyl)- 
glycine methvl ester (16).
The methyl ester (16), synthesised in a similar manner 
to that of compound (9) (Scheme 8.13). Assignment of the (3, 
y and 6 protons in the alkenyl side chain was made with the 
aid of a 2D 8 g COSY spectrum. These also provided a basis 
for assigning the alkenyl protons of compound (15) with 
more certainty. It should be noted that the carefully 
measured line separations of the -CH= proton multiplet may
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Scheme 8.13
not give true J values, since non-first order coupling is 
observed. Typical values of unsaturated systems are 
tabulated for comparison (Table 8.7 and 8 .8 ).
Table 8.7. H-H coupling constants (Hz) in unsaturated 
systems.
X trans cis gem Ref
(15) 18.0 9.5 1.5
H 19.1 11.7 2.5 56
CHj 16.81 1 0 . 0 2 2.08 57
CHfH 2 17.4 10.4 1.9 58
(ch3)2ch2 17.3 10.4 1 . 6 59
(c h3)3c 17.5 1 0 . 8 1.4 60
Using a NMR computer simulation program "Raccoon",^ 
it was possible to simulate approximately, the peak 
splitting observed in the actual spectrum (Fig 8.38, Table 
8.9). Only three protons are calculated for, 6 , e and 8 . 
Assignment of the 0, y and 6 carbons from NMR spectrum
Table 8 .8 . Proton chemical shifts and spin coupling 
constants of some alkyl substituted olefins.**





H H CHj 5.724 4.814 4.898 (1.83)b
H H H i-C^ 5.705 4.926 4.936 (2 .0 0 0^
H H H t<¥t 5.769 4.964 4.939 1.925
H H t-(*H 5.738 4.98 4.779 1.565
Oil t-qn 5.208 (1.562)c (1.724)c 1.875
Coupling constants (Hz)
R2 R3 R4 R4' J( 1,2) J(1.3) J( 1 f 4) J{2,3) J(2,4) J(3,4)
S I «3 CI3 10.37 17.22 (.41 1.74 -1.17 -1.43
H R 1 i-C 3P7 10.13 17.02 7.00 2.05 -1.15 -1.43
I H I t-CJ 9 10.02 17.10 7.46 2.37 -0.84 -1.32
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H H K 4 H9  fc-C 4 H9  9 .97 17.01 10.65 2.63  - 0 . 10  -0 .63
CH3  CH3  K 4 H9  K 4 H9  - 1 . 25  - 1 . 25  11.37 . . . e . . . e . . . e
a:- Spectrometer frequency=60.OOHz; b:- Assumed, not
analysed; c:- Assignment not certain; d:- J(H-CH3). 
e:- Not resolved, probably less than 0.2Hz.
Table 8.9. Data for "Raccoon” simulated spectrum of tert- 
butyloxycarbonyl-D,L-(pentenyl)glycine methyl ester (16).
Nimber of nuclei=5 Operating frequency=270Hz
Minimum chemical shift=4.80ppm Maximun chemical shift=6 .20ppm
Minimum intensity=0.020 Line width=0.50Hz
Chemical shifts (ppm)
-CH2- (1) = 5 .00 -CH2- ( 2 ) =5 .00
CH2= (3) = 5 . 49 CH2= ( 4) = 5 . 51
= CH- (5) = 6 .00
Coupling constants (Hz)
2 3 4 5
J(l:y) 7.0000 1.0000 0.0001 7.0000
J( 2:y) 1.0000 0.0001 7.0000
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was done by calculating their chemical shift using
calculated values with the observed values (Table 8.10). 
From the tabulated data, it is quite possible that the 
assignment of 8  and 6 could interchange, due to the 
closeness of the calculated values.
Table 8.10. Calculated and observed values of chemical 
shift (ppm) for the 8 / y and 6 carbons of tert- 
butyloxycarbonyl-D,L-(pentenyl)glycine methyl ester (16),






8.8 Synthesis of tert-butyloxycarbonyl-L-leucine-D.L- 
(pentenyl)qlyoine methyl ester (17).
This compound (17) (Fig 8.39) was synthesised in a 
similar manner to that of (11), and was isolated in 52% 





By performing a homonuclear 2D COSY experiment, it was 
possible to assign the protons unambiguously for both 
residues. The NMR spectrum of (17) indicates the
presence of two diastereomers due to the appearence of two 
3 CH2 resonances. For comparison, the calculated, and 
observed values of the chemical shift for this compound 
(17) are presented (Table 8.11). The pCHj-carbon was 
assigned on the basis that the aCH-carbon would show the 
biggest shift differences between each carbon pair of the 
two diastereomers.
8.9 Synthesis of cvclo-L-leucine-D.L-(pentenyllolycine (18) 
and (19).
The cyclo-peptides, (18) and (19), were synthesised
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Table 8.11. Calculated and observed values of chemical 
shift for the 3 , y and 6 carbons of tert-butyloxycarbonyl- 
L-leucine-D,L-(pentenyl)glycine methyl ester (16).
<CH3 >gC0C-#-ltu-r r OgCHg
Carbon Calculated Observed





using the same method as that used for the cyclisation of 
(13) and (14) (Scheme 8.14).
HCl.HdN‘
IB snti 19 sgn
a:- Toluene/butan-2-ol, reflux, 48h.
Scheme 8.14
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The two diastereomers, (18) and (19), were isolated in 
an approximate 1:1 ratio. NMR data was obtained for the 
anti-isomer (18), since the syn-isomer was insoluble in the 
normal NMR solvents. The configuration of each isomer was 
assigned from optical rotation data; anti-isomer (18), [o]D= 
+ 6.3°; syn-isomer (19), [a]D -35°.
In the %  NMR spectrum of (18), taken in CDClj, the two 
aCH protons are almost co-incident, but more separated in 
Dj DMSO. A homonuclear 2D COSY spectrum was obtained in 
order to identify the two near co-incident aCH protons. 
Correlation with other signals indicates that the aCH-Gly 
is at higher field than the aCH-Leu.
8.10 Synthesis of tert-butyloxycarbonyl-L-leucyl-L-leucyl- 
L-leucine-D.L-(pentenylIglycine methyl ester (22).
The synthesis of this tetra-peptide (22), was 
approached by two different methods (Scheme 8.15). 
Initially Method 1 was pursued, this being appearing to be 
the easier route to follow, on the basis of practical ease, 
and on past results with using IBC to form peptide bonds 
via mixed anhydride formation. However, the hydrolysis of 
the di-peptide methyl ester (3) to the free carboxylic 
acid, by the method of Iselin,^ gave very poor yields, on 
several attempts. The target compound (22) was then 
approached via method 2 which involves the formation of a 
hydrazide intermediate. This proved to be successful, the 
product (22), being isolated in 52% yield. The hydrazide
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Htthod 1 Htthod 2
BooH-«u2 -0 H# 3 Boc-Ltug-OH* 3
Boo-Leuo-OH 30 Boc-Lt^-NHNHg 22
Boo-LfUg-CptnttnyI)Cly-0H# 22
a:- NaOH (aq), MeOH, 0°C; b:- mixed anhydride formation via 
IBC + (17); c:- NHjNI^.HjO, MeOH, RT; d:- azide formation via 
butylnitrite + (17).
Scheme 8.15
intermediate was isolated in yields >95% using the 
procedure recommended by Guttmann and Boissonnas^ (Pig 
8.40). The hydrazide was converted to the azide in situ, by
H
*-“6 NHs * "0CHa
Pig 8.40
the method of Honzl and Rudinger.** These authors described 
in detail the influence on the reaction of temperature,
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solvents, acidity, the type of acid, and the nitrosating 
agent. They concluded that preparation of the azide was 
best conducted at low temperature, in homogeneous solution, 
at high acidity, and with an organic nitrate, all of which 
helps suppress the formation of amide, often a problem 
found during the formation of the azide from the hydrazide 
(Fig 8.41).^'^ In this study, the azide formed was not 
isloated, but reacted with the amino component after 
neutralisation with base. According to Honzl and Rudinger,^
H H
I H N 0 2  I
R-g-N-#H2 * » T -*h-H0
-h„0 -NOj
1
R - | - N H 2
Fig 8.41
the amide is not a re-arranged product of the azide, a view 
supported by the observation that no amide is formed if the 
azide is prepared from the acid chloride, and sodium azide. 
The proposed mechanism involves the cleavage of the bond 
between the a and (3 nitrogens of the nitrosated hydrazide. 
The mechanism of azide formation is very similar to the 
"normal" mechanism of azide formation (Fig 8.42).
After the azide is formed, it can be acylated by the 
amine component, or it can produce an isocyanate, via the
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SrJ^ -O" ■ 2H* » aR^L-OH
-2R1 *
0=N-0-N 0 ♦ H20 « ■ ■ * 2H0-^=0
R2-«HNH2 0=K* "0-H=O  ► R2— |— j-1— N 0
H H
-H
Rg.. H* 4 -  .± R2— |— Ijf— H = 0
K H
R2-jp.>i=# ♦ h20 i t - - : : - * r2-n=*N=*
H
Fig 8.42
Curtius re-arrangement (Fig 8.43).^ This is a uni-molecular 
process, its rate depending on both solvent and 
temperature, but it has also been shown to be dependant on 
the concentration of the reactants, including that of the 
azide peptide. This is the major route in the formation 
of by-products, as demonstrated by the investigations of 
Schnabel.*0 The isocyanate can in turn react with the amino 
component, to yield a urea derivative (Fig 8.44).**1** 
Symmetrical ureas can also form, if the isocyanate is 
partially hydrolysed to an amine, which in turn reacts with
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Fig 8.43
Rl-NH-CH-N=C=0 ♦ H2 N-R3 Rl-NH-CH-NH-C-NH-R3
Fig 8.44
the same isocyanate. The organic azide can also acyl ate the 
still unreacted hydrazide in the reaction mixture, to form 
symmetrical bis-acyl hydrazides, especially if the 
conversion of the hydrazide is incomplete, or the basicity 
is too low (Fig 8.45).
One of the reasons for the widespread use of the azide 
method in peptide synthesis, is that it was thought to be 
racemisation free. The optical stability of acyl azides was 
tentatively explained by Young and co-worker.^ They 
suggested that azides from which the N-hydrogen was 
abstracted by base assumed the structure shown in Fig 8.46. 
The oxygen of the benzyloxycarbonyl-group, instead of 
attacking the azide carbonyl group, is bound electrostatically
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to the central nitrogen atom of the azide group. For 
oxazolone formation, this bond has to be rotated 
by 90°, an unfavourable situation in the ring. An 
alternative explanation4 may that the azides are only 
moderately activate, hence it is harder to abstract the N- 
proton, and are also resistant to attack by nucleophilic 
oxygen. Their reactivity can be explained in an analogous 
manner to ammonolysis of anchimerically assisted active 
e s t e r s . T h e  incoming amine forms a hydrogen bonded ring, 
enhancing the acylation reaction, even though the azide is 
not a powerful electron-withdrawing group (Fig 8.47).
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77However, Weygand and co-workers found that asides do 
racemise in the presence of excess base. Anderson et al78 
isolated a racemised product (1.6% D,L), by treating Z-Gly- 







more substantial racemisation in the synthesis of a model 
peptide, and of Calcitonin M.*° For example, in the coupling 
of Z-Val-His-Nj, 5-10% D,L-histidine was found when one 
equivalent of TEA or NMM was employed, and 2-3% with di­
isopropylamine (DIPA). With 5 equivalents of TEA, NMM or 
D1PA used as base, the figures were ca 100, 30 and 100% 
racemisation respectively. In the synthesis of calcitonin 
M, 1-2% racemisation of histidine and phenylalanine was 
detected.
Kemp and co-workers*0 studied the racemisation in azide 
couplings, in the presence of excess base, using the 
isotope dilution method. The racemisation model studies 
used were those of Young's,^1 and Anderson's81 racemisation 
models. With distilled Gly-OC^Hj, the Anderson model yielded 
0.011 and 0.03% racemate, while the Young model yielded 
0.25 and 0.35% racemate. Acyl azide in DMF, with HCl.HjN-
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Gly-OCjHj, and one equivalent of TEA yielded 0.66% racemate 
by the Young model. With an excess of base, the Anderson 
model yielded 1.05% racemate. Kemp et al®® revealed that 
racemisation occurs even when the azide, in order to free 
it from excess acids used during its formation, is isolated 
with dilute hydrogen carbonate solution. Substantial 
racemisation occurred when azides were exposed to strongly 
basic media. 50.3% racemisation was found with the Anderson 
model after 15min at 0°C in DMF, containing 0.2M TEA. 
However, in practice, such excessive use of base is not 
required, but the results cautions against such use. Young 
applied his racemisation model to test azide racemisation 
at apparent pH9 in DMF, the azide being formed by the Honzl 
and Rudinger method,^ 2% racemate was formed. The same 
conditions were applied for the DCCI-HOBt method of Konig 
and Geiger,*® and the amount of racemate increased by 10- 
14%, demonstrating that while azide coupling, if properly 
performed, may produce a small amount of the undesired 
diastereomer, but this risk is far less than with the DCC1 
method.
8.10.1 Analysis of results.
Initially a model study was performed, based on the 
synthesis of oligo-tetra-L-leucine (5). The desired product 
was isolated in 40% yield, similar to the yield using the 
mixed anhydride method (41%). The synthesis of (22) was 
achieved in 52% yield.
The *H NMR spectrum of a diastereomeric mixture of
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(22), taken in Dj DMSO, shows two distinct sets of NH peaks 
due to the glycine residue (6=8.22 and 8.25ppm). However, 
the intergrals are not of equal height as would be 
expected, indicating that one diastereomer pre-dominates 
slightly over the other, perhaps due to different rates of 
reaction. The spectrum shows three groups of aCH protons at 
6 = 3.91, 4.23 and 4.35 for ocjCH-Leu, ct^ CH-Gly, and a^CH-Leu 
respectively. The o^CH-Gly is more complex due to accidental 
co-incidences. With the aid of a homonuclear 2D COSY 
spectrum, it was possible to assign the protons with some 
certainty. From the NMR spectrum, it was possible to 
observe nearly all six peaks due to the methyl group on the 
leucine residue, two peaks were co-incident at 6=22.84ppm. 
More interestingly it was possible to observe two peaks for 
each of the a4CH-Gly (6=51.44, 51.57), (3CH2 (6=32.44,
32,57), yCH2 (6=30.13, 30.26) and 6 CH2 (6=24.26, 24.36)
carbons. This would seem to indicate a more rigid 
conformation than that of compound (17), perhaps due to 
increased steric hindrance, resulting from an increase in 
the chain length by the addition of two leucine residues. 
TLC analysis also showed two spots, but they were too 
closely eluted, and no attempt was made to separate them, 
as a degree of cross contamination may have occurred.
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8.11 Attempted cyclisation of tert-butyloxycarbonyl-L-
leucyl-L-leucyl-L-leucine-D.L-(pentenyl)glycine____ methyl
ester.
In the synthesis of homodectic cyclic peptides, most 
methods of peptide bond formation are applicable for ring 
closure. Nonetheless, cyclisation requires special 
considerations. The readiness of open chain compounds, such 
as linear peptides to cyclise is a function of several 
properties, first and foremost among these is the size of 
the ring to be closed. Usually no difficulties arise in the 
cyclisation of peptides with six or more residues, but 
penta-peptides are often not the best starting materials in 
cyclisations, and ring closure is even more hampered in 
most tri- and tetra-peptides. Such small rings can be 
closed only if at least one of the peptides bonds has a cis 
rather than the more stable trans geometry (Fig 8.48). The 
ability and readiness of di-peptides to cyclise to form 
diketopiperazines, in which both amide bonds are in a cis 
rather than a trans arrangement, has already been 
mentioned.
Fig 8.48
Tri-, tetra- and penta-peptides are prone to cyclo- 
dimerisation, in which rings of twice the expected size are
-240-
formed (Fig 8.49). This was first noted in the synthesis
82of gramicidin S by Schwyzer and Sieber. The best 
explanation for this tendency for cyclo-dimerisation is the
2 h2 n-chr1-co-hh-chr2 -co-nh-chr3 -co-x
nh-chr1-co-nh-chr2 -co-nh-chr3-co
i!0-CHR3 -NH-C0-CHR2 -NH-C0-CHR1-NH 
Fig 8.49
assumption of an anti-parallel arrangement of two penta- 
peptide derivatives prior to cyclisation. The two chains 
being held together by hydrogen bonds in a |3-sheet like 
conformation (Fig 8.50). While no monomer was obtained in 
their early experiments,^ in subsequent studies conditions
Fig 8.50
were found which were more conducive to cyclisation than to 
cyclo-dimerisation.^ The coupling method applied for ring
-241-
closure also plays some role, for example, cyclo-
dimerisation is less pronounced when the open chain pre-
01
cursor is activated in the form of its azide0' than in 
cyclisation by other procedures. A more decisive influence 
is exerted, however, by the concentration of the peptide 
subjected to cyclisation. The principle of dilution^ must 
be adopted in cyclisation, if a uni-molecular reaction is 
the aim. At high concentrations of the activated peptide, 
bimolecular dimerisation, and polymerisation reactions 
emerge as serious competitors.
8.11.1 Attempted cyclisation methods.
Method a:- The linear tetra-peptide (22) was de­
protected in the same manner as for the di-peptide (1 1 ) 
using TFA/anisole (Scheme 8.16). Using the method of 
Schywzer and Seiber,®* an attempt at cyclisation was made 
to afford the cyclic tetra-peptide (24). However, 
cyclisation by this method proved unsuccessful primarily 
because the peptide was protected as its methyl ester, 
which is relatively un-reactive towards nucleophilic attack 
by the terminal amino function. The starting material, the 
de-protected linear tetra-peptide methyl ester, was 
recovered.
Method b:- The azide method of cyclisation, based on 
the method of Bodansky and Hemes,®7 was also attempted. 
Azides are frequently used for cyclisation of peptides of 
different chain lengths. The starting materials are the 
usual protected hydrazides. The amino protecting group is
-242-
/  JBoo-LtU3-H^C02CH3 --2_-* Boc-Ltug-N^CONHNHg
22 23
d, t
£I" H-K^-Ltuo-H^CO;TFA" g g H ^ C O j C H g  TFA‘ H g H * - L f u - N ^ C 0 - N 3
“ S b -
Y
24
a:- TFA/anisole, lh, RT; b:- DMF/pyridine, 65°C, 72h; c:- 
MeOH, NH2NH2.H20, 48h, RT; d:- TFA/anisole, lh, RT; e:- azide 
formation via butylnitrite.
Scheme 8.16
removed, the hydrazide converted to the azide, and the 
activated peptide allowed to cyclise. This is possible 
because the reaction of nitrous acid with the hydrazide 
group is considerably faster than that with the N-terminal 
amino group. Thus the amino group remains 
essentially intact during the conversion of the hydrazide
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to the azide. Also, because the reaction is carried in an 
acidic medium, the amino group is protonated, and becomes 
inert towards attack by the azide group, it is possible and 
practical^ to dilute the solution of the azide, and to 
expose afterwards the amino group to acylation afterwards 
(Fig 8.51).
cr HgN*-CHRl -C0---- NH-CHr2-C0-NHNH2
C l ’ HgN*-CHRl-C0- - - - - NH-CHR2 - C O - N = N * = N “
1) d i l u t i o n




However, when this method was applied to the hydrazide 
(23), a multi-component mixture was formed, which was not 
chromatographed or characterised. Several further attempts 
using this method proved equally unsuccessful, resulting in 
a multi-component reaction mixture in each experiment.
8.11.2 Other methods of cyclisation.
Because of the lack success of the two methods 
described above, a third cyclisation route was explored. 
This involves hydrolysis of the linear tetra-peptide methyl 
ester (2 2 ) to the free carboxylic acid, and subsequent re-
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esterification to a more activating ester group, such as p- 
nitrophenyl or pentafluorophenyl esters (Scheme 8.17).
Hydrolysis, using aqueous NaOH, of the linear tetra- 
peptide (22) has already been demonstrated, following the
carboxylic acid peptide (25) in 96% yield. This is in 
contrast to the previous attempts at hydrolysis on the 
methyl ester derivatives of compounds (10) and (20) (46% 
and 16% yield respectively) using the same method. Analysis
intact, and that the OCH3 group is no longer present.
The choice of the new ester group must be such that 
the reactive intermediates must be stable enough to 
withstand the unmasking of the N-terminal amino group. Thus 
formation of either the p-nitrophenyl or pentafluorophenyl
F
Scheme 8.17
method originated by Iselin et al, 31 to afford the free
of *H and NMR data showed that the linear peptide was
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ester seem suitable, since both activate the carbonyl 
carbon sufficiently to nucleophilic attack from the amino 
end, and both are good leaving groups, by virtue of the 
stability of the anions they form. The use of p-nitrophenyl 
esters has already been described by Schwyzer and Sieber®* 
in the synthesis of gramicidin S.
Synthesis of the pentafluorophenyl ester can be 
achieved using the method of Kisfaludy and co-workers,**"^ 
and subsequent cyclisation of the ester by the method of 
Sheh and Mokotoff.^
Alternatively, activation of the terminal carbonyl 
group of a peptide with an unprotected amino group can be 
used, but this is perhaps the more problematic alternative, 
since the method of activation must be selected with care. 
For instance, the reaction of free peptides with 
alkylchloroformates, should produce not only the mixed 
anhydride, but also urethanes, in which cyclisation is 
blocked (Fig 8.52). As mixed anhydrides are potent 
acylating agents, protonation of the amine does not provide 
complete protection. Yet in spite of this complication, 
cyclisation attempts via mixed anhydrides has provided 
valuable results ,**'** if ring formation is favoured by the 
geometry of the molecule. More favourable consideration can 
be given to coupling reagents, since these can activate 
carbonyl groups in the presence of amines.
Carbodimides can be particularly useful, because the 
rate of their reaction with amines is negligible, in 
comparison with the rate of acylation of carboxylic acids.
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On the other hand, while the reactive intermediates are 
potent acylating agents, if the cyclisation is impeded by 
an unfavourable geometry, they will produce, through 0->N 
acyl-migrations, N-acylurea derivatives, which contaminate 
the expected cyclic peptide (Fig 8.53). It is therefore not
too surprising that low yields are often observed in 
cyclisations with carbodimides, even when the reagent is 
applied in high concentration. Better results can be 
achieved if the conformation of the open pre-cursors 
favours cyclisations, as in the case of some hexa- 
peptides
Improvement might be expected if the 0->N acyl- 
migration is suppressed by the addition of auxiliary 
nucleophiles, such as N-hydroxysuccinimide^ or HOBt. 
Cyclisation with other coupling reagents, such as N-ethyl- 
N1-(3-dimethylaminopropyl)carbodimide, may suffer similarly 
from the disadvantage of 0->N acyl-migration, forming 
inactive W-acylurea. Yet in the synthesis of more simple 
cyclo-peptides fairly good results were obtained^ when the 
azides were generated from peptide hydrochlorides with the 
help of DPPA.*®® Another consideration is that, although 
coupling reagents are convenient to use, the activation and 
cyclisation steps cannot be separated. The activation step 
requires a high concentration of the coupling reagent and 
peptide, while cyclisation competes favourably with 
polymerisation at low concentration. In general, an excess 
of the coupling reagent is used, with the peptide at low 
concentration.
At present it would appear advisable to make a clear 
separation of activation and coupling. For example, in the 
attempted cyclisation of a hepta-peptide, with the sequence 
of evolidin, no tangible product was formed when the 
reaction was carried with the aid of DCCI, but a cyclo-
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hepta-peptide, with the properties of natural evolidin, 
could be secured through the conversion of the N-protected 
open chain intermediate to the p-nitrophenyl ester, 
followed by de-protection of the N-terminal amino group 
which led to ring closure.
-249-
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The next objective of this project was to chemically 
bond the cyclic peptides, 13, 14, 18, and 19, described in 
the previous chapter, onto the silicon centres of 
mononuclear silanes, and onto polysiloxanes. These could 
then be used to bond or coat the peptides, via an alkyl 
spacer chain, onto a variety of surfaces containing 
hydroxyl groups, such as silica or alumina. Alternatively 
the functionalised siloxanes could be used in the form of 
neat peptide functionalised fluids as supported liquid 
membranes, or in liquid-liquid partition chromatography. 
Initially, attention was directed towards bonding such 
compounds onto HPLC silica gel (Chromspher Si, 5um, 
spherical), and subsequently testing the capability of such 
stationary phases for enantiomer separations.
The development of column packings with covalent 
bonded phases is one of the factors that has led to the 
growth of HPLC during the past decade or so. To form bonded 
phase packings, silica typically is reacted with 
functionalised silanes (Eq 9.1), which contain one or more 
reactive groups (X), such as alkoxy or halide, and R is 
typically an alkyl or substituted alkyl group. This creates 
siloxane bonds between the si lane and the silicon atoms of
-257-
the solid support, giving a stationary phase where the R 
groups of the silane largely determine the chromatographic 
behaviour of the column packing.
Eq 9.1 Si-OH + SiXBR4-n > Si(OSiX^R^)
There are several variations in the type of reaction 
possible. Reaction with a monofuctional silane (n=l) may 
yield a surface monolayer. The reaction is reproducibile 
(Fig 9.1) and convenient, with the resultant phase 
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Fig 9.1. Representation of monofunctional si lanes bonded 
to a hydroxylated surface.
Bifunctional or trifunctional silanes may react with 
only one or two surface silanols1 so leaving Si-X residues 
which on exposure to moist air will hydrolyse to form new 
silanols groups (Fig 9.2). Such behaviour can be can 
especially detrimental in subsequent usage for the
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separation of basic solutes. A silanisation reaction using 









Fig 9.2. Representation of polyfunctional silanes bonded 
to a hydroxylated surface.
polymerised layer on the surface of the support following 
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Fig 9.3. Representation of polyfunctional silanes bonded 
to a hydroxylated surface.
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advantages over monolayer phases, in that the former are 
more resistant to hydrolysis, and partially mask residual 
acidic silanol surface groups. However, this type of phase 
is more difficult to form reproducibly, and variations in 
total organic content are often observed from one 
preparation to the next. Mass-transfer characteristics of 
such phases can be very poor* if the stationary phase is 
relatively thick, leading to poor column efficiencies.
The stability of bonded phase packings in HPLC is 
always an important consideration. Providing these 
materials are used in the pH range 4-7, in which 
the Si-O-Si linkage is stable, the organic proportion of 
the mobile phase is large (>2 0 %), and a column temperature 
of <60°C is maintained, the separation of many basic 
compounds, such as pharmaceutical and agricultural 
chemicals, also unprotected peptides and proteins, can be 
effected using reverse-phase HPLC. Typically, 
aqueous/organic mobile phases containing TFA are used* in 
peptide and protein separations because:- a) samples are 
soluble in TFA containing solvents; b) bio-molecules then 
produce good peak shape; and c) TFA can be easily removed 
by lyophilisation prior to further characterisation of the 
separated species. However, Kirkland and co-workers*, have 
shown that these columns are not stable, at low pH (<3), 
even over relatively short periods of time. They 
demonstrated that commercial HPLC columns with 
dimethylalkyl silane bonded phases showed a significant 
loss of bonded phase during use with low pH and TFA/water
-260-
acetonitrile gradient elution separations. In addition some 
bonded phases also change in nature, and both of these 
effects are highly detrimental in chromatographic 
separations.
of bonded phase that showed significantly increased 
stability over conventional types of columns. One uses 
bifunctional (or didentate-type) silanes, which contain one 
reactive site on each of two silicon atoms of the silane 
(Fig 9.4). The two silicon atoms are connected by variable 
bridging groups, such as -O- or -(CH2 )n etc., in order to 
adjust the spacing between the silicon atoms of the silane
Fig 9.4. Representation of bidentate silanes to a 
hydroxylated surface.
for the most favourable reaction with the SiOH sites on the 
surface of the silica support. Bonded phase packings with 
methyl, vinyl, phenyl, isopropyl, and tert-butyl functional 
groups exhibited similar properties, but with greater 
stabilities at low pH, than their corresponding
Kirkland and co-workers* then developed two new types
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dimethylsilyl derivatives.
The second type of novel bonded material employs mono­
functional silanes which contain one or two bulky 
substituents, such as isopropyl or tert-butyl. The bulky 
groups provide steric protection against hydrolysis at low 
pH, to the Si-O-Si bond on the surface of the silica 
support while still providing equivalent retention and 
column efficiency for analysis (Fig 9.5).
!*
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Fig 9.5. Representation of sterically protected mono­
functional silanes bonded to a hydroxylated surface.
RESULTS AND DISCUSSION.
9.2 Synthesis of silane and polvsiloxane attached peptides.
Three model reactions were first performed using allyl 
benzene, and dichloromethylsilane under differing reaction 
conditions in order to gain experience in the method before
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the target peptides were employed. Two reactions between 
allyl benzene and triethylsilane were also carried out, in 
order to determine whether steric factors would prevent 
complete reaction, as this could also be significant for 
bulky peptides containing short spacer chains. Reaction 
with short-chain commercially-available polysiloxanes 







was also performed (Fig 9.6) using chioroplatinic acid 
(HjPtCl^. xHjO, Spiers catalyst) for the hydrosilylation 
reaction. This proved satisfactory for the allylbenzene- 
Et3SiH reaction, although yields were lower than expected 
(Scheme 9.1). This may have been due to steric effects or 
the presence of water. The reaction between allyl benzene 
and the 3,5-siloxane polymer afforded the required product 
(Scheme 9.1) in 8 8 % yield.
Table 9.1 lists the reaction conditions, solvent 
combinations, and the catalyst used for the reaction of the 
peptides with various silicon moieties. Reaction of the 
cyclic peptides with Et3SiH was successful (Scheme 9.2), 
with yields ranging from 38-87%. The conditions for these 
reactions were quite different from analogous reactions 
involving allylbenzene, and will be discussed later.
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Scheme 9.1. a:- EtjSiH, Toluene/butan-2-ol, HjPtClj catalyst, 
reflux, 24h; b:- 3,5-siloxane polymer, HjPtClj catalyst,
reflux, 48h.
Scheme 9.2. Toluene/MeCN, CpjPtClj, EtSiH, heated in sealed 
reaction tube.
Attempts to synthesise a siloxane attached cyclic 
peptide by catalysed reaction of the cyclic peptide (13, 
14, 18, or 19) with the 3,5-siloxane polymer, yielded a 
multi-component mixture of siloxanes containing various 
peptide loadings. Attempts to chromatograph these mixtures 
on silica gel proved unsuccessful, resulting in the 
appearance, on elution, of several new components. It seems
0
probable that the steric sise of the cyclic peptide 
prevents complete reaction, thus leaving a mixture still 
containing Si-H bonds. As silica surfaces are particularly 
acidic, they will bond the short chain siloxane to the 
surface via reaction of the remaining Si-H groups. Attempts
Table 9.1. Conditions used for the reaction between the 
cyclic peptides and various silicon moities (Scheme 9.2).







1 Tol/Bu-2-CH (2:1) I^PtCl6
1 Tol/Bu-2-CH (2:1) HftClj
1 Tol/MeCN (2:1) I^PtClg
1 Tol/BuOH (2:1) I^PtClg













80-9CPc, 6 days 










80-90°C, 3 days 
90-10(fC, 48h, ^
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3 Tol/MeCN (2:1) I^ PtClg
3 MeCN Cp^PtCl2
50-6CPC, 3 days 
90°C, 5 days, 
sealed tube
-[MeSi(H)0]2c 1 MeCNAol (70:2) H2PtCl6 80°C, 24h
MeSiH(OMe) 1 DCM H2PtClj reflux, 24h, N2
EtjSiH 1 t-BuOH I^PtCl6
1 Tol/MeCN (1:3)D h^ PtClg
3 Tol/MeCN (1:3)D Cp^PtC^
3 Tol/MeCN (1:3)D Cp^ PtClj





80°C, 32 days, 1^ , 
(45$)
15CPc, 8 days, ty, 
sealed tube,
(48$)
150°C, 48h, ty, 
sealed tube,
(31315)
a:- numbers in parenthesis refer to the ratio of solvents 
by volume. D, degassed solvents; b:- MejSiAOSiMepj- 
(OsiHMe^-OSiMej; c:- ((MejSiO) (SiMeH2 )2 ]0; d:- numbers in
parenthesis refer to reaction yield.
to elute these materials led to fragmentation. Neither 
alumina nor fluorosil, proved suitable for chromatographic
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separation of the products. Gel permeation chromatography 
was also used in an attempt to identify the product/s, but 
with inconclusive results. Only in one reaction was the 
required reaction achieved, and the NMR spectrum of the 
completely reacted major product could be completely 
assigned. However, this result could not be reproduced, and 
the reaction was finally abandoned.
Reaction of the cyclic peptide with other siloxanes 
(Fig 9.7) was also attempted, but again either no reaction 
was evident, and the starting material was recovered, or 
a multi-component mixture was produced from which it was 
not possible to isolate or identify positvely the 
individual components.




In the second model study, the synthesis of 
dichlorosilane derivatives (32) were attempted, using a 
similar method to that described by Pirkle and Pochapsky* 
(Scheme 9.3). The product was expected to be extremely 
easily hydrolysed on contact with moist air, and reactions 
were therefore performed with careful exclusion of 
moisture. Due to the difficulty of handling chlorosilanes 
only NMR data is available on the product, but it shows 
that the cyclic peptide remained intact throughout the
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course of the reaction, despite the very large excess of 
chlorosilane used in the model study.
Scheme 9.3. Toluene/DCM, HjPtClj, MeSi(Cl)2H, R.T. , 48h,
reflux 30min or reflux 48h.
Transference of the dichloromethylsilyl derivative of 
the peptide (see below) into a stirred suspension of silica 
gel in toluene, was done via a cannular, under nitrogen 
gas. In the initial study of the peptide modification of 
silica gel (12pm, 90% ±7pm), triethylamine was added to
bind any HCl liberated. Subsequently this was omitted in 
order to avoid any possibility of the base de-activating 
the silica gel.
9.2.1 Effect of solvent composition on hydrosi1ylation 
reactions of peptides.
The choice of solvent was found to be a very important 
factor in determining the success of the reaction. The 
solvent was required to dissolve the cyclic peptide, but 
not compete in the reaction, nor boil at too low a 
temperature. In many hydrosilylation reactions, involving
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liquid reactants, no solvent is used.*”5 In this reaction a 
mixture of toluene and butan-2 -ol was-used initially, as 
the peptides were prepared in this solvent combination, and 
are soluble in it. However, it appeared from NMR evidence 
on the reaction products, that butan-2 -ol reacted with the 
Si-H groups in the siloxane polymer. This was confirmed by 
heating the solvent combination with the 3,5-siloxane 
polymer in the presence of catalyst, to afford the 
appropriate product (28) (Scheme 9.4), which was identified 
by NMR spectroscopy. Although primary alcohol sSi-H 
reactions are facile, sterically hindered secondary 
alcohols are generally slow to react in the presence of a 
1-alkene, and a platinum catalyst. This suggests that 
hydrosilylation of the alkenyl functionalised peptide might 
require forcing conditions.
fH3 OH
♦ c h04h3CHCH2CHg —
Ch 3Ch ch2g h 3
28
Scheme 9.4
Other solvent systems evaluated included toluene alone 
or mixed in various proportions with tert-butanol, or 
acetonitrile, dichloromethane, and also pure tert-butanol. 
Toluene/acetonitrile was finally chosen as this allowed a 
fairly high temperature to be used during reaction, and was 
easier to handle than tert-butanol, which although
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chemically suitable, is a low melting point solid.
9.2.2 Mechanism of hydrosi1ylation.
In general, hydrosilylation involves the addition of 
an Si-H unit to an unsaturated molecule (Fig 9.8). The 
reactions are usually accomplished by one of the following 
methods:-
ssi-H + >C=C< ---> =Si->C-C<-H
i ii i
sSi-H + i o III 0 1 1 1 1 > ssi-C=C-H
in w H- 1 + > c = o ---> H->C-0-Si=




ESi-H + -N+- C e ' --- > -N=C<
Sis
Fig 9.8
a) by heating the reactants together, usually at 
300°C or higher under high pressure
b) by using a radical initiator, such as an
organic peroxide or an azo compound
c) by exposure to UV- or y-radi^tion, or
electrical discharge
d) by catalysing the reaction with transition 
metal salts, such as ^PtCl^, bis(dicyclopentadienyl )- 
platinum dichloride, CpjPtC^, Co2(C0)g etc., or a Lewis
base, such as pyridine.
Platinum salts are the catalyst of choice for 1-alkene
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reactions, and either HjPtClg or Cp2PtCl2 was used in this 
study. The catalyst may be used homogeneously or 
heterogeneously and in some supported catalyst systems, 
reaction is thought to occur at metal sites which remain 
bonded to the support during the reaction.*® Both the type 
and identity of the catalyst affect the overall yields and 
selectivities. The suggested mechanism for platinum 
catalysed addition® is shown in Scheme 9.5.*®
W  R SIH C










In general, the presence of electron-withdrawing 
substituents on the alkene will reduce reactivity, this 
effect being related to the ease of initial complex 
formation. The addition is tolerant of a wide variety of 
functional groups on both carbon and silicon, but a strong
NB It is assumed that a similar mechanism exists for 
Cp2PtCl2
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steric influence is exerted, with silicon bonding to the 
less hindered end of the alkene. It has been shown that the 
structure of the asi-H containing compound can play an 
important role in determining the position of the Si— C 
bond in the alkyl groups formed by hydrosilylation.^ Por 
example, the addition of Cl^iej^SiH (x=3, 2, 1) to
phenylalkenes in the presence of i^PtClg yields two products 
(Fig 9.9).7 Terminal alkenes are hydrosilylated more readily
PMCHj^SiCljMej., and PhCH(SiClxMe3.x) (CH2 ),CH3
Pig 9.9
than internal alkenes, which are known to isomerise prior 
to addition, so yielding terminal products in many 
instances (Pig 9.10).*
H81 H819-h«pt*n» ■■■■■■■■#■» 1 - h M t t n *  —  ■ ■■■■* ■»
Fig 9.10
In an attempt to define more precisely the platinum 
catalytic species, Chandra et al12 studied the reaction of 
Spiers catalyst with sym-tetramethyldivinyldisiloxane 
(MejViSi^O (Vi=vinyl), (solution A) (Scheme 9.6). They 
suggest that this reaction generates Pt(0) species, their 
evidence coming from:*- a) the isolation and 
characterisation of a three-co-ordinate complex, 
[Pt{ (uCHjCHMejSi )20) (P-t-Buj) ] , after addition of P-t-Bu3 to
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solution A; b) the high yield synthesis of other Pt(0) 
complexes from solution A (Table 9.2); and c) cyclic
H2 FtCl6 .xH2 0
1> <H»2 V18I>2 0, 30°C, 4h
2) H1HCO3 t o  n o u t r a Mf o
3) r n t o r
(PtC«i-Ho2 V l $ l O < H « 2 8 1 0 ) x81H t 2 U l - n ) y )
s o l u t i o n  A
Scheme 9.6
Table 9.2. Pt(0) complexes synthesised by Chandra et al^
from reaction with solution A.
Reactant Product Yield (%)












voltammetry, 1,5Pt NMR data, and gas chromatographic 
evidence. Chandra et al12 suggest that the initiator in the 
HjPtClg. xHjO-vinyl si loxane hydrosilylation system is a bis(^- 
vinyl)-chelating Pt(0) complex:-
Pt(CH2==CHMe2SiOSioMe2 CH==CH2)2]
! . . . . . . . . .   ...S
being the principal ingredient. Furthermore, a convenient 
source of Pt(0) complex can be obtained by treating 
HjPtClg.xHjO with a vinylsiloxane, which is a simpler 
alternative to "naked" platinum complexes, such as [Pt(i)~ 
or [Pt(COD)2] (COD=l,5-cyclo-octadiene).
9.2.3 Other factors affecting hydrosilylation.
Successful hydrosilylation reactions were carried out 
in a sealed reaction tube in order to permit high pressure 
conditions. The design of the tube (Fig 9.11) was such that 
all the solvents and reactants had minimal contact with air 
and a positive pressure of nitrogen gas was maintained 
above the reaction mixture.
All solvents used were degassed by bubbling nitrogen 
gas through them for ca 30min. This was found to maintain 
the activity of the catalyst, which otherwise is reduced to 
the metal, as seen by a darkening of the reaction mixture 
before the reaction is complete, and after the "induction 









Fig 9.11. Design of sealing reaction tube used in the 
reactions between the cyclic peptides and triethyl si 1ane.
proceeds.
9.2.3 Analysis of results.
In all cases a 2-5 fold excess of the silane or
siloxane was used in the reaction. All reactions involving 
Et^SiH were successfully chromatographed on silica gel. NMR 
data also confirmed that no unreacted 1-alkene remained. 
Thus signals due to -CH=CH2 in the region 5-6ppm were 
absent in NMR spectra were replaced by signals at ca 1.81 
and 0.91ppm for (30) and ca 1.33 and 0.50ppm for (31) 
(Table 9.3 and 9.4). Of particular note are the changes in 
chemical shift of the NH protons of (13), (30) and (18),
(31) due to the shielding effect of the silicon atom, on
addition of the Et^Si-group to the double bond. A de­
shielding effect is experienced by the NH protons of (32)
Tube capacity was ca 6cm and 12cm .
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Table 9.3. Effect of silicon moiety on the chemical shift
(Sj ppm) of selected protons of the cyclic peptide.
90 82
NH Gly NH Leu aCH Gly aCH Leu YCH2 6C^
73® 6.21 6.48 4.04 4.00 2.83 5.24 5.76
30 7.22 7.40 3.95 3.92 ca 1.90 1.81 0.91
32b 7.51 7.64 4.27 4.20
a:- Protons y and 6 for 13 refer to the terminal double 
bond; b:- NMR solvent CD2CI2 , all others in CD^ Cl .
on addition of the C^MeSi-group.
Addition of the silicon moiety occurred at the 
terminal carbon atom, as opposed to the penultimate carbon 
atom (Fig 9.12). However, due to the short length of the 
spacer chains, it seem likely that steric hindrance, would 
strongly favour addition at the terminal carbon atom. The 
yields of the triethylsilyl derivatives ranged from 87% for 
(30) to 38% for (31). The lower yield of (31) is due mainly 
to incomplete reaction.
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Table 9.4. Effect of silicon moiety on the chemical shift




HH Gly XH Leu aCH Gly <tCH Leu 0CH2 yCH2 6CH2 €CH2 60^
If 8.15 8.04 3.97 3.96 1.82 1.62 2.10 5.78 5.05
31 7.27 7.22 3.98 3.96 ca 1.33 ca 1.33 ca 1.33 ca 1.33 0.50
9 . 3  A t t a c h m e n t  o f  t h e  c y c l i c  p e p t i d e  t o  s i l i c a  s u r f a c e .
The attachment of the cyclic peptide, via a spacer 
chain, to the surface of the silica gel was achieved via a 
reactive dichloromethyl silane intermediate, Both the 
extent and permanency of the attachment, as well as the 
spacer chain length, are of importance for applications of 
this material.
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9.3.1 Extent of modification.
Modification of the silica gel has already been 
discussed above. As discussed earlier, the properties of a 
silica bonded phase are profoundly affected by coverage. 
Por adsorbents, the bonding reaction is determined by the 
type, the activity, and steric factors affecting the 
reactive sites at the silica surface.** Colin and Guiochon** 
suggest that the coating density increases with increasing 
temperature at first, and becomes constant above 75°C.
Qualitative carbon analyses caa be used to measure 
coverage density of the silca gel. While giving an 
indication of the extent of the reaction between silanols 
and chlorosilane molecules, such analyses is considered to 
be misleading.*'** The extent of the modification/loading, in 
this study, is expressed in mMg’* of silica gel (Table 9.5), 
and the figures corrected for, by comparison with an 
untreated sample of silica. Loadings were calculated by 
comparison of the theorectical and observed elemental 
analyses. Preliminary modification experiments using HPLC 
grade silica gel, yielded a stationary phase with loadings 
lower (ca 3-5 times lower) than those tabulated in Table
9.5. Loadings were increased by oven drying the silica gel 
prior to modification with the cyclo-peptide. The loadings 
calculated for CSP 2 and 3 are comparable to those obtained 
by Pirkle and co-workers,*'** who obtained values ranging 
from 0 . 23-0. 37mMg’* and 0 .19-0.30mMg‘*, based on carbon and 
nitrogen analyses respectively.
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Table 9.5. Corrected elemental analyses of modified silica 
gel and calculated loadings.
61
--0
CSP n Elemental analysis (%) Loading (mMg"* of
silica gel)
C H N C H N
2 3 4.93 0.66 0.95 0.34 0.30 0.34
3 5 4.82 0.62 0.75 0.29 0.24 0.27
9.2.2 Oven curing.
The modified silica was oven cured in order to 
increase its stability, as there is evidence that
relatively few covalent bonds are formed on completion of
17the grafting reaction. 1 The effect of oven curing was 
studied by Waddell et al*7, who studied silica immobilised 
(3-aminopropyl)triethoxy (81), methyldiethoxy (82), and 
dimethylethoxy (83) as models. They found that oven curing 
times of 3h at 80°C were sufficient to achieve maximum 
silane-surface stability. At zero curing times, they found 
the order of stability of each type of silica to be (81) >
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(82) > (83), and concluded that the number of covalent
bonds initially formed to the surface was related to the 
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10.1.1 Enantiomeric separations on chiral stationary 
phases.1
For enantiomeric separation to occur, two conditions 
must be fulfilled. Diastereomeric complexes must be formed 
between the CSP and at least one of the enantiomers, and 
these must also differ in their free energy of formation. 
The latter has already been discussed (CHAPTER 4 section
4.5.)
The formation of diastereomeric complexes occurs as a 
result of attractive interactions between the analyte 
enantiomers and the CSP, removal of the analyte enantiomers 
from a reverse mobile phase, or by passive diffusion of the 
analyte enantiomers into a chiral environment. In the 
latter case, chiral recognition is sterically controlled, 
and can be likened to a stationary phase containing chiral 
cavities, in which chiral recognition results from the 
ability of the individual enantiomers to "enter" the chiral 
cavity.
Free energies are often small when chromatographic 
separation of enantiomers involves interaction between CSP 
and analyte, implying that the molecules are free to
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"tumble1' and exert little mutual conformational control 
with respect to each other. The diastereomeric complex 
having the lowest energy conformation will principally 
determine the degree of enantioselectivity observed. An 
important note to recognise is that it is the time weighted 
average of all possible interactions that is important for 
determining the retention and enantioselectivity. In some 
cases, more than one chiral recognition process may be 
involved in contributing to the overall chromatographic 
behaviour.
The efficiency of the system employed also influences
the difference in free energy, 6G, and hence the
chromatographic separations observed. If the system 
employed is highly efficient, so that narrow peaks are
observed, 6G need only be relatively small, eg., small- 
scale analytical separations. For such applications peak 
separation is the main requirement, and enantioselectivity 
is of secondary importance. High enantioselectivity is, 
however, required for preparative separation of
enantiomers, this requiring an increase in 6G, thereby 
increasing enantioselectivity of the CSP.
It should be noted that no attempt to proposed a 
mechanism of separation is made, and the reader is referred 
to several recent articles on the mechanistic aspects of 




A model column (CSP 1) was slurry packed, using 4.0g 
of the modified stationary phase and propanol (30cm^), into 
a stainless steel column (20 x 0.49 I.D. cm) under high 
pressure. The column was conditioned using methanol, 
hexane, and 50% methanol/water. The test columns (CSP 2 and
3), with dimensions 25 x 0.45 I.D. cm, were similarly 
treated. A guard column (50 x 0.49 I.D. cm) was filled with 
silica. All columns were fitted with Swagelok female 
fittings, and 2nm stainless steel frits.
The following equipment was used:- Gilson piston 
pumps, model 303; Gilson dynamic mixer, model 811B; Gilson 
manometric module, model 802 or 802C; Rheodyne syringe 
loading sample injector, model 7010 fitted with a 20^1 loop 
or model 7125 fitted with a 50yil loop; LDC/Milton Ray UV 
Spectromonitor III or Gilson UV Detector, model 116, both 
with UV detection at 214nm; Gilson HPLC System controller, 
model 702 V3.0 or 714 VI. 2 with Gilson systems interface 
module, model 506B.
All solvents were of HPLC grade. Water was distilled, 
and TFA was distilled from KMnO^. Table 10.1 lists the 
solvents used and the gradient elution profiles. System I 
is frequently used in the laboratory for the qualitative 
analysis of peptides and amino acids using a HPLC
column. System III has been frequently used with chiral 
stationary p h a s e s , a n d  was used to study the effect of a
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Table 10.1. Gradient elution profiles of System I, II and 




Gradient elution profile 
(t/min, % solvent)
ti=0, 95%A; t2=5# 95%A; 
t3=52 .5, 0%A; t4=57.5, 0%A 
t3=76.5, 95%A; re-condition 
until t®=86.5
11=0, 100%C; t2=5, 100%C; 
t3=10, 95%C; t4=15, 95%C; 
t3=20, 100%C; re-condition 
until t6=25
t*=0, 100%C; t2=5, 100%C; 
t3=10, 90%C; t4=15, 90%C; 
t3=20, 100%C; re-condition 
until t6=25
System I:- Water (A) and MeCN/water (B), both containing
0.1% TFA; System II:- Hexane (C) and acetonitrile (D); 
System III:- Hexane (C) and isopropanol (E).
change in polarity of the solvent system. System II was 
used under isocratic conditions with varying compositions
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of C and E. After each composition change, the column was 
allowed to re*-equilibrate. It should be noted that no 
optimisations of the chromatographic parameters, such as 
flow rate, solvent composition etc were undertaken in the 
limited time available at the end of this project. All 
columns were equilibrated with the System (I, II or III) 
over several hours, or until a stable base line was 
recorded. The test compounds were (11), (13), (14) and
(15), all samples were dissolved in ethanol.
The model column (CSP 1) was of the type shown in Fig 
10.1, and was tested using System I under the conditions 
described. CSP 1 Was initially tested using (11). The 




by TLC analysis, by collection of the fraction eluted from 
the column and analysis with an authentic sample of (11). 
It can be seen from the recorded chromatogram (Fig 10.2), 
that at the apex, there are two peaks of almost equal 
height. Injection of a blank sample, ethanol, and re­
injection of (11) confirmed that this was not a 
characteristic of the column.
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50 J*5 U 0 35 30 25 20 15 10 5 0
Fig 10.2. Qualitative HPLC analysis of tert-
buty1oxycarbonyl-L-1eucine-D,L-(al1y1)glycine methyl ester 
(11) on CSP 1 using System I eluent under the described 
chromatographic conditions.
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Using CSP 1, an attempt was made to resolve the two 
diastereomers of the cyclic peptides, (13) and (14), using 
System I, the resultant chromatogram is presented (Fig 
10.3). For comparative purposes the cyclic peptides were 
also injected onto a Cj8 column. The tabulated results 
(Table 10.2) show a small improvement in the resolution of 
the two cyclic peptides using CSP 1 over that of the 
column. There is also a considerable decrease in retention
Table 10.2. Comparison of retention times of cyclic
peptides (13) and (14) on and CSP 1 columns using System
I.
(13) (14)
R^/min k' R^/min k' a
C18 20.38 10.65 22.38 11.79 1.11
CSP 1 9.13 2.84 6.75 1.84 1.54
time with a reversal of elution order. Dappen et al,® also 
observed a reversal of elution order, in his study of the 
separation of enantiomeric amine derivatives, in which the 
component that is first eluted is of opposite configuration 
to that of the chiral selector bonded to the stationary 
phase (Fig 10.4). The test compound used, under the 
condition described by Dappen et al,* was R,S-N-(1- 
pheriylethyl)-3,5 dinitrobenzoylamide (Fig 10.5). The first 
peak eluted using CSP 21 was of S( + )-configuration, and for
-289-
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90 85 80 75 70 65 60 55 50 U S  U 0 35 30 25 20 15 10 5 0
Fig 10.3. Qualitative HPLC analysis of cyclo-L-1eucine-D,L-(al1y1)glycine 
(13) and (14) on CSP 1 using System I eluent under the described 
chromatographic conditions.
CSP 22 this was of R( -)-configuration. The small 
improvement in the separation factor (a) is, however, 
misleading, since it suggests increased baseline resolution 
of (13) and (14) on CSP 1 over that of the Cjg column.
However, it can seen from the chromatogram (Fig 10.3) that 
no base line resolution is observed. This can be explained 
by the fact that the calculation of capacity ratio (k*) 
values is peak to peak, and does not take into account such 
factors as trailing peaks. Hence, "realistic" a values, can 
only be calculated if the system has been optimised to 
achieve maximum resolution of the required components. 
Therefore, the a value calculated does not give a realistic
CSP 21 # R - c o n f l e u r a t i o n ;  R * = 0 C H 3 , R2 r C H 3




view of the resolution, but the result is still encouraging 
with regards to the reversal of the eluted components, 
since this suggests that a separation mechanism is taking 
place.
Further tests were performed on CSP 2 and (3) (Fig 
10.6) using System II. The test compound was a racemic 
mixture of (16) (Fig 10.7) which had retention times of 2.0 
and 3.0min for CSP 2 and 3 respectively. Chromatograms 
following injections of (16) onto CSP 2 and 3 are presented 
(Fig 10.8 and 10.9), and show a major peak with a smaller 
shoulder. It seems unlikely that this signifies enantiomer 
resolution in view of the very different peak heights. 
However, the reason for the appearance of this second peak 
is not obvious.
81
Fig 10.7. CSP 2, n=3; CSP5, n=5
Fig 10.7
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7 6 5 ^ 3 2 1  0
Fig 10.8. Qualitative HPLC analysis of tert-
butyloxycarbonyl-L-1eucine-D,L-(pentenyl)glycine methyl
ester (16) on CSP 2 using System II eluent under the
described chromatographic conditions.
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6 5 3 2 1 0
Fig 10.9. Qualitative HPLC analysis of tert-
butyloxycarbonyl-L-leucine-D,L-(pentenyl)glycine methyl 
ester (16) on CSP 3 using System II eluent under the 
described chromatographic conditions.
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Since (16) was eluted rather quickly using System II, 
an attempt was made to increase the retention time. Hence, 
the less polar solvent combination of isopropanol and
hexane was employed (System III). The use of pure hexane 
caused an increase in retention time (Fig 10.10)
(R^=4.77min), but no separation was observed. Various 
mixtures of isopropanol/hexane were then investigated 
briefly (Table 10.3). The effect of increasing the
isopropanol content served to produce a decrease in 
retention time, but in all cases no resolution was
observed. From the chromatogram (Fig 10.10), two side peaks
Table 10.3. Retention time of (16) injected on CSP 3 using 
isopropanol/hexane mixtures under isocratic elution 
conditions.






(R^=4.41 and 5.37min) are visible either side of the main 
peak (Rt=4.77min) . It is possible that these two side peaks 





Fig 10.10. Qualitative HPLC analysis of tert-buty1oxycarbony1-L-1eucine- 
D, L-(penteny1)glycine methyl ester (16) on CSP 3 using hexane as the 
eluent.
enantiomers of the racemate (15). Unfortunately this could 
not be confirmed, as collection of the required eluting 
fractions was not possible without cross-contamination from 
the major peak. A gradient elution profile was also
investigated briefly (Table 10.1). A chromatogram from 
these investigations is shown (Fig 10.11). A useful
increase in retention time was observed (R^  = 5.75min), but no
resolution of the enantiomer of (16) could be observed.
Again the two side peaks (^ = 4.91 and 6.83min) are visible, 
and much better resolved. However, confirmation of the 
identity of the two peaks again could not be made.
10.3 Conclusions.
It is evident that more work is required to determine 
whether resolution of enantiomers using cyclic peptides as 
the chiral selectors can be achieved. Initial results from 
the analysis of the two diastereomeric cyclic peptides, 
(13) and (14), are encouraging, as the elution order of the 
cyclic peptides was reversed when using CSP 1, indicating 
that a separation mechanism is operating. No observable 
resolution of the peptides (11), (16) were achieved with
CSP 1, 2 or 3. This may reflect on incorrect choices of 
conditions or the fact that the columns used in this study 
were not end-capped, and therefore, it is likely that more 
than one separation mechanism may be operating, which 
may/may not have a cancelling effect on any resolution that 









Fig 10.11. Qualitative HPLC analysis of tert-buty1oxycarbony1-L-1eucine- 
D,L-(pentenyl)glycine methyl ester (16) on CSP 3 using System III eluent 
under the described chromatographic conditions.
the active sites is necessary, providing more interactive 
sites for resolution to occur. It should also be borne in 
mind that the choice of substrate may also determine if a 
resolution is observed.
Optimisation of the solvent system will be necessary, 
since the appropriate conditions have not yet been 
established, and long term stability of the columns will 
also need to be investigated.
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E X P E R I M E N T A L
CHAPTER ELEVEN.
EXPERIMENTAL.
11.1 Instrumentation and experimental technique.
Melting points (m.p.) were determined on commercially 
available apparatus (Electrothermal Mk III or Gallenkamp), 
and are uncorrected. Optical rotations were measured using 
a Perkin Elmer 141 Polarimeter fitted with a sodium lamp 
and a filter to isolate the sodium D line (589hm).
Infrared spectra were recorded in the range 4000- 
600cm'* using a Perkin Elmer 1310 grating spectrometer and 
peaks are reported as (o^) wavenumbers (cm'*). Spectra of 
liquid samples were recorded on thin films, and solid 
samples were mulled with nujol.
Proton magnetic (*H N.M.R.) spectra were recorded at 
270MHz on a JEOL GNM GX FT 270 spectrometer (as presented) 
unless otherwise stated, and on Hitachi Perkin Elmer High 
Resolution R-32B and Varian Anaspect EM-360 spectrometers. 
*^ C N.M.R. spectra were recorded on a JEOL GNM GX FT 270 
spectrometer. *H and **C N.M.R. spectra were recorded in 
CDClj, unless otherwise stated, and are expressed in parts 
per million (p-p.m.) downfield from internal 
trimethylsilane (TMS). Multiplets are given as follows:- 
singlet (s), doublet (d), triplet (t), quartet (q), quintet 
(quin), sextet (sex), heptet (h), multiplet (m) and broad 
(br).
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Routine mass spectra from both electron impact (E.I.) 
and chemical ionisation (C.I.)/ and high resolution mass 
determinations were recorded with a VG Analytical 7070E 
instrument with a VG2000 data system. Unless otherwise 
stated, the data provided is that from C.I. using isobutane 
as reagent gas. E.I. spectra were produced with an ionising 
potential of 70eV. Where possible, the molecular ion peak 
M* or [M+l]* and the base peak are indicated, as are all 
sizeable fragmentations with assignments. Elemental 
analyses were carried out using a Carlo Erba 1106 Elemental 
Analyser.
For experimental procedure, a complete description is 
given, and details quantities of reagent, yield and 
characterisation details are included.
Thin layer chromatography (T.L.C.) was used 
extensively as a qualitative guide during reactions and for 
assessing purity of compounds. Whatman AL Sil G/UV or Merck 
DC-Alufolien Aluminiumoid 60 Fjjj sheets (dipped in 
triethylamine and air dried) containing fluorescent 
indicator were used for this purpose. Visualisation of 
reaction components was achieved by illumination under 
short wavelength (254nm) ultraviolet light when possible, 
plates were developed with 5%(w/v) aqueous solution of 
potassium permanganate (KMnOj) and then washed in water or 
a 7%(w/v) methanol solution of dodeca-molybdophosphoric 
acid (PMA), followed by warming of the T.L.C. plate.
Unless otherwise stated, petroleum refers to petroleum 
spirit with a boiling point range 60-80° and which was
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distilled before use as eluant in column chromatography.
Medium pressure flash column chromatography was 
routinely employed using Amicon Matrex Silica Si 
Chromatography Medium (particle size 35-70pm). A pressure 
gradient was developed using a small, commercially 
available hand bellow (Gallenkamp). Columns were prepared 
in the eluting or the least polar solvent, and then eluted 
isocratically or with solvent mixtures of steadily 
increasing polarity. Materials that were pre-adsorbed onto 
the chromatography support were applied as a thin layer to 
the top of the column.
Tetrahydrofuran (THF) was pre-dried over sodium wire, 
then refluxed over sodium benzophenone ketyl under dry 
nitrogen until anhydrous* This was redistilled immediately 
prior to use.
Glassware used for water sensitive reactions was baked 
in an oven at 1 2 0 ° for 1 2 h and allowed to cool in a 
desiccator over CaClj. Flasks and stirring bars were 
additionally flame dried under nitrogen.
In all experiments, the excess solvent was evaporated 
with a Biichi rotary evaporator using a water aspirator at 
room temperature or in a water bath at a temperature of 
<40°C to avoid unnecessary heating. All yields quoted are 
for the purified products, and are uncorrected.
All other general reagents and solvents were purified 
and dried when required using the methods described in A.I. 
Vogel "Textbook of Practical Organic Chemistry” 4^ Edition, 
Longman, London and New York 1978.
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2D Homonuclear shift correlated spectra for &g 
couplings using the C.O.S.Y. microprogram have been used 
extensively throughout this project when proton assignments 
were unclear. The lettering system used for the alkenyl 





The numbering system used to denote the position of 
the chiral carbon when more than one chiral centre is 




Synthesis of tert-butrloxycarbonyl-L-leucine.^ 3 (1)
NjH-Leu-OH ---- ► Boc-Leu-OH (1)
A suspension of L-Leucine (3.0g, 0.023H) in dioxane/HjO 
(70cm3, 2:lv/v), was treated with Na^ COj, (2N, 45cm3) added, 
and then cooled to 0°C when (Boc)20 (5.74g, 0.026H, 1.13eq) 
was added. The reaction mixture was stirred and allowed to 
warm to R.T. overnight. Dioxane was removed in vacuo and 1^0 
(100cm3) was added to dissolve the suspension. The aqueous 
layer was washed with EtOAc (300cm3) and cooled to 0^ C when 
citric acid (IN, 75cm3) was added to the aqueous phase to 
precipitate the product. The product was recrystallised 
fromMeOH/HjO and dried over silica gel (self-indicating) to 
give the product (1) as the mono-hydrate (4.80g, 84%).
m.p. 87-88^C; [Lit3 78-81^C; Lit3 67-72^0 (mono-hydrate)]. 
[a]jj= -22.1° (c=l, acetic acid); [Lit3 [a]D= -24° (c=2.002, 
acetic acid)].
vul(nujol); 3440 (OH, water of recrystallisation), 3250 (NH 
str), 1665 (C=0 str), 1240cm"3 (C-0 str).
S^CDClj); 0.96[6H, d, (CH3)2, J=6.5Hz], 1.45[9H, s, (CH3)3],
Lit 3:- P. Schwyzer, P. Sieber and H. Kappeler; Helv. Chim. 
Acta.,1959,281,2622.
Lit . - J.C. Sheenan and G.P. Hess; J. Amer. Chem. Soc., 
1955,77,1067.
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1.50-1.72[3H, brm, CH, CHj], 4.32[1H, brm, <*CH], 4.95[1H, 
brd, HH urethane, J=8.0Hz].
m/e (C.I.); 232[(M+1),, 8 %], 176[(M+l),-(CHj )3C, 100],
130[176-COj, 71], 86[130-C0j, 27].
Found:- C,53.5; H,9.55; N,5.62. C^H^NOj requires C,53.2; 
H,9.24; N, 5.62%.
Synthesis of L-leucine methyl ester hydrochloride. (2)
N2H-Leu-0H ____ ► HCl .HjN-Leu-OMe (2)
Method 1 3
To leucine (l.Og, 7.6mM) was added 2,2 
dimethoxypropane (100cm3) and conc. HCl (7.5cm3), and the 
reaction mixture stirred at R.T. for 48h. The volatile 
components were then removed in vacuo at a water bath 
temperature not exceeding 50°C, and the residue dissolved in 
the minimum volume of dry MeOH. Addition of dry ether (ca 
250cm*) precipitated the crude product (2), which was 
filtered and re-crystallised from MeOH/ether (0.9466g, 
68%).
m.p. 148-149°C; (Lit3 146-148; Lit4 147-148°C).
[q]d= +13.4 (c=l, H20); [Lit4 [o]D= +13.4 (c=5.075, H20)]. 
uM1(nu jol); 1730 (C=0 str), 1250, 1220cm‘* (C-0 str).
Lit J.R. Rachele; J. Org. Chem., 1963,28,2898.
Lit 4:- M.F. Scholl, J.B. Larkin, L.B. Rochland and M.S. 
Dunn; J. Org. Chem., 1947,12,490.
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60MHz, 6H(CDC13); 1.0[6H, (CH3)2), 1.9[3H, CH, CHj], 3.8[3H, 
OCH3], 4.2 [ 1H, aCH].
m/e (E.I.); 146[(M+1)4, 100%), SeCM+l-CO^CHj, 92).
Method 2.lit 4
Dry HCl gas was bubbled through a suspension of 
leucine (20g, 0.15M) in dry MeOH (120cm3) until a sample of 
the reaction mixture gave one spot by T.L.C. (solvent 
system; butanol :AcOH: 1^ 0; 4:l:l:v/v; ninhydrin). The solvent 
was removed in vacuo until constant weight was achieved. 
The product was recrystallised from MeOH/ether and dried 
over P2Oj in vacuo (24.13g, 87%).
m.p. 147.5-148°C; (Lit4 147-148°C).
[a]D= +13.6 (c=1,H20); [Lit4 [a]D= +13.4 (c=5.075, H20)]. 
i>Bai(nujol); 1730 (C=0 str), 1240, 1220cm‘* (C-0 str). 
6 g(CDCl3); 0.95[ 6 H, q, (CH3)2, J=2.5Hz], 1.74[2H, brm, CHj], 
1.85[1H, brm, CH], 3.84[3H, s, OCH3), 4.15 [1H, t, aCH,
J=7.0Hz].




Boc-Leu-OH + HCl .NjH-Leu-OMe -----► Boc-Leuj-OMe (3)
Dicyclohexylcarbodimide method.*1** 7,8
To a cooled (0°C) solution of (1) (71mg, 0.31mM, l.leq) 
HOB1 (45mg, 0.33mM) and DCCI (64mg, 0.31mM) in DCM (5cm3), 
was added the free amino component of (2), prepared by 
dissolving the HCl salt (50mg, 0.28mM) in DCM (5cm?), adding 
diisopropylamine (0.05cm3) and cooling to 0°C. The reaction 
mixture was stirred at 0°C for 3h and then at R.T. 
overnight. The reaction mixture was filtered and the filter 
cake thoroughly washed with EtOAC (15cm3). The organic layer 
was washed with citric acid (IN), NajCOj (IN), saturated 
brine, dried over MgSOj and the solvent removed in vacuo to 
leave an oil. The oil was chromatographed on silica gel 
(DCM/MeOH, 4:lv/v) and the product (3) recovered as a white 
solid (28mg, 28%).
m.p. 100-105°C; (Lit6 132-133°C; Lit7 136-137°C; Lit8 141- 
142°C).
Lit 8:- W. Konig and R. Geiger; Chem. Ber., 1970,103,788.
Lit 6:- D.E. Nitechi, B. Halpern and J.W. Westley, J. Org. 
Chem., 1964,33,869.
Lit 7:- K. Suzuki, Y. Saski, N. Endo and Y. Mikara; Chem. 
Pharm. Bull., 1981,29,233.
Lit 8:- J.E. Shields, S.T. McDowell, J. Pavlos and G.R. 
Gray; J. Amer. Chem. Soc., 1968,90,3549.
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[ct]jj= -26 (c=l, MeOH); [Lit* [a]D= -50.4 (c=l, MeOH); Lit7 
[a]D= -55.0 c=l, MeOH); Lit1 [a]D-25.7 (c=0.3, MeOH)].
6 |(CDCl^); 0.94[12H, dt, 2X(CH3)2/ J=6.5Hz], 1.44[9H, s,
(CH3)30], 1.50-1.66[6H, brm, CH, CHj], 3.73[3H, s, OCH3], 
4.11[1H, brm, aCH], 4.61[1H, dt, a2CH, J=8.5Hz], 4.90[1H, 
brd, NH urethane, J= 8.0Hz], 6.50[1H, brd, NK amide,
J=8 .0Hz].
Mixed anhydride method.^
Boc-Leu-OH + HCl .NjH-Leu-OMe ---- ► Boc-Leu2-OMe (3)
Method 1.
The free amino component was formed by dissolving (2) 
(1.12g, 4.8mM) in DMF (5cm3) with warming, adding TEA
(0.36cm3, 4.8mM) and cooling to -15°C. (1) (l.lg, 4.8mM) was 
dissolved in THF (14cm3), NMM (0.53cm3, 0.48mM) added, and 
the solution cooled to -15°C when 1BC (0.63cm3, 0.48mM) was 
added. After ca lmin the free amino component was added 
slowly . The reaction mixture was stirred and allowed to 
warm to R.T. overnight. The reaction mixture was filtered 
and the filter cake thoroughly washed with EtOAc. The 
volume of the filtrate was reduced until the liquid became
Lit 3:- J.R. Vaughan Jr. and R.L. Osato; J. Amer. Chem. 
Soc., 1951,73,3547.
Lit T. Wieland and M. Bernhard; Ann. Chem.,
1951,572,190.
Lit R.A. Boissonnas; Helv. Chim. Acta., 1951,34,874.
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oily/ and the product precipitated with HjO (50cm5), dried 
over P205 before recrystal lising with MeOH/HjO 1.37g, 80%, 
m.p. 138-139°C).
[a]D= -49.8 (c=l, MeOH).
uM 1(nujol); 3360, 3270 (NH str), 1760, 1680, 1650 (C=0 str), 
1550cm’*.
6 g(CDCl3); 0.93[12H, dt, 2X(CH3)2, J=6 .0Hz], 1.44[9H, s,
(CH3)3CO], 1.48-1.70[6H, brm, CH, CHj], 3.73[3H, s, OCHj], 
4.10[1H, brm, OjCH], 4.63[1H, dt, QjCH, J=8.5Hz], 4.88[1H, 
brd, NH urethane, J=7.5Hz], 6.46[1H, brd, NH amide,
J=8.0Hz].
m/e (C.I.); 359[(M+1)\ 71%], 303[ (M+1)+-(CH3 )3C, 94],
254[303-CO2, 41], 186[(M+l)*-CONHC5H10CO2CH3, 24], 130[186-
CjHj, 57], 86[130-CO2, 100].
Method 2.
(1) (9.24g, 0.041m) Was dissolved in DMF (40cm5), NMM 
(4.5cm5, 0.041M) added and the mixture cooled to -15^C when 
IBC (5.5cm5, 0.041M) was added. The free amino component was 
formed by dissolving (2) (7.78g, 0.043M, 1.05eq) in DMF
9120cm5), NMM (4.7cm5, 0.043M) added, cooled to -15^ and 
then added to the cooled solution of (1). The reaction 
mixture was stirred at -15°C for 6 h and filtered, the filter 
cake being thoroughly washed with EtOAC. The volume of the 
filtrate was reduced to a light oil consistency and HjO (ca 
300cm5) was added to precipitate the product. The product 
was recrystallised fromMe0H/H20 and dried over P2Oj in vacuo
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(12.85g, 8 8 %, m.p. 138-139°C), and found to be identical to 
the product (3). synthesised by the method described above 
(Method 1).
Deprotection of tert-butylozycarbonyl-L-leucyl-L-leucine 
methyl ester.^ ^
Boc-Leuj-OMe ---- ► TFA’HjN4 -Lei^-OMe
A solution of (3) (0.72g, 2mM) in TFA (6.0cm*) was 
allowed to stand at R.T. for lh while protected by a CaClj 
drying tube. The solvent was removed in vacuo leaving an
oil. The de-protected di-peptide was precipitated from 
ether/pet ether and used without characterisation.
Synthesis of tert-butyloxycarbonyl-L-leucyl-L-leucyl-L- 
leucine methyl e s t e r . * (4)
Boc-Leu-OH + HjN-Leuj-OMe ---- ► Boc-Leuj-OMe (4)
Boc-Leuj-OMe (4) Was prepared from (1) and HjN-Leuj-OMe 
(from treatment of (3) with TFA), by a similar method to 
that used for the preparation of the di-peptide (3). The 
product (4) was isolated in 72% yield.
m.p. 157-159®C; (Lit8 156-159°C).
Lit H. Kappeler and R. Schwyzer; Helv. Chim. Acta.,
1960,43,1453.
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[<*]„= -64.3 (c=l, MeOH); [Lit8 [a]D= -21.7 (c=0.4, MeOH)]. 
uB„(nujol); 3290 (NH str), 1745 (C=0 str), 1680, 1660, 1630 
(C-0 str), 1530cmT*.
6 g(CDCl3); 0.92[18H, m, 3X(CH3)2], 1.44[9H, s, (CH3)3CO],
1.46-1.75[9H, brm, CH, CHj], 3.72[3H, s, OCHj], 4.32[1H, 
brm, a^CH], 4.48[2H, brm, a2,a3CH], 5.21[1H, brd, NH 
urethane, J=6.5Hz], 6.69[1H, brd, NH-ct2CH amide, J<=8.0Hz], 
6.79[1H, brd, NH-a3CH amide, J=8.0Hz].
m/e (C.I.); 472[ (M+l)*, 15%]. 416[ (M+1)4-(CH})}, 30],
372[416-COj, 12].
Synthesis of tert-butylogycarbonyl-L-1eucyl-L-leucy1-L- 
leucyl-L-leucine methyl e s t e r . 8 (5)
Boc-Leu-OH + H2N-Leu3-OMe -----» Boc-Leu^-OMe (5)
Boc-Leuj-OMe (5) Was prepared from (1) and H2N-Leu3-OMe 
(from treatment of ( 4)  with TFA), by a similar method to 
that used for the preparation of the di-peptide (3). The 
product (5) was isolated in 41% yield.
m.p. 200-201°C; (Lit* 207-208,C).
[a]|= -86.9 (c=l, MeOH). [Lit* [tt]t= -16.4 (c=0.25,
trifluoroethanol),
S^CDClj); 0.92[24H, brs, 4X(CH3)23 , 1.43[9H, s, (CH3)3CO],
1.50-1.75[12H, brm, CH, CH2], 3.71[3H, s, OCH3] , 4.35[1H, 
brm, OjCH], 4.45-4.80[3H, brm, a2,a3 ,a^ CH], 5.64[1H, brd, NH 
urethane], 7.58[3H, brm, NH-a2,a3 ,a^ CH amide].
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m/e (C.I.); 585[(M+1)*, 18%], 529[ (M+l)*-(CHj )jC, 10],
485[529-COj, 29].
Synthesis of benirlldine glycine methyl e s t e r “ (6) 
HjNCHjCOjH ---- ► PhCH=NCHjCOjCHj (6 )
To a suspension of HCl-Gly-OMe (lOg, 0.08M) in DCM 
(160cm*) was added benzaldehyde (8 .8 cm*, 0.08M, l.Oeq), TEA 
(11.8cm*, 0.16M) and MgSOj (8.0g). The reaction mixture was 
stirred at R.T. for 48h while protected by a CaClj drying 
tube. The reaction mixture was filtered and the solvent 
removed in vacuo. To the crude product was added HjO 
(100cm*), ether (100cm*) as an extractant. The aqueous layer 
was further extracted with another litre of ether. The 
organic layer was washed with saturated brine (2 0 0 cm?), 
HjO(200cm*), dried over MgSOj and the solvent removed in 
vacuo to give the product (6) as lemon-coloured oil 
(11.72g, 83%).
t>|ax(liquid film); 3040, 3010 (Ar-H, C=C str), 1720 (C=0
str), 1625 (C=C str), 1420 (-CH= str), 1230 (C-0 str), 725- 
680cm’* (5 adjacent H, mono substituted Ar ring).
^(CDClj); 3.76[ 3H, s, OCHj], 4.41[2H, d, CHj], 7.42, 
7.77[5H, m, CgH5 ], 8.28[1H, s, -CH=].
Lit **:- G.S. Stork, A.Y.W. Leong and A.M. Touzin; J. Org. 
Chem., 1976,41,3491.
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Synthesis of D.L-fallvl)qlycine methyl e s t e r . ^  (7)
PhCH=NCH2C0 2CH3 -----» HCl .H2N-(al lyl )Gly-OMe (7)
+
HCl.H2N-(allyl)2Gly-OMe (6)
(6) (11.72g, 0.066M) Was dissolved in THF (130cm3) and 
cooled to -78^. The temperature of the reaction was 
monitored with a thermometer inside the reaction flask. A 
suspension of KOBu* (sublimed), in THF (105cm3) was slowly 
added dropwise, keeping the temperature of the reaction 
mixture below -70^. The dark red solution was stirred for 
a further 0.5h after complete addition of KOBu*, when a 
solution of allyl bromide (11.2cm3, 0.066M, l.Oeq) in THF 
(75cm3) was slowly added dropwise, keeping the temperature 
of the reaction below -70^ C. The reaction mixture turned 
slowly from red to yellow at which stage it was allowed to 
warm slowly to -10°C and kept at -10°C for ca 12h. The 
reaction mixture was washed with saturated NH^Cl solution 
(300cm3) and separated. The aqueous layer was further 
extracted with ether (450cm3) and the organic layers 
combined. The organic layer was washed with saturated NHjCl 
solution (300cm3), H^ O (300cm3), then dried over MgSOj, and 
the solvent removed in vacuo to leave a yellow oil. The oil 
was dissolved in aqueous MeOH (90% MeOH, 150cm3) and HCl gas 
bubbled through the solution. The solvent was removed in 
vacuo and the oil dissolved in H20 (150cm3), washed with 
ether (300cm3) and the H20  removed in vacuo to give a thick
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oil (6.53g, 60%).
The yield of the mono-alkylated product (7) was determined 
by N.M.R. analysis by comparison of the two OCHj peaks with 
the aCH peak height. The presence of the di-alkylated 
product (8 ) was confirmed by M.S. analysis.
Analytical data for mono-alkylated product (7):- 
SgCDjO); 3.85[ 3H, s, OCH3 ] , 4.28[1H, q, aCH, J=5.0Hz],
5.33[2Hr tm, =CH2~, J=10.0 (trans), 8.0 (cis), 1.5Hz (gem)], 
5.77[1H, m, -CH=].
m/e (C.I.); 130[(M+1)*, 100%], 88[ (M+D'-CjHs, 64], 70[130- 
COjCHj , 51].
Analytical data for di-alkylated product (8 ):- 
6g(D20); 3.88(3H, s, OCH3]. 
m/e (C.I.); 170[(M+1)*, 28%]
Synthesis of tert-butyloxycarbonyl-P,L-(allyl)glycine 
methyl ester.^* (9)
HCl .H2N-(allyl)0ly-0Me -----► Boc-(allyl)Gly-OMe (9)
(7) (1.31g, 7.9mM) Was dissolved in dioxane/H20 (72cm*, 
2:lv/v) and cooled to 0^ when NajCO^ (2N, 32cm*) was added, 
followed by (Boc)20 (3.49g, 16.0mM, 2.0eq). The reaction 
mixture was stirred at R.T. overnight. Dioxane was removed 
in vacuo and H2 0  was added to give a total volume of ca 
100cm*. The aqueous layer was extracted with EtOAc (150cm*).
-316-
The extract was dried over MgSOj and the solvent removed in 
vacuo to a£ford the product (9) as an oil (1.54g, 83%).
uiai(liquid film); 3340 (NH str), 2960 (C-H str), 1780,1700 
(C=0 str), 1480, 1360 (CH def), 1150cm'1 (C-0 str). 
6 g(CDCl3); 1.44[ 9H, s, (CHj)3], 2.49[1H, m, -CH2], 3.74[3H, 
s, OCH3], 4.36[1H, m, aCH], 5.14[2H, tm, =CH2, J=11.0
(trans, 5.0Hz (cis)], 5.20[1H, d, NH urethane, J=8.0Hz], 
5.70[1H, brm, -CH=].
8C(CDC13); 28.02 [CH3)3], 36.46, 36.59[CH2], 51.86[OCH3],
52.71[ftCH], 84.78[-CO-], 118.65[=CH2] , 132.21[-CH=],
154.97(C=0 urethane], 172.26[C=0 ester].




Boc-NH-(allyl)Gly-OMe ---- ► Boc-(allyl)Gly-OH (10)
(9) (0.2789g, 1.22mM) Was dissolved in MeOH (3.0cm^) 
and cooled to 0°C when aqueous NaOH (IN, 1.8cm1) was slowly 
added dropwise. The reaction mixture was kept at 0°C for a 
further 3h after the complete addition of base. The 
reaction mixture was acidified with citric acid (IN, 
6.0cm1). MeOH was removed in vacuo and H20 (10cm1) added. The
Lit B. Iselin, M. Fuerer and R. Schwyzer; Helv. Chim.
Acta., 1955,38,1508.
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aqueous layer was extracted with EtOAc (30cm?), the extract 
dried over MgSOj and the solvent removed in vacuo. The crude 
product was chromatographed on silica gel (DCM/MeOH, 
19:lv/v) to afford the product (10) as an oil (0.1205g, 
46%).
D*a|(nujol); ca 3600-2800 (OH str), 2940 9NHstr), 3060, 3020 
(unsaturated str), 1760 (C=0 str), 1550, 1440,1410 (C-H
def), 1190cm** (C-0 str).
6g(CDjOD); 1.44[9H, s, (CH3)3], 2.43[2H, m, -CHj-], 2.57[2H, 
m], 4.17[1H, dq, aCH, J=7*5, 3.0Hz], 5.10[1H, dt, =CHj ,
J=17.0 (trans), 9.5 (cis), 2.0Hz (gem)], 5.80[1H, m, -CH=].
Synthesis of tert-but yloxycarbony 1-L-leucine-D.L-
(allyl)alYcine methyl ester. (11)
HCl ,H2N-(allyl)Gly-OMe + Boc-Leu-OH -----►
Boc-Leu-(allyl)Gly-OMe (11)
Method 1: Mixed anhydride method.*1* *
(7) (0.7379g, 4.46mM) Was dissolved in DMF (6 cm*), TEA 
(0.62cm*, 4.46mM) was added and the mixture cooled to -20°C. 
(1) (1.0336g, 0.447mM, l.Oeq) was dissolved in dmf (4cm*), 
NMM (0.49cm*, 4.47mM) added and the mixture cooled to -20°C 
when IBC (0.53cm*, 4.47mM) was added. The reaction mixture 
was stirred at -20°C for ca 5min after which the free amino 
component was added, and the mixture was stirred at -20°C
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for 6 h and then at R.T. overnight. DMF was removed in vacuo 
and H20 (75cm3) was added. The aqueous layer was extracted 
with EtOAc (150cm3), the extract dried over MgSOj and the 
solvent removed in vacuo. The crude product was 
chromatographed on silica gel (EtOAc/pet ether, l:20-> 
3:10v/v) to afford the product (11) as a waxy solid 
(0.7466g, 49%).
uMZ(nu jol); 3320, 3260 (NH str), 3060 (C=C str), 1750, 1680, 
1650 (C=0 str), 1520, 1270, 1240, 1170cm"1 (C-0 str). 
6 g(CDClj); 0.93[6H, dt, (CH3) 2 leu, J=6.0Hz], 1.44[9H, s,
(CH3)3], 1.51[1H, m, CH], 1.66[2H, m, CH2], 2.48[2H, brm, 
CH2], 3.72(8), 3.37(4) [3H, sX2, OCHjX2], 4.22[1H, brm, c^CH 
leu], 4.65[1H, m, <*2CH S1?]' 5.11[2H, tm, =CH2, J=16.0
(trams), 7.5 (cis), 3.0Hz (gem)], 5.41[1H, brd, NH
urethane, J=7.5Hz], 5.69[1H, m, -CH=], 7.11[1H, brd, NH
amide].
m/e (C.I.); 343[ (M+l)4 , 62%], 287[ (M+l)*-(CHj)jC, 100],
269[ (M+l)*-CHj) jCO, 8], 243[M+1-(CHj)jCOCO, 66] 186[22],
130[54], 86[89].




phenyl ester.^* *s (12)
Boc-Leu-OH + pNP ---- ► Boc-Leu-OpNP (12)
(1) (4.20g, 0.018M) And pNP (2.50g, 0.018M, l.Oeq) 
were dissolved in distilled EtOAc (35cm3) and cooled to 0°C 
when DCC1 (3.71g, 0.018M), in EtOAc (4cm3) was added. The 
reaction mixture was stirred at 0°C for a further 30min and 
then at R.T. overnight while wrapped in aluminium foil to 
minimise exposure to light. The reaction mixture was 
cooled to 0 °C again and DCU was filtered off and the solid 
thoroughly washed with EtOAc. The washings and filtrate 
were combined and the solvent removed in vacuo to leave a 
crystalline solid. The solid (12) was re-crystallised from 
pet ether (3.82g, 60%).
m.p. 93-93.5cC; (Lit15 83-84°C)
uMX(nu jol) ; 3290 (NH str), 1745, 1660 (0=0 str), 1505,
1340cm"* (NOj asym and sym str).
6 „(CDCl3); 1.02[6H, dd, (CH3)2, J=5.0, 1.0Hz], 1.47[9H, s,
(CH3)3], 1.85[3H, m, CH, CHj], 4.53[1H, m, aCH], 4.96[1H, 
brd, NH urethane, J=7.0Hz], 7.30, 8,28[5H, m, Ar-H]. 
m/e (C.I.); 353[(M+1)\ 0.9%], 337[1.4], 297[ (M+1)*-(CHj)3C, 
21], 253[(M+l)*-COj, 8 ], 158[57], 140[100], 130[253-CjH^O2, 
89], 86[130-C0j, 61].
Lit 15:- K. Vogler, R. Stader, P. Lanz, W. Leiger and E. 
Bohni; Helv. Chim. Acta., 1965,126,1161.
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Synthesis of____ tert-but vloxycarbony 1 -L-leucine-D.L-
(allYl)alvcine methyl ester. (11)
HCl .H2N-(allyl)Gly-OMe + Boc-Leu-OpNP ►
Boc-Leu-(allyl)Gly-OMe (11)
Method 2: Active ester method.1,11^  (11)
(7) (0.57g, 3.4mM) Was dissolved in DMF (10cm*), TEA 
(0.8cm*, 5.9mM) was added and the mixture stirred at R.T. 
tor ca 15min. This mixture was added (12) (2.10g, 6.0mM, 
1.8eq) in DMF (10cm*) and HOBt (0.58g, 43mM) in DMF (2cm*). 
The reaction vessel was covered in aluminium foil and the 
contents stirred for 48h at R.T. DMF was removed in vacuo 
and EtOAc (80cm*) was added. The organic layer was washed 
with citric acid (IN, 80cm*), Na2C03 (IN, 80cm*), saturated 
NHjCl solution (40cm*), HjO (160cra*), dried over MgSOj and the 
solvent removed in vacuo to leave a dark red oil. The oil 
was chromatographed on silica gel (DCM— >0.1% DCM/MeOH) to 
remove pNP and then re-chromatographed on silica gel 
(EtOAC/pet ether, l:3v/v) to afford the pure product (11) 
(0.45g, 38%) after removal of solvents in vacuo,
uBax(nujol); 3330, 3250 (NH str), 3060 (C=Cstr), 1750, 1680, 
1650 (C=0 str), 1520, 1270, 1240, 1170cm’1 (C-0 str). 
5h(CDC13); 0.93[6H, dt, (CH3) 2 leu, J=6.0Hz], 1.45[9H, s,
Lit W. Konig and R. Geiger; Chem. Ber. , 1973,106,3626.
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(CH3)3], 1.51[1H, m, CH leu], 1.68[2H, m, CH2 leu], 2.55[2H, 
brm, CHj gly], 3.73(9), 3.74(3)[3H, sX2, OCH3X2], 4.14[1H, 
brm, ct|CH leu], 4.64[1H, dq, ctjCH gly], 4.95[1H, dd, NH 
urethane, J=7.5, 1.5Hz], 5.13[2H, tm, =CHj, J=14.0 (trans), 
1.0Hz (gem)], 5,67[1H, m, -CH=], 6.69, 6.76[1H, dX2, NH 
amide, J=7.5 and 7.0Hz].
Found:- C,60.2; H,9.06; N,7.89. CjjH^NjOj requires:- C,59.7; 
H,8.77; N,8.19%.
Synthesis of tert-but vloxvcarbonv 1-L-leucine-D. L-
fallrl)alYcine methyl ester. (11)
HCl .H2N-(allyl)Gly-OMe + Boc-Leu-OH -----*
Boc-Leu-(allyl)Gly-OMe (11)
Method 3: Azide method.^ ^ (11)
(7) (5.59g, 0.034M) Was warmed in .DMF (40cm3) to effect 
dissolution, and then cooled to R.T. when TEA (94.7cm, 
0.034M) was added and the mixture cooled to 0°C. (1) (9.92g, 
0.046M, 1.4eq) was dissolved in DMF (40cm3) and cooled to 
0°C, then TEA (6.4cm3, 0.046M) and DPPA (9.9cm3, 0.046M)
added. After ca 5min the free amino component was added and 
the stirred reaction mixture allowed to warm slowly to R.T.
Lit ^:- T. Shioira and S. I. Yamada; Chem. Pharm.
Bull.,1974,22,849.
Lit *3:- T. Shioira and S. I. Yamada; Chem. Pharm.
Bull. ,*1974,22,855.
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over 24h. DMF was removed in vacuo to leave an oil. The oil 
was dissolved in EtOAc (300cm3) and washed with H20 (300cm3), 
citric acid (IN, 400cm3), Na2C03 (IN, 400cm3), saturated NH^Cl 
solution (400cm3), H20 (400cm3), dried over MgSOj and the 
solvent removed in vacuo to leave an orange oil. 
Chromatography on silica gel (EtOAc/pet ether, l:3v/V 
yielded the product (11) as a white solid (7.08g, 61%).
i>iax(nujol); 3320, 3240 (NH str), 3030 (C=C str), 1740, 1670 
(C=0 str), 1640, 1520, 1260, 1240cm’1 (C-0 str).
6j(CDC13); 0.94[6H, dt, (CH3)2 leu, J=6.0 2.0Hz], 1.44[9H, s, 
(CH3)3], 1.52[[1H, m, CH leu], 1.68[2H, m, CH2 leu], 2.54[2H, 
m, CH2 gly], 3.74[3H, s, OCH3], 4.16[1H, brm, a^CH leu], 
4.66[1H, m, o2CH gly], 5.08[1H, br, NH urethane], 5.11[2H, 
tm, =CH2, J=15.0 (trans), 5.0 (cis), 1.5Hz (gem)], 5.68[1H, 
m, -CH=], 6.77, 6.86[1H, dX2, NH amide, J=7.5 and 6.5Hz]. 
6c(CDC13); 22.1, 23.0[(CH3)2 leu], 24.8[CH leu], 28 . 4[ (CH3)3 ] , 
36.4[CH2 gly], 41.3[CH2 leu], Sl.eCfltjCH leu], 52.3[OCH3], 
53.1[ct2CH gly], 80.2( -CO- ] , 119.2[=CH2], 132.2[-CH=], 155.7, 
172.0, 172.5[C=0].
m/e (C.I.); 343[ (M+l)*, 21%], 287[(M+1),-(CH})JC/ 100],
243[287-C02, 84], 186[26], 130[61], 86[130-CC>2, 80]. 
Found:- C,59.6; H,9.11; N,8.19. C^H3qN205 requires:- C,59.7; 
H,8.77; N,8.19%.
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(11) (7.08g, 0.021M) Was dissolved in TFA/anisole
(60cm3, 5%) and stirred for lh at R.T. while protected by a 
a CaClj drying tube. The solvent was removed in vacuo and 
the de-protected dipeptide was used without purification or 
characterisation as the TFA salt, TFA.H2N-Leu-(allyl)-Gly- 
OMe, which was dissolved in toluene/butanol(500cm3, 2:lv/v) 
and heated under reflux for 36h while protected by a CaCl2 
drying tube. The solvents were removed in vacuo to leave an 
off white solid, which was chromatographed on silica gel 
(DCM/MeOH, 25:lv/v) in order to separate the two 
diastereomers (13), (14). Yields were 1.95g for the anti
(13) and 1.83g for the syn (14) isomers (total yield 3.78g, 
86%). Both isomers were individually purified by re­
crystallisation from MeOH/HjO.
Analytical data for the anti-isomer (13):- 
m.p. 238-240°C.
[a]D= +13 (c=0 . 28, MeOH).
uBai(nujol); 3120, 3040 (NH str), 1650cm"1 (C=0 str).
and 13C N.M.R.; see Tables 1 and 2 respectively, 
m/e (E.I.); 210[(M)\ 37%], 169[M*-C3H5, 57], 154[M+-C^H9,
44], 141[169-C02, 100], 113[ 154-C3H5, 33], 85[113-C02 , 33].
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Table 11.1. Proton chemical shift [5H(DMS0)] and coupling











0.87, q, 7.0Hz 0.87, t, 6.5Hz
1.54, t, 7.0Hz 1.54, dm
1.79, h, 7.0Hz 1.82, h, 6.0,
1.5Hz
Leu
aCH Leu 3.70, dt, 3.0Hz 3.76, brm
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Table 11.2. Carbon chemical shift [6c(DMSO)] and coupling
constants (Hz) of the diastereomers (13) and (14).
Carbon/s HN'
$








qCH Leu 52.8 52.4
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Calculated for;- 210.2754; Found:- 210.1367.
Found:- C,65.2; H,9.35; N,11.7. requires:- C,65.6;
H, 9.2 4; N,11.8%.
A crystal of suitable dimensions was obtained from MeOH for 
X-ray crystallographic analysis. Details of the structure 
have been described in Chapter 8, section 8.6, and 
crystallographic data is to be found in Appendix 1.
Analytical data for the syn-isomer (14):- 
m.p. 219-222°C.
[<*]„= -53.9 (c=0.32, MeOH).
i> M1(nujol); 3140, 3060 (NH str), 1660cm"* (C=0 str).
*H and **C N.M.R.; see Tables 1 and 2 respectively, 
m/e (E.I.); 210[(M)*, 43%], 169[M*-CjH5, 84], 154[M*-C£I!f
74], 141C169-COJ 100], 113(154-^5, 54], 86[113-C02, 54].
Calculated for:- C^H^NjOj , 210.2754; Found:- 210.1367. 
Found:- C,65.3; H,9.61; N,11.8. CjjH ^ N ^  requires:- C,65.6; 
H,9.24; N,11.8%.
Synthesis of D.L-(pentenyl)-glycine methyl ester.*11**3 (15) 
PhCH=NCH2C02CH3 ---- * HCl .H2N-(pentenyl )Gly-OMe (15)
HCl .H2N-(pentenyl )Gly-OMe (15) Was synthesised in a 
similar manner to that used for (7) using 5-bromo-pent-l- 
ene and was isolated in 63% yield.
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^(DjO); 1.52[2H, brm, y CH2], 1.99[2H, brm, /3CH2], 2.12[2H, 
q, £CHj, J=7. 0Hz] , 3.84[3H, s, OCHj] , 4.16[1H, t, aCH,
J=6.5Hz], 5.05[2B, tm, =CH2, J=15.0 (trans), 10.0 (cis), ca 
1.5Hz (gem)], 5.86[1H, m, -CH=].
v MX(liquid film); (benzylidine derivative) ; 3040, 3010 (Ar- 
H, HC=C str), 2840, 2910 (CH str), 1740cm*1 (C=0 str). 
m/e (C.I.); 158[(M+1)+, 100%], 98[(M+1)*-C02CH3, 61].
Synthesis of tert-butyloxycarbonyl-P,L-(pentenyl)alvcine 
methyl ester.1,11 1 (16)
HCl .H2N-(pentenyl)Gly-OMe  r
Boc-(pentenyl )Gly-*OMe (16)
(15) (2.22g, 0.015M) Was dissolved in dioxane/H20
(80cm*, l:lv/v), cooled to 0°C, when NajCO^ (2n, 60cm*) was 
added, followed by (Boc)20 (4.9g, 0.023M, 1.5eq). The
reaction mixture was stirred overnight at R.T. Dioxane was 
removed in vacuo and was added to a total volume of ca 
100cm*. The aqueous layer was extracted with EtOAc (200cm*). 
The extract was dried over MgSOj and the solvent removed in 
vacuo to afford the crude product which was finally 
chromatographed on silica gel (EtOAc/pet ether, l:20v/v) to 
afford the product (16) as a clear oil (1.21g, 31%).
v MX(liquid film); 3640 ( NH str), 3060 (C=C str), 2940 (C-H 
str), 1700 (C=0 str), 1490, 1430 (C-H def), lieOcnf1 (C-0 
str).
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6g(CDCl3); 1.44[9H, s, (CH3)3], 1.62[2H, m, SCHj], 1.81[2H, 
m, Y CHj]' 2.06[2H, dq, /3CH2, J=7.5Hz], 3.73[3H, s, OCH3], 
4.31[1H, q, ctCE, J=7.5Hz], 5.02[2H, tm, =CH2, J=18.0
(trans), 9.5 (cis), 1.5Hz (gem)], 5.16[1H, d, NH urethane, 
J=9.0Hz], 5.78[1H, m, -CH=].
<5^ (CDCL3); 24. 42[ <5CH2] , 28.15[ (CH3)3] , 31.95[y CH2],
32.21(/3CH2], 51.99[OCH3], 53.19[aCHj, 79.56 [-CO-],
114.88[=CH2], 137.75[CH2=], 155.23[C=0 urethane], 173.20[C=O 
ester].
m/e (C.I.); 258[(M+1)4, 1.5%], 242[ (M+l)*-CHj, 5.9], 202[86], 
198[(M+l)*-COjCHj, 25], 158[ (M+l)*-(CH3)3COCO, 100], 142[49], 
98[66], 81[26].
Found:- C,60.7; H,8.95; N,5.45. C^H^NO^ requires:- C,60.7; 
H,9.16; N,5.43%.
Synthesis of____tert-Jbut yloxycarb onv 1-L-leuci ne-D.L-
fpenteny 1)glycine methyl ester.^ (17)
HCl.H2N-(pentenyl)Gly-0Me + Boc-Leu-OH -----*
Boc-Leu-(pentenyl)Gly-OMe (17)
Boc-Leu-(pentenyl)Gly-OMe (17) Was prepared from (1) 
and (15) by a similar method to that used for the di­
peptide (11) (Method 3. Azide method). The product (17) was 
isolated in 53% yield in a semi-crystalline state.
i> WI(nu jol); 3340 (NH str), 1750, 1690, 1650 (0=0), 1530,
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1170cm"1 (C-O).
<5,(CDCLj) ; 0.95[6H, m, (CH})2 leu], 1.44[9H, sX2, (CHj)j)], 
1.39-1.51[4H, brm, CH2 leu, y CH2 gly], 1.68[2H, ra, #CH2 
gly], 1.85[1H, brm, CH leu], 2.02[2H, q, £CH2 gly, J=7.5Hz], 
3.73, 3.74[3H, sX2, OCH3X2], 4,10[1H, brm, aCH leu],
4.58[1H, brdd, <*CH gly, J=8.0Hz], 5.00[2H, tm, =CH2, J=1.50 
(trans), 9.5 (cis), 1.5Hz (gem)], 5.69[1H. brs, NH
urethane], 5.75[1H, brm, -CH=], 6.74, 6.88[1H, brdX2, NH 
amide, J=7.5 and 6.5Hz].
^(CDCLj); 22.8, 22.99[(CH3)2 leu], 24.39[r CH2 gly],
24. 62 [CH leu], 28.22[ (CH3)3] , 31.66, 31.75[/3CH2 gly],
33.05[«5CH2 gly], 41.00[CH2 leu], 51.90[aCH leu], 
52.22[OCH3], 52.97[ oCH gly], 115.08[=CH2] , 137.72[-CH=],
172.30, 172.59, 172.68[C=0 amide].
m/e (C.I.); 371[(M+1)}, 54%], 315[ (M+1)*-CH3C, 87],
271[ (M+1)*-(CH3)jCOCO, 66] , 186[ (CH3)3COCONHC5Hl0, 33] ,
130[186-(CH3)3C, 68], 86[130-CO2, 100].
Found:- C,61.8; H,9.58; N,7.48. Cj3H3^ N203 requires:- C,61.6; 
H,9.19; N,7.57%.




Cyclo-Leu(pentenyl)-Gly (18),(19) Was prepared from 
H2N-Leu-(pentenyl)-Gly-0Me (from treatment of (16) with
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TFA/anisole) by a similar method to that used for the 
preparation of the cyclic peptides (13) and (14), 
Chromatography was performed on silica gel (DCM/MeOH, 
25:lv/v) to separate the two diastereomers. Beginning with 
4.36g, 0.012M of compound (16), yields were 1.20g for the 
anti-isomer and 1.09g for the syn-isomer (total yield 2.29, 
82%). The two diastereomers were individually purified by 
re-crystallisation from (Me0H/H20).
Analytical data for the anti-isomer:- 
m.p. 156°C (sub), 241-242°C (dec).
+6.83 (c=l.01, HeOH). 
v MI(nujol); 3180, 3040 (NH str), 1670cnf* (C=0 str). 
5j(CDCL3); 0.97 [ 6H, brt, (CH3)2 leu, J=6.0Hz], 1.56[4H, m, 
flCHj gly, CH2 leu], 1.80[3H, m, /3CH2 gly, CH leu], 2.10[2H, 
brq, <5CH2 gly, J=6.5Hz], 3.95[2H, brs, aCH gly, aCH leu], 
4.99[2H, brt, =CH2~, J=17.0 (trans), 10.0Hz (cis)], 5.77[1H, 
m, -CH=], 8.05[1H, brs, NH leu], 8.15[1H, brs, NH gly]. 
«5c(CDCL3); 21.18, 23.28[(CH3)3 leu], 24.10[CH leu],
24.13[nCH2 gly], 33.15[/3CH2 glyj, 33.93[£CH2 gly],
43.83[CH2 leu], 53.23[oCH leu], 54.91[aCH gly], 
115.14[=CH2], 137.72[-CH=], 168.95, 169.60[C=O]. 
m/e (E. I. ) ; 238[(M)*, 90%], 182[ (M)*-C4H3, 93], 170[ (M)* -CjHj , 
74], 152[89], 126[NH-CfHu -CO, 31], 113[NH-C5H10-CO, 39],
98(126—CO, 72], 86(113—CO, 100], Calculated for.— Cj3H22N202 , 
238.1860; found:- 238.1680.
Found:- C,65.2; H,9.35; N,11.7. ci3H22N202 requires:- C,65.6; 
H,9.24; N,11.7%.
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Analytical data for the syn-isomer (19):- 
m.p. 207^0 (sub), 254-256°C (dec).
-35 (c=l .02, MeOH). 
v MI(nujol); 3180, 3050 (NH str), 1660cm"* (0=0 str). 
m/e (E.I.); 238{(M)*, 64%], 182[ (M)+-C4H9, 74], 170[ (M)1 -CjHj , 
66], 126CNH-CJHJJ-CO, 75], UStNH-CjH^-CO, 31], 98(126-00, 
64], 86(113-00, 90]; Calculated for , 238.1860;
found 238.1675.
Found:- 0,65.3; H,9.61; N,11.8. 0^22^02 requires: - C,65.6; 
H,9.24; N,11.7%.
Synthesis of tert-butyloxvcarbonyl-L-leucyl-L-leucine J*1* ** 
(20)
Boc-Le^-OMe  r Boc-Le^-OH (20)
(3) (1.64g, 4.6mM) Was dissolved in MeOH (45cm*) and 
cooled to 0°C and sufficient aqueous NaOH (IN) was added to 
produce a thick white precipitate and just turn the 
solution permanently blue in the presence of 
thymolphthalein indicator (ca pH10.5). EtOAc was added as 
a diluent on occasions when if the thick precipitate 
rendered the stirrer inoperative during the addition . MeOH 
and EtOAc were removed finally in vacuo and fyO (50cm*) 
added. The aqueous layer was extracted with EtOAc (150cm?) 
and the organic layer was repeatedly washed with H2O until 
it became clear. The organic layer was then dried over MgSOj 
and the solvent removed in vacuo. The product (20) was
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recrystallised from H;0 (0.25g, 16%).
v u|(nujol); 3330, 3240 (NH str), 3040 (OH str), 1750, 1670, 
1640 (C=0 str), 1550, 1510 (C-H def), 1150cm-1 (C-0 str). 
S^ ( CDCLj); 0.92[12H, t, (CH3)3X2, J=6.0, 4.5Hz], 1.43[9H, s, 
(CH3)3], 1.47 [ 2H, m, CH], 1.65[4H, m, CH2], 4.22[1H, g, d^CH, 
J= 6.0Hz], 4.60[1H, m, a^CH], 5.33[1H, d, NH urethane,
J=8.0Hz], 7.03[1H, d, NH amide, J=8.0Hz], 8.07[1H, brs, OH, 
not observable on shaking with D20].
^(CDClj); 21.83, 22.83[(CH3)2], 24.68[CH], 28.28[ (CH3)3],
40.97, 41. 45[CH2X2] , 52.22, 52. 93[ Op afH] , 79.95[-CO-],
155.75[C=0 urethane], 172.46, 173.17[C=0].
Found:- C,59.8; H,9.30; N,7.45. C27H32N203 requires:- C,59.3; 
H,9.30; N,8.14%.
Synthesis of tert-butyloxycarbonyl-L-leucyl-L-leucine 
hrdraside.111 1 (211
Boc-Leu2~OMe ---- *. Boc-Leu2-NHNH2 (21)
(3) (10.17g, 0.028M) Was weighed into a flamed dried 
flask, blanketed with N2, and dissolved in MeOH (40cm^). 
Hydrazine hydrate (4.0cm*, 0.084M) was added and the
reaction mixture stirred at R.T. for 24h. The solvents were 
removed in vacuo and the crude product chromatographed on 
a short silica gel column (DCM/MeOH, 20:lv/v) to afford the
Lit G. Guttmann and R.A. Boissonnas; Helv. Chim. Acta.,
1960,43,200
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product (21) as a crystalline solid (lO.Olg, 98%).
v MI(nu jol); 3260 (NH str), 1700, 1630 (C=0 str), 1150cm‘l 
(C-0 str).
5g(CDCl3); 0.91[9H, m, (CHj)^], 1.44[9H, s, (CH3)3J,
1.56[6H, brm, CH2X2, CHX2], 3.95[2H, d, NH2, J=3.5Hz],
4.18[1H, brq, ^CH, J=6.0Hz], 4.56[1H, m, &2CH], 5.35[1H, 
brd, NH urethane, J=8.0Hz], 7.19[1H, brd, NH amide,
J=8.0Hz], 8.70[1H, brs, NH].
m/e (C.I.); 359[(M+1)\ 12%], 303[ (M+1)4-(CHj )3, 74],
285[(M+1)4-(CHj)3CO, 67], 271[44], 259[285-CO, 6], 225[33], 
157[16], 130[14], 86[100].
Found:- C,56.57; H,9.76; N,15.5. C22H34N404 requires:-
C,56.98; H,9.50; N,15.6%.
Synthesis of tert-butylozycarbonyl-L-1eucyl-L-leucyl-L- 
leucyl-L-leucine methyl ester. (Azide method).^ 3 (5)
Boc-Leu2-NHNH2 + H2N-Leu2-OMe -----„ Boc-Leu4-OMe (5)
H^-Leu^OMe (48.8mg, 0.19mM), From treatment of (3) 
with TFA, was dissolved in DMF (0.3cm?), cooled to -20°C and 
NMM (0.021cm3, 0.19mM) was added. (21) (61.2mg, 0.17mM) was 
dissolved in DMF (0.3cm3), cooled to -20°C and then treated 
with a 2M HCl solution in THF (0.26cm3). The solution was 
stirred for ca 15min when butyl nitrite (0.004cm3, 0.34mM)
Lit J. Honzl and J. Rudinger; Colin. Czech. Chem. Comm.,
1961,26,233.
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was added, followed by NMM (0.048cm3, 0.34mM) ca 5min
afterwards. This was followed by the addition of the free 
amino component ca lmin afterwards. The reaction mixture 
was Stirred at -20°C for lh and then kept at a temperature 
of 4-10°C for 24h. The solvent volume was reduced by ca 
30cm3 and HjO added to triturate the product which was 
finally recrystallised from EtOAc/pet ether (40.0mg, 40%).
v M1(nu jol); 3340, 3200, 3060 (NH str), 1670cm‘l (C=0 str). 
Sj(CDCL3); 0.89[24H, m, (CH3)jX4], 1.43[9H, s, (CH3)3],
1.55[4H, m, CHX4], 1.63[8H, m, CH2X4], 3.71[3H, s, OCH3], 
4.29[1H, brm, ^CH], 4.63[3H, m, <*2, cty <*4CH] 5.58[1H, brd,
NH urethane, J=8.0, 8.5Hz], 5.58[1H, brm, NH amide], 
m/e (C.I.); 585[(M+1)\ 25%], 511[(M+l)f-(CH3)3CO, 52],
485[(M+l)*-(CH3)3COCO, 53], 327[21], 86[100].
Found:- C,61.4; H,9.75; N,9.57. C30H56N4O7 requires:- C,61.6; 
H,9.59; N,9.59%.
Synthesis of tert-butyloxycarbonvl-L-leucyl-L-leucyl-L- 
leucyl -P.L-fpentenvl lalrcine methyl ester.^ ^  (22)
Boc-LeUj-NHNHj + H2N-Leu-(pentenyl )Gly-0Me --— r
Boc-Leu3-(pentenyl )Gly-OMe (22)
(16) (6.46g, 0.018M) Was dissolved in TFA/anisole
(45cm3, 5%v/v) and stirred for lh at R.T. while protected by 
a CaClj drying tube. The solvent was removed in vacuo and
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the deprotected dipeptide was used without purification or 
characterisation. (21) (9.03g, 0.025M, 1.4eq) was dissolved 
in a 2M HCl solution in THF (130cm3) and cooled to -20cm3 
when butyl nitrite (30cm3, 0.25M) was slowly added dropwise. 
The reaction mixture was stirred for a further 4-5min when 
a pre-cooled (-20°C) solution of the free amino component in 
DMF (65cm3) was added, followed by the dropwise addition of 
NMM (28cm3, 0.25M). The reaction mixture was stirred and 
allowed to warm to overnight R.T. The solvent was removed 
in vacuo and H20 (600cm3) was added. The aqueous layer was 
extracted with EtOAc (600cm3) and the organic layer was 
dried over MgSOj. The solvent was removed in vacuo and the 
crude product was chromatographed on silica gel (EtOAc/pet 
ether l:3v/v) to afford the product (22) as a semi­
crystalline solid (5.37g, 52%).
v M|(nujol); 3320, 3280 (NH str), 1750, 1720, 1690, 1640 
(C=0 str), 1530, 1170cm'1 (C-0 str).
£g(DMSO); 0.84[18H, (CH3)2X3 leu], 1.37[9H, s, (CH3)3],
1.40[ 6H, m, CHjX3, y CH2 gly], 1.56[5H, brm, CHX3, /JCHj 
gly], 2.00[2H, quin, 5CH2, J=6.5Hz], 3.59, 3.60[3H, s,
OCH3X2], 3.91[1H, brq, rtjCH leu, J=8.5Hz], 4.23[1H, brm, 
CH gly], 4.35[2H, br quin, o^o^CH leu, J=7.0, 1.5Hz], 
4.97[2H, tm, =CH2, J=14.0 (trans), 9.0 (cis), 2.0Hz (gem)], 
5.76[1H, brm, -CH=], 6.94[1H, d, NH urethane, J=7.5Hz],
7.85(2H, brm, NH amideX2], 8.22, 8.25(1H, dX2, NH glyX2, 
J=7.5 and 7.5Hz].
45c(DMSO); 21.55, 21.65, 22.84, 22.90, 22.97[(CH3)2 leu, two
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co-incident peaks], 23.91, 24.00, 24.13 [CH leu], 24.26, 
24.36[y CH2 gly], 32.44, 32.57[j9CH2 gly], 40.48, 40.67,
40.84[CH2 leu], 50.47, 50.60, 50.76[ ^ ^ C H  leu], 51.44, 
51.57[oCH gly], 52.81[OCH3], 77.91[-C-0-C=0], 114.92[=CH2 ] , 
138.11[-CH=], 155.20[C=O urethane], 171.36, 171.42, 171.91, 
172.26, 172.33[C=0 amide].
m/e (C.I.); 597[(M+1)4, 3%], 541[ (M+l)*-(CHj)jC, 5],
497[(M+l)*(CHj)jCOCO, 2], 454[(M+1)4-C(H1#C02CH}, 2], 440[454- 
NH, 1], 358[36], 130[13], 86[100].
Found:- C,61.8; H,9.41; N,9.25. j requires:- C,62.4;
H,9.40; N,9.40%.
Synthesis of tert-butyloxycarbonyl-L-leucyl-L-leucyl-L- 
leucyl-P,L-(pentenyl )<jlrcine hrdrazide.^ ^  (23)
Boc-L-Leu3-(pentenyl )Gly-0Me ---- *
Boc-Leu3-(pentenyl )Gly-NHNH2 (23)
(22) (0.5945g, 0.9975mM) Was weighed into a flask and 
quickly flame-dried under a stream of N2 gas. The solid was 
dissolved in MeOH (40cm*) and hydrazine hydrate (0.15cm*, 
3eq) was added. The reaction mixture was stirred at R.T. 
for 48h in a sealed flask. The solvent was removed in vacuo 
and the crude product chromatographed on silica gel 
(DCM/MeOH, 30:lv/v) to afford the product (23) as a white 
solid (0.5129g, 86%, m.p. 219-220°C.).
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^(DMSO); 0.85[18H, m, (CH3)2X3 leu], 1.37[9H, s, (CH3)3], 
1.42[6H, m, CH2X3 leu, r CH2 gly], 1.56[5H, brm, CHX3, #CH2 
gly], 1.97[2H, quin, 6CH2, gly, J=6.5Hz], 3.92[1H, brq, <a^ CH 
leu, J=8. 5Hz], 4.21[2H, m, NH2], 4.33[3H, m, a^ , <*3CH leu, 
orjCH gly], 4.95[2H, td, =CH2, J=16.0 (trans), 9.5 (cis), 
2.5Hz (gem)], 5.77[1H, m, -£H=], 6.94[1H, d, NH urethane, 
J=10.0Hz], 7.8, 8.0[3H, m and brt, NH amides, J=8.0Hz], 
9.10[1H, brs, NH].
^(DMSO); 21.34, 21.47, 21.54, 21.60, 22.87, 22.96[(CH3)2 
leu], 23.91, 24.00, 24.13[CH leu], 24.33[«5CH2 gly],
28.06[(CH3)3], 31.62, 32.88[r CH2 gly], 32.57, 32.73[/?CH2
gly], 40.51, 40.67, 40.84[CH2 leu], 50.57, 50.73,
51.18[ai,ar2,<*jCH leu], 52.74[or4CH gly], 77.91[-CO- 
urethane], 114.79[=CH2] , 138.24[-CH=] , 155.20[-C=O
urethane], 170.58, 171.29, 171.52, 171.61, 172.30[C=O
amide].
m/e (C.I.); 597[(M+1)\ 41%], 86[100].
Found:- C,60.6; H,9.61; N,13.9. C^H^N^O^ requires:- C,60.4; 
H,9.61; N,14.1%.
Attempted synthesis of cyclo-L-leucyl-L-leucyl-L-leucyl- 
D,L-{pentenyl)Qlycine.llt * (24)
Boc-Leu3-(pentenyl )Gly-0Me ---- ►
cyclo-Leu3-(pentenyl)Gly (24)




(22) (0.9788g, 1.64mM) Was dissolved in TFA/anisole 
(4cm* v/v) and stirred for lh at R.T. while protected by a 
CaClj drying tube. The solvent was removed in vacuo and the 
de-protected tetra-peptide was used without purification of 
characterisation as the TFA salt/ TFA.H2N-Leuj- 
(pentenyl)Gly-OMe, which was dissolved in DMF (16cm*) and 5 
drops of glacial acetic acid added. The solution was slowly 
added dropwise to pyridine (60cm*) heated to ca 65°C. The 
reaction mixture was allowed to stir at 65°C for 3 days. The 
solvents were removed in vacuo to leave a yellow solid 
which was chromatographed on silica gel (DCM/MeOH/ 
25:lv/v)/ to give the major product (0.5694g, 70%) which 
was not the cyclic peptide (24), but the linear tetra- 
peptide methyl ester which was unprotected at the amino 
end.
v iax(nujol); 3250, 3040 (NH str), 1750, 1690, 1650, 1630
(C=0 str), 1540cm'*.
<5g(DMSO); 0.85[18H, q, (CH3)2X3 leu, J=6.5Hz], 1.44[6H, m, 
CHjX3 leu, y CHj gly], 1.58[5H, brm, CHX3 leu, /9CH2 gly], 
2.00C2H, br quin, £CH2 gly, 5.5Hz], 3.61, 3.62[3H, sX2,
OCHj], 4.25[1H, brm, 4a^ CH gly], 4.34(/3H, brm, a^ , ct}, a^CK 
leu], 4.97[2H, tm, =CH2, J=17.0 (trans), 8.5 (cis), 1.0Hz 
(gem)], 5.77[1H, brm, -CH=], 7.84[2H, dX2, NH gly,
J=8.4Hz], 8.14, 8.19, 8.24[3H, dX3, NH amide, J=7.0, 6.5 
and 8.0Hz respectively].
m/e (C.I.); 496[(M+1)*-H, 15%], 368[15], 149[49], 86[100].
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Found:- C,62.6; H,9.46; N,10.2. C2gH^N<0< requires:- C,62.9, 
H,9.68; N,11.3%.
Method 2.
(23) (0.5552g, 0.9315mM) Was dissolved in TFA/anisole 
(8cm*, 5%v/v) and stirred for lh at R.T. under a CaClj
drying tube. The solvent was removed in vacuo and the de­
protected tetra-peptide was used without purification of 
characterisation as the TFA salt. TFA.HjN-Leuj- 
(pentenyl)Gly-OMe was dissolved in DMF (3.2cm*), treated 
with a  2M HCl solution in THF (4.7cm*) and cooled to -20°C 
when butyl nitrite (1.1cm*, 9.315mM) was slowly added
dropwise. The reaction mixture was stirred for a further 
5min and diluted with pre-cooled DMF (23cm*) when NMM 
(1.1cm*, 9.315mM) was slowly added dropwise. The stirred
mixture was allowed to warm to R.T. overnight, then the
*
solvents removed in vacuo and HjO (25cm ) added. The aqueous 
layer was extracted with EtOAc (50cm*) and the organic layer 
dried over MgSOj. T.L.C. analysis of the crude product 
indicated the formation of a multi-component mixture which 
was not chromatographed or characterised.
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Synthesis o f  t e r t - b u t y l o x Y c a r b o n v l - L - l e u c y l-L-leucyl-L-
leucyl -P. L-fpentenvl )glycine.^ ^  (25)
Boc-Leu3-(pentenyl )Gly-OMe ---- *
Boc-Leu3-(pentenyl )Gly-OH (25)
(22) (0.9702g, 1.63mM) Was dissolved in MeOH (13cm3) 
and cooled to 0°C when aqueous NaOH (1M, 5.0cm3, 1.5eq) was 
added dropwise, to give a precipitate. The suspension was 
stirred at 0°C for a further 3h when a further 5.0cm? of 
NaOH (5.0cm3) was added. The reaction mixture was stored at 
ca 5°C for ca 12h. The resultant clear solution was 
acidified with HCl (1M, 10.0cm3) to precipitate a solid 
which was filtered off, washed with water, dissolved in 
MeOH (25cm3), and stored over molecular sieves (type 3k) for 
24h to dry. The dissolved product was decanted, and MeOH 
was removed in vacuo to afford the product (25) as a white 
solid (0.9153g, 97%).
£g(DMSO); 0.84[18H, t, (CH3)2X3 leu, J=6.5Hz], 1.36[9H, s, 
(CH3)3], 1.43[6H, m, CH2X3 leu, y CH2 gly], 1.58[5H, m, CHX3 
leu, /8CH2 gly, J=6.5Hz],2,08[2H, quin, £CH2 gly], 3.95[1H, 
brq, <a^ CH leu, J=8.0Hz], 4.08[2H, brm, ct^f a^CH leu],
4.31[2H, br sex, <*4CH gly, J=8.0Hz], 4.94[2H, t, =CH2,
J=17.0 (trans), 10.0Hz (cis)], 5.72[1H, brm, -CH=],
6.92[1H, dd, NH urethane, J=8.0, 3.0Hz], 7.76, 7.85,
8.03[3H, d, q and brt respectively, J=7.5, 6.5 and 9.5Hz
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respectively].
£c(DMSO); 21.57, 21.67, 22.90, 23.03[(CH3)2X3 leu], 23.97, 
24.07, 24.20[CHX3 leu], 24.16, 24.33[<5CH2 gly],
28.09[(CH3)3], 31.17, 32.50[r CH2 gly], 32.86, 32.92[/3CH2
gly], 40.64, 40.87, 41.13[CH2X3 leu], 50.63, 51.25,
51 .54[<*j,<*2 ,£2t3CH leu], 52.29, 52.84[<*4CH gly], 77.91[-CO- 
urethane], 114.63[=CH2] , 138.08[-CH=], 155.20[-C=O
urethane], 171.16, 171.36, 171.52, 171.58[C=0 amide],
173.89, 173.98[C=0 carboxyl].
m/e (C.I.); 583[(M+1)*, 3%], 483[ (M+l)1-{CH3)3COCO, 5%],
327[(M+l)*-C17H3lN204, 20], 271[17], 227[16], 149[21],
130[14], 113[10], 98[10], 86[130-CO2, 100].
Synthesis of phenylnropyltriethylsilane.^ * (26)
C{H5-CH2-CH=CH2 + HSiEt3  r CjHj-(CH2)$-SiEt3 (26)
Method 1.
Allylbenzene (1.18g, 1.3cm*, lOmM) and triethylsilane 
(1.16g, 1.6cm*, lOmM, l.Oeq) were dissolved in
toluene/butan-2-ol (2cm*, 2:v/v) and treated with H^tClj 
catalyst, dissolved in toluene/butan-2-ol (ca 10’* mol per 
mol of allyl benzene). The reaction mixture was heated 
under reflux for 24h. The solvents were removed in vacuo 
and the crude product chromatographed on silica gel (pet 
ether) to afford the product (26) as an oil (2.47g, 53%).
Lit J.L. Spier, J.A. Webster and G.H. Barnes; J. Amer. Chem. 
Soc., 1974, 57, 974
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V MI(nujol); 3020, 3000 (Ar-H str), 2880 (C-H str), 1950- 
1740 (mono-substitution overtones), 1580, 1480, 1440, 1400, 
1370, 1340 (aromatic C=C str, CH2, CH; str), 710, 680cm’* 
(aromatic C-H).
£g(CDCl3); 0.50[ 6H, m, CHjCHjSi-], 0.90[9H, t, CH^CHjSi, 
J=8.0Hz], 1.59[2H, brm, y CH2], 1.81[2H, dd, /?CH2, J=6.5, 
1.5Hz], 2.55[2H, t, 6CH2, J=7.0Hz], 7.10-7.27[5H, m, Ar-H].
CDCLj) ; 3.34[CHj-CHjSi- ] , 7.43 [CHj-CHjSi ] , 11.29[ SCH2 ] ,
26.ll[y CH2], 40.25[/3CH2], 125.30, 125.59, 125.82, 126.66, 
128.18, 128.41[aromatic C=C].
m/e; no M4 or (M+l)4 ion present at 234 mass units; 205[M4- 
CjHj, 83%].
Found:- C,80.0; H,10.9. C^HjjSi requires:- C,79.9; H,ll.l%. 
Method 2.
Synthesis o£ (26) using Cp2PtCl2 as catalyst was 
performed by a similar method. Beginning with 2,36g of 
allylbenzene and 2.22g of triethylsilane, the yield of the 
desired product (26) was 2.85g (55%), and it was confirmed 
as being identical all respects to the product synthesised 
by Method 1.
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Synthesis of Me3-/’OSiMeJ>j-fOSiMer(CHj)3CgH57)5-OSiMe3.llit22 ( 27)







The siloxane polymer (3.1g, 45mM) and allyl benzene 
(3.45g, 0.03M) were dissolved in toluene/butan-2-ol (lcm*, 
2:lv/v) and treated with ^PtClg catalyst, dissolved in 
toluene/butan-2-ol (ca 10’* mol per mol of siloxane 
polymer). The reaction mixture was heated under reflux for 
48h while protected by CaCl2 drying tube. The progress of 
the reaction was monitored by observing the Si-H peak in 
the I.R. spectrum (ca 2130cm’*). Solvents were removed in 
vacuo and the clear oil chromatographed on silica gel 
(CHClj/pet ether, 5%v/v) to afford the product (27) as a 
clear oil (5.90g, 86%).
t> MI(nujol); 3040 (Ar-H str), 2940, 1590 (Ar, C=C str) , 1240 
(Si-CHj asym and sym str), 1100, 1000 (Si-O-Si asym str). 
£g(CDClj); 0.00[51H, brm, Me^SiO and SiMe], 0.48[10H, brm, 
Si-CHj], 1.58[10H, brm, SiCHj-CHj], 2.52[10H, brm, SiCH2CH2-
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CH2], 7.12[25H, Ar-H].
SQ{ CDClj); -3 . l[MeSiO] , 1.2[Me2SiO, 1.7[SiMe3], 17.3[Si-CH2],
25. [SiCH2-CH2], 39.5[SiCH2CH2-CH2]# 125.6, 128.2, 128.4,
142.6[Ar-H].
m/e; no H+ or (M+l)+ ion present at 1274 mass units; 
177{[OSi(CH3)(CH2)3C{H5]+, 30%}, 147{[Si(CH3)2OSi(CH3)3 ]*, 3}, 
73[(CH3)3SiO)\ 100].
Synthesis of Mej-{OSiMe2}s-{QSiMeroCH(CH3)CHjCHj1}f-OSiMe3. 
tU” (28)
Reaction of siloxane polymer [Me3Si-(OSiMe2)3-(OSiMeH)3-OSiMe3 
with butan-2-ol.
H, #•
CH3CH(OH)CH2CH3 + — <-0— i l ►y- ----- ► —<-0— Si^ 5-
CHgCHChgCHg
28
The siloxane polymer (l.Og, 1.5mM) was dissolved in 
toluene/butan-2-ol (30cm3, 2:lv/v) and treated with H2PtClj 
catalyst, dissolved in toluene/butan-2-ol (ca 10“* mol per 
mol of siloxane polymer). The reaction mixture was heated 
under reflux while protected by a CaCl2 drying tube for 24h. 
The solvents were removed in vacuo and the oil 
chromatographed on silica gel (CHCl3/pet ether l:4v/v) to 
afford the major product (28) as a clear oil (0.56g, 37%).
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t> M1(nujol); 2160 (Si-H str), 1255 (Si-CH3 str), 1050 (Si-O- 
Si br aliphatic peak), 800cm"1 (Si-CH3).
£g(CDCl3); 0.10[51H, brm, CHjSiO, SiCHj], 0.87[15H, t, Cgj- 
CHj, J=7.5Hz], 1.16[15H, m, CHj-CH], 1.46[10H, brm, 
CHj-CHj], 3.91[5H, brm, -CH-].
6^(CDClj); -3.25[CH3SiO], 0.94[ (CH3)2SiO] , 1.75[ (CH3)3SiO,
9.96[CH3-CH2], 22. 93[CH3-CH] , 32.01[CH3-CH2] , 69. 64[SiO-CH] . 
m/e; no M+ or (M+l)f ion present at 1374 mass units; 
73((CH3)3SiJ
Synthesis of Me3-SifOSiMej)j-fOSiMefcyclo-Leu-(allyl )Oly7>- 
OSiMeylit 22 (29)




The cyclo-peptide (5mg, 0.02mM) and the siloxane
polymer (260Mg, 0.38mM) was suspended in toluene/MeCN
(60cm^, 2:lv/v), treated with HjPtClg catalyst, dissolved in
toluene/MeCN (ca 10’* mol per mol of cyclic peptide), and 
heated at 80-90^C for 6 days, with the addition of HjPtClg 
catalyst every 24h. The solvents were removed in vacuo and 
the residue chromatographed on silica gel (MeOH/CHClj, 
2%v/v) to afford 54mg of the major product which was weakly 
UV active and unreactive towards KMnO^ (white spot) 
indicator.
6c(DMSO); 0.9[Me3SiO], 1.6[Me2SiO], 1.7[MeSiO], 17.9[SCH2 
gly], 21.4, 23.1[[(CH3)2 leu], 24.1[CH leu], 29.7[/3CH2 gly], 
35.3[y CH2 gly], 42.4[CH2 leu], 53.3[<*CH gly], 54.6[**CH 
leu], 169.1[C=0].





(13) (0.275g, 1.18mM) Was suspended in toluene/MeCN
(8cm^ , 4:lv/v, degassed under N2), and under N2, HSiEt3
(0.375cm*, 2.36mM, 2eq) was added. Cp^tC^ catalyst,
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dissolved in toluene/MeCN (ca 10’* mol per mol of cyclic 
peptide) was added, the reaction tube sealed, and then 
heated to 150°C. After 24h the tube was opened under N2 gas 
and a further volume a catalyst was added. The tube was re­
sealed and heated for a further 24h after which, the tube 
was allowed to cool to R.T., and MeOH was added to the 
solidified solution. The solvents were removed in vacuo to 
leave a solid which was chromatographed on silica gel 
(DCM/MeOH, 9:lv/v) to afford the product (30) (0.3344g, 
87%, m.p. 241-242°C. ) .
[<*]„= -8.2 (c=0.135, MeOH).
«> MI(nujol); 3270, 3040 (NH str), 1650 (C=0 str), 1320, 
1140, 1080, 1000, 820, 720cm’1.
6jj(DMS0); 0.47[8H, q, CHj-CHj-SiXS, «5CH2 gly, J=8.0Hz],
0.89[15H, Ca3-CH2SiX3, (CH3)2 leu, J=6.5, 8.5Hz], 1.31[2H, m, 
Y CH2 gly], 1.53[2H, dt, CH2 leu, J=7.0, 1.5Hz], 1.68[2H, m, 
/3CH2 gly], 1.78[1H, m, CH leu], 3.68[1H, brdt, aCH leu, 
6.5, 2.0Hz], 3.83[1H, brt, aCH gly, J=5.0Hz], 8.12[1H, brs, 
NH gly], 8.15[1H, brd, NH leu, J=2.5Hz].
5c(DMSO); 2.95[CH3-CH2-Si], 7 . 47[CH3-CH2Si ] , 10.96[aCH2 gly], 
18.49[r CH2 gly], 21.92, 22.93[(CH3)2 leu], 23.61[CH leu], 
35.97[i9CH2 gly], 42.03[CH2 leu], 52.90[aCH leu], 53.58[otCH 
gly], 168.21, 168.92[C=0],
m/e (C.I.); 327[(M+1)\ 7%], 297(M+1)*-CH3CH2, 57],
213[(M+l)*-SiEt3, 100], 170[19], 156[213-C4H9, 49].
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Synthesis of cvclo-L-leucine-D-(ventenvl)gylcine triethyl




Method 1. Under nitrogen gas at atmospheric pressure.
(18) (SO.Sing, O.21mM0 Was suspended in toluene/MeCN 
(2cm*, 3:lv/v)# HSiEt^ (0.17cm*, 1.67mM, 5eq) and treated 
with Cp2PtCl2 catalyst, dissolved in toluene/MeCN (ca 10"* 
mol per mol of cyclic peptide). The reaction was heated to 
80°C under an atmosphere of ^  A further volume of catalyst 
was added 24h later and the reaction continued for a 
further 32 days. The reaction mixture was allowed to cool 
to R.T. and MeOH was added to dissolve the solidified 
solution. The solvents were removed in vacuo and the crude 
product chromatographed on silica gel (EtOAc/pet ether, 
l:4->EtOAc) to afford the product (31) as a white solid 
(33.7mg, 45%).
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Method 2. Under nitrogen gas in a pressurised reaction
tube.
(18) (0.0488g, 21mM) Was suspended in toluene/MeCN
(2cm^ , 3:lv/v, degassed under Nj), HSiEtj (0.16cm^, 1.03mM, 
5eq) and treated with CpjPtC^ catalyst, dissolved in 
toluene/MeCN (ca 10’* mol per mol of cyclic peptide). The 
reaction tube was sealed and heated to 150°C for 7 days, 
after which the tube was re-opened under N2 and a further 
volume a catalyst was added. The tube was re-sealed and 
heated for a further 7 days. The reaction tube was allowed 
to cool to R.T. and MeOH was added to the solidified 
solution. The solvents were removed in vacuo to leave a 
solid which was chromatographed on silica gel (DCM/MeOH, 
45:lv/v) to afford the product (31) (0.0354g, 48%).
The above experiment was repeated as described above 
(Method 2) except that the reaction tube was heated for 48h 
at lSO^C with an addition a a further volume of catalyst 
after 24h. The yield of the product (31) was 31%.
m.p. 207-209*^ 0.
[e]D= +1.9 (c=0.271, MeOH).
o^nujoD,* 3270, 3040 (NH str), 1650 (0=0 str), 1330, 1120, 
1080, 1000, 960, 810, 720cm’1.
6h(DMSO); 0.47 [8H, qd, CH3-CH2“SiX3, {CH2 gly, J=8.0Hz], 
0.87 [15H, m, CHj-CH^i, (CH3)2 leu], 1.27[6H, m, yCH2, 5CH| , 
€CHj gly], 1.53[2H, dt, CH2 leu, J=7.5, 1.5Hz], 1.64[2H, brm, 
|JCH2 gly], 1.79[1H, dq, CH leu, J=7.0Hz], 3.70[1H, brdt, aCH 
leu, J=6.5, 2.5Hz], 3.83, brdd, aCH gly, J=5.0Hz], 8.08[1H,
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brs, NH gly], 8.15[1H, d, NH leu, J=2.5Hz].
^.(DMSO); 2.92CCH3-CH2--Si], 7 . 39[CH3-CH2Si ] , 10.76[{CH2 gly], 
21.96, 22.90[(CH3)2 leu], 23.29, 23.48[5CH2, €CH2 gly],
23.58[CH leu], 31.75[yCH2 gly] 33.08[3CH2 gly], 42.03[CH2 
leu], 52.87[<tCH leu], 53.61[ftCH gly], 168.11, 168.82[C=0]. 
m/e (C.I.); 355[(M+1)*, 8%], 325[ (M+l^-C^Hj, 29], 279[325- 
CjHj, 22], 167[23], 149[100], 113[23], 71[20].
Synthesis of cyclo-L~leucine-D-(allyl)alycine dichloro- 








(13) (17.2mg, 0.082mM) Was dissolved in dry
toluene/DCM (30cm3, 2:lv/v) and treated with H^tClj
catalyst, dissolved in toluene/MeCN (ca 10"* mol per mol of 
cyclic peptide). After ca 15min stirring, HSiMeCl2 (0.1cm , 
0.97mM, 12eq) was slowly added dropwise. The reaction
mixture was slowly stirred at R.T. for 48h and then heated
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under reflux for 30min. The solvents were removed in vacuo 
and excess HSiMeClj was removed by azeotropic distillation 
with DCH. The product (32) readily hydrolyses on exposure 
to moist air. NMR spectroscopic data only was obtained 
due to handling difficulties. Subsequent syntheses of this 
compound were used at once without purification or 
characterisation.
«„(CD£12); 0.00-0.04[15H, brm, Si-CHj], 0.82[6H, brm, (CH3)2 
leu], ca 1.0-2.0[9H, brm, CH2, CH leu, flCH2, yCH2, $CH2 gly], 
4.23[2H, brm, aCH leu, ftCH gly], 7.65[1H, m, NH leu], 
7.67[1H, m, NH gly].
Preliminary investigation into the derivatisation of silica 
gel based supports.1*1* 3 (CSP 1)
CSP 1
(13) (104.4mg, 0.50mM) Was suspended in dry DCM (50cm3) 
and treated with H2PtClg catalyst, dissolved in 
toluene/MeCN, (ca 10"* mol per mol of cyclic peptide). The
Lit *3:- W.H. Pirkle, T.C. Pochaphsky, G.S. Mahler, D.E. Corey, 




solution was stirred at R.T. for ca 5min and then HSiMeClj 
(0.052cm^, 0.5mM, l.Oeq) was added dropwise. The reaction 
mixture was stirred at R.T. for a further 30min and heated 
under reflux under an atmosphere of dry N2 for 48h. The 
solution was transferred to a suspension of silica gel 
(l.Og 12pm, 90% ± 7pm) in toluene (lOcrn^ ), TEA (7.0cm?) was 
added dropwise and the suspension stirred at R.T. for lh 
and then at reflux for 3h. The solvents were removed by 
distillation at aspirator pressure, and the treated silica 
heated at 125^C f or 24h in vacuo. The beige coloured silica 
was washed with MeOH, MeCN, MeCN/HjO (l:lv/v), I^ O and MeOH 
to remove un-reacted cyclic peptide and the silica was 
finally dried at 40°C in vacuo. An untreated sample of 
silica was similarly washed for comparison.
Corrected elemental analysis for the treated silica gavel­
e t . 37; H,0.67; N,0.06%; giving a loading of 0.32mmol/g and 
0.30mMg"* of silica gel based on the carbon and hydrogen 
analyses respectively.
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Treatment of hi ah performance liquid chromatography silica
q el with cyclo-L-leucine-L-(al1yl)qlycine and cyclo-L- 
leucine-L-fpentenvl Iqlycine.^ ^* (CSP 2) and (CSP 3)
,S 1 -f CHgSI
/ 0
(14) (0.525g, 2.5mM) Was suspended in dry DCM (100cm*) 
and the reaction vessel blanketed with Nj before treating 
with I^ PtClj catalyst, dissolved in toluene/MeCN (ca 10-4 
mol per mol of cyclic peptide). The suspension was stirred 
for ca 15min and then HSiMeCl2 (0.26cm*, 2.5mM, l.Oeq) was 
added. The reaction mixture was heated under reflux for 
24h. A further volume of HSiMeCl2 was added and the 
reaction continued for a further 24h. DCM was distilled off 
and DCM (100cm ) was added as a "chaser". The volume was 
reduced by ca 10cm and the solution transferred to a 
toluene (150cm*) suspension of silica gel (5.0g), which had 
been oven dried for 48h at 130°C. The suspension was 
blanketed with Nj and the suspension heated under reflux for 
3 days. The solvents were distilled off leaving an off 
white powder which was oven cured at 100°C for 24h. The 
silica was washed three times with MeCN and then with I^O 
and once with MeOH before oven drying at 65°C for 24h. An 
untreated sample of silica gel was similarly washed for
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comparison. The treated silica gel weighed 5.55g.
Corrected elemental analysis for the treated silica 
gel gave:- C,4.93; H,0.66; N,0.95%; giving a loading of 
0.34, 0.30 and 0.34mMg’* of silica gel based on the carbon, 
hydrogen and nitrogen analyses respectively. An internal 
check for the correct C:H:N ratio gave:- 7.47:1.00:1.44. 
1^2H22N2 re<3uires:" 6.55:1.00:1.27.
Treatment of silica gel (5.0g) with (19) (0.595g, 
0.25mM) was achieved similarly. The silica gel weighed 
5.63g after derivatisation.
Corrected elemental analysis for the treated silica 
gel gave:- C,4.82; H,0.62; N,0.75%; giving a loading of 
0.29, 0.24, 0.27mMg‘* of silica gel based on the carbon, 
hydrogen and nitrogen analyses respectively. An internal 
check for the correct C:H:N ratio gave:- 7.77:1.00:1.21. 
CUH!6N2 requires:- C,6.46; H,1.00; N,1.08.
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Table A.1-A.5. Supplementary data of anisotropic factors, 
and hydrogen poistions for cyclo-L-leucine-D-(allyl)glycine 
(13).
Table A.I. Fractional atomic co-ordinates and thermal 
parameters (A) for cyclo-L-leucine-D-(allyl)glycine (13),
Atcm X y z Uiso or Ueq (***)
01 0.55977 0.0590 -0.4901(6) 0.37(4) ***
02 0.4375(7) -0.0061(9) -0.0009(6) 0.039(4) ***
N1 0.4670(8) -0.1094(12) -0.3419(7) 0.032(4) **♦
N2 0.5112(8) 0.1676(11) -0.1541(6) 0.032(4) ***
Cl 0.5217(9) 0.0436(14) -0.3805(8) 0.026(5) ***
02 0.5425(10) 0.2017(15) -0.2869(8) 0.030(4) ***
C3 0.4576(9) 0.0149(13) -0.1169(8) 0.026(5)
C4 0.4013(9) -0.1316(13) -0.2216(7) 0.026(4) ***
C5 0.7238(11) 0.2908(13) -0.2585(9) 0.042(5) ***
06 0.8740(12) 0.1716(16) -0.1821(11) 0.053(6) ***
C7 1.0008(13) 0.2144(18) -0.0658(11) 0.064(7) ***
C8 0.1959(10) -0.1416(14) -0.26754(9) 0.032(5) ***
C9 0.1121(10) -0.3020(14) -0.3534(9) 0.040(5) ***
C10 -0.0887(11) -0.2879(17) -0.3922(11) 0.055(6)
C11 0.1739(14) -0.4704(15) -0.2793(12) 0.064(7)
-359-
Table A.2. Fractional atomic co-ordinates for the hydrogen






























Table A.3. Anisotropic thermal parameters for cylco-L
Ieucine-D-(allyl)glycine (13),
Itoi Oil 022 033 023 013 012
01 0.045(4) 0.034(4) 0.032(4) 0.000(3) 0.012(3) -0.003(3)
02 0.054(4) 0.033(4) 0.031(4) -0.002(3) 0.015(3) -0.003(3)
11 4.031(5) 0.030(4) 0.035(4) 0.002(4) 0.015(3) -0.004(3)
12 1.041(4) 0.022(4) 0.025(4) 0.005(4) 0.015(3) -0.004(3)
Cl 0.022(4) 0.034(5) 0.022(5) 0.004(4) 0.006(3) 0.005(4)
C2 0.035(4) 0.025(4) 0.031(4) -0.004(4) 0.013(3) -0.002(4)
C3 0.024(40 0.031(5) 0.022(5) 0.005(4) 0.005(3) 0.006(4)
Cl 0.024(4) 0.024(4) 0.030(4) 0.003(4) 0.000(3) -0.003(4)
CS 0.042(5) 0.044(5) 0.041(5) -0.003(4) 0.016(4) -0.014(4)
C( 0.034(5) 0.052(5) 0.043(2) -0.013(5) 0.014(5) 0.000(5)
Cl 0.055(4) 0.040(2) 0.052(2) 0.015(2) 0.015(5) 0.001(6)
C8 0.030(4) 0.032(5) 0.034(4) 0.002(4) 0.002(3) 0.000(4)
Cl 0.042(5) 0.031(5) 0.045(5) -0.003(5) 0.015(4) -0.008(4)
CIO 0.035(5) 0.055(5) 0.023(2) -0.012(5) 0.004(4) •0.010(5)
cu 0.053(2) 0.032(5) 0.031(3) -0.010(4) 0.013(6) -0.015)
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Table A.4. Internulcear distances (A) for cylco-L-leucine 
D-(allyl)glycine.
01...H102 2.91 1 -1.0 0.0 0.0
01...Nl 3.00 2 1.0 -1.0 -1.0
01...H21 2.64 2 1.0 0.0 -1.0
01...H52 2.98 2 1.0 0.0 -1.0
01...H91 2.76 2 1.0 -1.0 -1.0
02...N2 2.88 2 1.0 0.0 0.0
02...H41 2.56 2 1.0 -1.0 0.0
02...H51 2.79 2 1.0 0.0 0.0
02...Hill 2.72 2 1.0 -1,0 0.0
C1...H101 2.94 2 0.0 -1.0 -1.0
H21...C11 2.99 1 0.0 -1.0 0.0
C7...H113 2.99 1 -1.0 -1.0 0.0
Table A.5. Intramolecular distances (A) for cylco-L 
leucine-D-(allyl)glycine.
01...Nl 2.26 01...C2 2.36
01...H21 2.65 01...C5 2.89






















































































































































A P P E N D I X
-365-
T W O
Fig Al. NMR (CDClj)
s p e c t r u m  of t - 
b u t y l o x y c a r b o n y l  - L - 
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Fig A2. AH NMR (DMSO) 





Fig A3. 'lH NMR (CDClj) 
s p e c t r u m  of t - 
butyl o x y c a r b o n y 1 - L - 





Fig A4. :H NMR (CDCl 3) 
spectrum of cyclo-L- 






Fig A5. ]H 2D COSY NMR (CDClj) 
spectrum of t-butyloxycarbonyl-L- 
leucine-D,L-(pentenyl)glycine methyl 
ester.
Fig A6. :H NMR (CDCl 3) 
s p e c t r u m  of t - 







Fig A 7. 2D COSY NMR (CDClj)
spectrum of t-butyloxycarbonyl-L-
__Z^Wv.




Fig A8. lK NMR (DMSO) 






Fig A9. AH NMR (DMSO) 
spectrum of cyclo-L- 
1 e u c i n e - D -  
( p e n t e n y l  ) g 1 y c i n e  
triethyl silane.
iw-4AI
Fig A10. AH 2D COSY NMR (DMSO) 
spectrum of cyclo-L-1eucine-D-
(pentenyl)glycine.
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